DE102012222764A1 - Cosmetic composition, useful for deodorization and protection against long-lasting body odor, comprises, in a cosmetic carrier, steroid consisting of 16-androstenedione and estrene steroids, and phospholipid - Google Patents

Abstract

Cosmetic composition comprises, in a cosmetic carrier, (a) 1x 10 -> 7> to 1x 10 -> 2> wt.% of at least one steroid consisting of 16-androstenedione (I) and estrene steroids (II), and (b) 0.01-7.5 wt.% of at least one phospholipid. Cosmetic composition comprises, in a suitable cosmetic carrier, (a) 1x 10 -> 7> to 1x 10 -> 2> wt.% of at least one steroid consisting of 16-androstenedione of formula (I) and estrene steroids of formula (II), and (b) 0.01-7.5 wt.% of at least one phospholipid. R1 : oxo, OH, 1-6C-alkoxy, acyloxy or benzoyloxy; R2 : H, OH, 1-6C-alkyl, hydroxy-1-6C-alkyl, 1-6C-alkoxy-1-6C-alkyl, 1-6C-alkoxy, acyl, acyloxy, acyl-1-6C-alkyl or acyloxy-1-6C-alkyl; a, b : dashed lines for alternative location of a double bond; R4 : oxo, H, hydroxy, 1-6C-alkyl, sulfate, 3-cyclopentylpropionate group or acetate; R5 : H or hydroxy; R6 : H, 1-6C-alkyl, benzoyl, 3-cyclopentylpropionate, acetyl, 1-6C-acyl or sulfate; and c : dashed line for an optional double bond. An independent claim is included for deodorization, comprising applying the cosmetic composition to the skin and then removing the composition by washing or removing the make-up or showering for at least 30 minutes up to several hours. [Image].

Description

The present application relates to skin-applied cosmetic products for improving the emotional well-being and long-lasting protection against body odor, which contain as active ingredient at least one selected pheromone and at least one phospholipid. Furthermore, the present application relates to the use of pheromones and phospholipids and optionally at least one perfume to improve the emotional well-being and long-lasting protection against body odor.

Washing, cleansing and caring for one's own body is a fundamental human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. In addition to the basic functions - skin cleansing and subsequent conditioning of the skin with fats and moisturisers - modern skincare products should also meet specific consumer requirements. Thus, the state of the art knows anti-wrinkle agents with active ingredients intended to slow down certain processes of skin aging, sunscreens with UV-absorbing filter substances, and skin lighteners which contain active ingredients which break down the skin's own melanin. Finally, in the prior art antitraspirates or deodorizing products are known which influence the body's perspiration in various ways and lead at least to a reduction of the unpleasant odor. These agents are formulated in a variety of dosage forms, mostly as (possibly oil and fat-free) gel, as a cream, in stick form, as a liquid or gel roll on application, as a soaked flexible substrate (anti-pimple pad), but also as a powder or spray. The consumer also wants an emotional effect that can be experienced by him, a feeling of "feeling good". This is insufficiently fulfilled by today's cosmetic compositions for the consumer.

It is an object of the present invention to provide topical cosmetic compositions for the effective treatment of the skin, in particular compositions for cleaning, care and deodorization, for the prophylaxis, reduction, elimination and / or alleviation of bacterial, fungicidal and / or viral infections and yet free of side effects and provide as gentle as possible to the skin, based on safe and legally authorized active ingredients and also give the consumer a soothing, harmonizing, invigorating, stimulating, brightening, attractiveness-enhancing after-application.

From the EP 562 843 B1 For example, compositions containing pheromones are known. In this context, the use of pheromones in perfume compositions and cosmetics has already been proposed. The term pheromone is understood to mean, even in very low concentrations, effective signaling substances which serve to chemically communicate organisms of a species. Pheromones occur in the communication systems of nearly all organisms from unicellular organisms to mammals and play a prominent role as a sex attractant.

In US 5,272,134 and US 5,278,141 describes the use of certain human pheromones of the 16-androstenoid and estrogen types in perfume compositions. Possible applications include personal care products as well as household and industrial products.

The use of these human pheromones in cosmetic products is interesting in that they not only impart a characteristic odor, but can also bind in their function as signaling substance to the corresponding receptors of the human organism. The corresponding agent or its user transmits to other people, in particular the people of the respective other sex, targeted natural signals that can influence the assessment of the attractiveness of the agent or of the user. A disadvantage of the use of these pheromones, however, is that their inherent odor is generally perceived as rather unpleasant, such as the WO 2004/009051 A2 can be seen, which deals with ways to prevent by suitable perfume ingredients just the natural formation of these pheromones.

However, none of these documents describes compositions containing the active ingredient combination of pheromones and phospholipids described here and their enhanced action with regard to protection against body odor.

A simple increase in the amount of perfume oils does not lead to the desired goal. The increase causes the opposite effect. Deratige compositions with a high amount of perfume oils are described by the consumer as unpleasant and way too intense. Furthermore, by too high Amount of perfume oils the compatibility are adversely affected. For deodorization, aluminum salts are often used to achieve long-lasting deodorization and long-lasting protection against body odor. Many consumers are increasingly sensitive to aluminum salts, causing skin irritation. Deodorants without aluminum salts and deodorants with a high content of aqueous alcoholic carriers therefore lack sufficient and long-lasting protection against body odor.

Surprisingly, it has now been found that cosmetic agents containing in a cosmetically acceptable carrier pheromones and phospholipids and in a preferred embodiment, at least one perfume are excellent for deodorizing the consumer on the one hand long-lasting use of the agent and protect it from body odor and on the other hand him to give him the pleasant, soothing, harmonizing, invigorating, stimulating, uplifting, attractive-enhancing feeling he expected.

• a) 1 × 10^–7 bis 1 × 10^–2 Gew.-% mindestens eines Steroids ausgewählt aus – 16-Androstensteroiden der Formel (I)
  
  wobei R¹ für eine Oxogruppe, eine Hydroxygruppe, eine C₁-C₆-Alkoxy-, eine Acyloxy-, oder eine Benzoyloxygruppe steht, R² für Wasserstoff, eine Hydroxygruppe, eine C₁-C₆-Alkyl-, Hydroxy-C₁-C₆-Alkyl-, C₁-C₆-Alkoxy-C₁-C₆-Alkyl-, C₁-C₆-Alkoxy-, Acyl-, Acyloxy-, Acyl-C₁-C₆-Alkyl- oder Acyloxy-C₁-C₆-Alkyl-Gruppe steht, und die gestrichelten Linien a und b für alternative Stellen einer Doppelbindung stehen, und – Estrensteroiden der Formel (II)
  
  wobei R⁴ für eine Oxogruppe, Wasserstoff, eine Hydroxygruppe, eine C₁-C₆-Alkylgruppe, Sulfat, eine 3-Cyclopentylpropionatgruppe oder Acetat steht, R⁵ für Wasserstoff oder eine Hydroxygruppe und R⁶ für Wasserstoff, eine C₁-C₆-Alkylgruppe, eine Benzoyl-, 3-Cyclopentylpropionat-, Acetyl-, C₁-C₆-Acyl- oder eine Sulfatgruppe steht, und die gestrichelten Linien c für eine fakultative Doppelbindung steht, und
• b) mindestens 0,01 Gew. % bis zu 7,5 Gew.% bezogen auf das Gesamtgewicht der Zusammensetzung mindestens eines Phospholipides.

A first subject of the present invention are therefore cosmetic compositions containing in a cosmetically acceptable carrier

• a) 1 × 10 ^-7 to 1 × 10 ^-2 wt .-% of at least one steroid selected from - 16-Androstensteroiden of formula (I)
  
  wherein R ^{1 is} an oxo group, a hydroxy group, a C ₁ -C ₆ alkoxy, an acyloxy, or a benzoyloxy group, R ^{2 is} hydrogen, hydroxy, C ₁ -C ₆ alkyl, hydroxyC C ₁ -C ₆ -alkyl, C ₁ -C ₆ -alkoxy-C ₁ -C ₆ -alkyl, C ₁ -C ₆ -alkoxy, acyl, acyloxy, acyl-C ₁ -C ₆ -alkyl- or acyloxy-C ₁ -C ₆ -alkyl group, and the dashed lines a and b represent alternative sites of a double bond, and - Estrensteroiden of formula (II)
  
  wherein R ^{4 is} an oxo group, hydrogen, hydroxy, C ₁ -C ₆ alkyl, sulfate, 3-cyclopentylpropionate or acetate, R ^{5 is} hydrogen or hydroxy and R ^{6 is} hydrogen, C ₁ -C ₆ -Alkyl group, a benzoyl, 3-cyclopentylpropionate, acetyl, C ₁ -C ₆ acyl or a sulfate group, and the dashed lines c is an optional double bond, and
• b) at least 0.01% by weight up to 7.5% by weight, based on the total weight of the composition of at least one phospholipid.

The pheromone used are the abovementioned 16-androsten steroids of the formula (I) and / or estrogens of the formula (II).

In this case, the radical R ^{1 is} an oxo group, ie an oxygen atom which, unlike the schematic representation of the attachment of the radical R ¹ in the formula (I), is attached via a double bond to the ring system, a hydroxyl group, a C ₁ -C ₆ - Alkoxy, an acyloxy or benzolyoxy group and R ^{2 is} hydrogen, hydroxy, C ₁ -C ₆ alkyl, hydroxyC ₁ -C ₆ alkyl, C ₁ -C ₆ alkoxy C ₁ -C ₆ -alkyl, C ₁ -C ₆ -alkoxy, acyl, acyloxy, acyl-C ₁ -C ₆ -alkyl or acyloxy-C ₁ -C ₆ -alkyl group. Examples of suitable C ₁ -C ₆ -alkoxy groups include methoxy, ethoxy, propoxy, butoxy, pentoxy and hexyloxy. Suitable acyloxy groups are in particular groups which are derived from the corresponding C ₁ -C ₆ -carboxylic acids, for example formyloxy, acetoxy or propionoxy. Examples of suitable C ₁ -C ₆ -alkyl groups are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl and hexyl, suitable hydroxy-C ₁ -C ₆ -alkyl groups hydroxymethyl, α-hydroxyethyl, β-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxybutyl, 2-hydroxybutyl, 3-hydroxybutyl, 4-hydroxybutyl, 1-hydroxypentyl, 2-hydroxypentyl, 3-hydroxypentyl, 4-hydroxypentyl, 5-hydroxypentyl, 1- Hydroxyhexyl, 2-hydroxyhexyl, 3-hydroxyhexyl, 4-hydroxyhexyl, 5-hydroxyhexyl and 6-hydroxyhexyl, suitable C ₁ -C ₆ -alkoxy-C ₁ -C ₆ -alkyl groups methoxymethyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, Ethoxymethyl, ethoxyethyl, ethoxypropyl, ethoxybutyl, ethoxypentyl, ethoxyhexyl, propoxymethyl, propoxyethyl, propoxypropyl, propoxybutyl, propoxypentyl, propoxyhexyl, butoxymethyl, butoxyethyl, butoxypropyl, butoxybutyl, butoxypentyl, butoxyhexyl, pentoxymethyl, pentoxyethyl, pentoxypropyl, pentoxybutyl, pentoxypentyl, pentoxyhexyl, Hexyloxymethyl, hexyloxyethyl, hexyloxypropyl, hexyloxybutyl, hexyloxypentyl and hexyloxyhexyl.

Preferably, such 16-Androstensteroide of formula (I) are used, the radical R ^{1 is} an oxo group, a hydroxy group, a methoxy, an acetoxy, a proprionoxy or a Benzoyloxygruppe, particularly preferably those whose radical R ^{1 is} an oxo group or a hydroxy group.

Furthermore, 16-Androstensteroide of formula (I) are preferred, the radical R ^{2 is} hydrogen, a hydroxy group, a methyl, ethyl, n-propyl, iso-propyl, methoxy or ethoxy group, particularly preferably those , whose radical R ^{2 is} hydrogen or a methyl group. Particular preference is given to using those 16-androsteno-steroids of the formula (I) whose radicals R ¹ and R ^{2 represent} the preferred or particularly preferred groups mentioned.

A most preferred pheromone is 4,16-androstadien-3-one, which is represented in formula (III).

Preferred Estrensteroide are compounds of formula (II), wherein R ^{4 is} an oxo group, a hydroxy group or hydrogen.

Also preferred are Estrensteroide of formula (II), wherein R ^{5 is} hydrogen or a hydroxy group, and / or wherein R ^{6 is} hydrogen.

Particularly preferred estrogens are compounds of the formula (II) in which R ⁴ , R ⁵ and R ^{6 have} the abovementioned preferred meanings. Particular mention may be made of 1,3,5 (10) estriene-3,17β-diol, 1,3,5 (10) estriene-3,16α, 17β-triol, 1,3,5 (10) estratriene 3-ol-17-one and 1,3,5 (10), 16-estratetraen-3-ol. Very particular preference is given to 1,3,5 (10), 16-estratetraen-3-ol.

In a preferred embodiment, the compositions according to the invention comprise a mixture of at least one 16-androstene steroid of the formula (I) and at least one estrogen steroid of the formula (II), where again 16-androstenoids of the formula (I) and estrogens of the formula (II) according to the above Embodiments are preferred and particularly preferred.

Most preferably, the composition contains a mixture of 4,16-androstadien-3-one and 1,3,5 (10), 16-estratetraen-3-ol.

The agents according to the invention contain the steroid or the steroid mixture in an amount of from 1 × 10 ^-7 to 1 × 10 ^-2 % by weight, preferably in an amount of from 1 × 10 ^-4 to 5 × 10 ^-3 % by weight, particularly preferably in an amount of 3 × 10 ^-4 to 1 × 10 ^-3 wt .-%, each based on the total cosmetic agent, wherein in the event that the cosmetic agent contains propellant, this is disregarded. If a mixture of different steroids is used, the amounts given refer to the sum of the steroids used, it being possible for the ratio of the various steroids with one another to be varied freely.

If the composition comprises a mixture of at least one 16-androstene steroid of the formula (I) and at least one estrogen steroid of the formula (II), 16-androstene steroid and estrogen steroid are preferably used in amounts such that the weight ratio of the sum of the 16-androstene steroids used Sum of Estrensteroide used is 1: 100 to 100: 1, preferably 1:10 to 10: 1.

The ingredient b) according to claim 1 is a phospholipid. As the phospholipid, both natural and synthetic phospholipids are useful. As phospholipids in particular compounds of the formula (phosphol-I) can be used.

In the formula (phosphol-1), y is an integer of 0 to 2, x is an integer of 1 to 3, provided that the sum of x and y is 3.

In the phospholipids of the formula (phosphol-1), furthermore, M is hydrogen, one equivalent of an alkali or alkaline earth metal cation, an ammonium cation or an alkyl radical having 1 to 4 carbon atoms, which is optionally substituted by one or more hydroxy groups. Particularly preferred are compounds in which M is a sodium cation.

Furthermore, B in the formula (Phosphol-I) of the phospholipids to be used according to the invention is one equivalent of a physiologically tolerated anion. As the anion, e.g. Chloride, bromide, iodide, sulfate, perchlorate, tetrafluoroborate, tetraphenylborate and tetrachlorozincate. Preferably, the chloride ion.

in der z für eine ganze Zahl von 1 bis 4, insbesondere für 3, steht und R¹ und R² unabhängig voneinander für einen C₁- bis C₄-Alkylrest stehen, der gegebenenfalls mit einer oder mehreren Hydroxygruppe(n) oder einer Acylgruppe substituiert ist. R in the formula (phosphol-1) is a radical of the formula (II)

in which z is an integer from 1 to 4, in particular 3, and R ¹ and R ² independently of one another are a C ₁ - to C ₄ -alkyl radical which is optionally substituted by one or more hydroxy group (s) or an acyl group is substituted.

A represents, according to the invention, one of the moieties -O-CH ₂ -CH ₂ -CH ₂ -, -O-CH ₂ -CH ₂ - or -O-CH ₂ -CHOH-CH ₂ -, where the moiety is -O-CH ₂ -CHOH-CH ₂ - is particularly preferred.

• (a) einen verzweigten oder unverzweigten, gesättigten C₈- bis C₁₈-Acylrest oder
• (b) einen verzweigten oder unverzweigten, einfach oder mehrfach ungesättigten C₈- bis C₁₈-Acylrest.

The radical R ³ stands for

• (a) a branched or unbranched, saturated C ₈ to C ₁₈ acyl radical or
• (B) a branched or unbranched, mono- or polyunsaturated C ₈ - to C ₁₈ acyl radical.

Particularly preferred saturated radicals R ³ are the radical of stearic acid and also the radicals of the mixture of the fatty acids which are obtained from coconut oil.

A particularly preferred unsaturated radical R ³ is the radical of linoleic acid.

Examples of the C ₁ - to C ₄ -alkyl groups mentioned as substituents in the compounds according to the invention are the groups methyl, ethyl, propyl, isopropyl and butyl. Ethyl and methyl groups are preferred alkyl groups. Very particular preference is given to methyl groups. Very particularly preferred phospholipids of the formula (phosphol-1) are the substances known under the INCI names linoleneamidopropyl PG-dimonium chlorides phosphates, cocamidopropyl PG-dimonium chlorides phosphates and stearamidopropyl PG-dimonium chlorides phosphates. These are sold, for example, by the company Mona under the trade names Phospholipid ^EFA® , Phospholipid ^PTC® and Phospholipid ^SV® . Another manufacturer is the company Croda with the product Arlasilk ^® phospholipid PTC Furthermore, the glycerol phospholipids, which are obtained for example as lecithins or phosphatidylcholines, for example from egg yolks or plant seeds, in particular soybeans, used as inventive phospholipids. Phospholipids are in particular phosphoglycerides.

In general, all phosphoglycerides are suitable. Furthermore, the compounds described in more detail below are used. Glycero-phospholipids which are particularly suitable according to the invention are obtained from soybeans. Of these, the phosphatidylcholines, phosphatidylethanolamines, phosphatidylserines and phosphatidylinositols and mixtures of these substances are particularly preferred.

in der die Reste R¹ und R² jeweils unabhängig voneinander eine Acylgruppe aus Fettsäuren mit einer Kohlenstoffanzahl von 8–30 C-Atomen, bevorzugt 10–24 und besonders bevorzugt 12–22 C-Atomen, darstellen. Die Fettsäurereste können sowohl gesättigt als auch einfach oder mehrfach ungesättigt sein. Bevorzugt sind die gesättigten Acylreste von C₁₂-C₂₂-Fettsäuren. Besonders bevorzugt sind die Acylreste der Myristinsäure, Palmitinsäure, Stearinsäure, Arachinsäure und Behensäure. The particularly preferred phosphatidylcholines have the formula (phosphol-II),

in which the radicals R ¹ and R ² each independently represent an acyl group of fatty acids having a carbon number of 8-30 carbon atoms, preferably 10-24 and particularly preferably 12-22 C atoms. The fatty acid residues can be both saturated and monounsaturated or polyunsaturated. Preference is given to the saturated acyl radicals of C ₁₂ -C ₂₂ -fatty acids. Especially preferred are the acyl radicals of myristic acid, palmitic acid, stearic acid, arachic acid and behenic acid.

in denen die Reste R¹ und R² dieselbe Bedeutung haben wie für Formel (Phosphol-III) dargestellt. The preferred phosphatidylethanolamines according to the invention are those of the formula (phosphol-IIa) or (phosphol-IIb),

in which the radicals R ¹ and R ^{2 have the} same meaning as shown for formula (phosphol-III).

Particular preference is given to phosphatidylethanolamines in which R ¹ and R ² independently of one another represent saturated acyl radicals of fatty acids having 16 or 18 carbon atoms, in particular a palmitoyl or stearoyl radical.

in denen R¹ und R² dieselbe Bedeutung haben wie für Formel (Phosphol-II) dargestellt. Besonders bevorzugt sind Phosphatidylserine, bei denen R¹ und R² unabhängig voneinander gesättigte Acylreste von Fettsäuren mit 16 oder 18 Kohlenstoffatomen, insbesondere einen Palmitoyl- oder Stearoyl-Rest, darstellen. The phosphatidylserines preferred according to the invention are those of the structural formula (IIIa) or (IIIb)

in which R ¹ and R ^{2 have the} same meaning as shown for formula (phosphol-II). Particular preference is given to phosphatidylserines in which R ¹ and R ² independently of one another represent saturated acyl radicals of fatty acids having 16 or 18 carbon atoms, in particular a palmitoyl or stearoyl radical.

bei der die Reste R¹ und R² dieselbe Bedeutung haben wie für Formel (Phosphol-II) dargelegt. Für R¹ sind Acylreste aus Palmitinsäure, Stearinsäure und Arachinsäure bevorzugt; besonders bevorzugt ist ein Stearinsäureacylrest. R² stellt in besonders bevorzugter Weise einen linearen gesättigten C₂₀-Fettsäureacylrest (Arachoylrest) dar. The phosphatidylinositols preferred according to the invention have the structural formula (IVa) or (IVb)

in which the radicals R ¹ and R ^{2 have the} same meaning as set forth for formula (phosphol-II). For R ¹ , acyl radicals of palmitic acid, stearic acid and arachidic acid are preferred; particularly preferred is a stearic acid acyl radical. R ² is most preferably a linear saturated C ₂₀ fatty acid acyl radical (arachoyl radical).

In a particularly preferred embodiment, the oil-in-water emulsions of the present invention are stabilized with a mixture of cured glycerophospholipids substantially corresponding to the composition of hydrogenated natural soy lecithin. The glycerophospholipids used according to the invention have an iodine value of not more than 10, preferably of not more than 5.

According to the invention it is also possible to use a mixture of several phospholipids.

An inventively preferred phospholipid is 100 (Cognis) commercially available under the name Emulmetik ^®. Especially preferred according to the invention are phospholipids with the INCI names linoleic amidopropyl PG-dimonium chlorides phosphates, cocamidopropyl PG-dimonium chlorides phosphates and stearamidopropyl PG-dimonium chlorides phosphates. These are sold, for example, by the company Mona under the trade names Phospholipid ^EFA® , Phospholipid ^PTC® and Phospholipid ^SV® . Most preferred in the invention is the phospholipid having the INCI name Cocamidopropyl PG-Dimonium Chloride Phosphate. The phospholipids according to the invention are present in the compositions in concentrations of from 0.01% by weight to 7.5% by weight, preferably from 0.01% by weight up to 5% by weight, very particularly preferably in amounts of 0.01% by weight % to 3% by weight, most preferably in amounts of 0.1 to 1.5% by weight and most preferably in amounts of 0.05 to 0.8% by weight.

In a particularly preferred embodiment of the present invention is included as a further essential component of the present invention, a fragrance.

The definition of a fragrance within the meaning of the present application is in accordance with the expert definition, as they RÖMPP Chemie Lexikon, as of December 2007 , can be taken. Thereafter, a fragrance is a chemical compound with smell and / or taste that excites the hair cell receptors (adequate stimulus). The necessary physical and chemical properties are a low molecular weight of at most 300 g / mol, a high vapor pressure, minimal water and high lipid solubility and weak polarity and the presence of at least one osmophoric group in the molecule. In order to delineate volatile, low molecular weight substances which are usually and also not regarded as perfuming agents, but primarily as solvents, for example ethanol, propanol, isopropanol and acetone, according to the invention fragrances have a molecular weight of 74 to 300 g / mol, contain at least one osmophoric group in the molecule and have a smell and / or taste, that is, they excite the receptors of the hair cells of the olfactory system. A fragrance in the sense of the present invention can be a singular substance but also an extract or essential oil or a resin or a resinoid. According to this definition "fragrances" can also be used in the context of the invention, several fragrances. For the purposes of the present invention, the term "fragrances" does not include perfumes and / or perfume compositions or fragrance compositions with fragrance components composed of different sources. An example should clarify the complex facts. Star anise oil is a fragrance within the meaning of the present invention, although this oil consists of 15 individual components. Star aniseed oil is obtained by steam distillation. For the purposes of the present invention, the term "fragrance" does not include the so-called "notes". By "notes", the perfumer understands blends of various individual discrete ingredients to a particular fragrance body, such as rosebuds. Furthermore, the term "fragrances" in the sense of this invention does not include substances which, on the one hand, cause odor, but on the other hand, are usually also used for other purposes in cosmetic compositions. These are in addition to the beretis mentioned compounds ethanol, propanol, isopropanol and acetone in particular phenoxyethanol and benzyl alcohol. Phenoxyethanol is commonly used for its preservative effect. Benzyl alcohol is commonly used as a solvent. The essence of the invention is that at least one fragrance is formulated with oxytocin in a cosmetically acceptable carrier. In this cosmetic carrier may of course be included for the purpose of perfuming the overall composition in addition to the fragrance or the perfumes a perfume.

As fragrances can be used, for example, all in the book "The Cosmetic Preparations, 4th Edition, Volume I, The Perfumery, Publishing House for Chemical Industry, H. Ziolkowsky KG, Augsburg, Ga Nowak, Chapter I and Chapter II , listed fragrances.

A fragrance can itself already cause an emotion. Such fragrances may be preferred for the purposes of the present invention. Particular preference may be given to fragrances which cause a pleasant and positive mood.

A fragrance according to the invention may for example be a synthetic product of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are known e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate (DMBCA), phenylethylacetate, benzylacetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate. The ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g. the linear alkanals having 8-18 C atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones e.g. the ionones, α-isomethylionone and methylcedryl ketone, among the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene.

However, the fragrances may also contain natural fragrances as are available from plant sources, e.g. Pine, citrus, jasmine, patchouly, rose or ylang-ylang oil. Also suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and labdanum oil and orange blossom oil, neroliol, orange peel oil and sandalwood oil.

Adhesive-resistant fragrances which are advantageously usable in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, arnica blossom oil, basil oil, Bayöl, Champacablütenöl, Edeltannenöl, Edeltannenzapfenöl, Elemiöl, eucalyptus oil, fennel oil, spruce alder oil, galbanum oil, geranium oil, ginger grass oil, guaiac wood oil , Gurdyalic, helichrysum, ho-oil, ginger, iris, cajeput, calamus, chamomile, camphor, kanaga, cardamom, cassia, pine, copaivabalam, coriander, spearmint, caraway, cumin, lemongrass, musk, myrrh, clove, neroli, niaouli , Olibanum oil, Origanum oil, Palmarosa oil, Patchouli oil, Peru balsam oil, Petitgrain oil, Pepper oil, Peppermint oil, Pimento oil, Pine oil, Rose oil, Rosemary oil, Sandalwood oil, Celery oil, Star aniseed oil, Thuja oil, Thyme oil, Verbena oil, Vetiver oil, Juniper berry oil, Vermouth oil, Wintergreen oil, Ylang-ylang -Oil, Hyssop oil, cinnamon oil, cinnamon leaf oil and cypress oil.

But also the higher-boiling or solid fragrances of natural or synthetic origin can be used in the context of the present invention advantageously as adherent fragrances. These compounds include the following compounds and mixtures thereof: ambrettolide, α-amylcinnamaldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, ethyl benzoate, benzophenone, benzyl alcohol, borneol, bornyl acetate, α-bromostyrene, n -Decylaldehyde, n-dodecylaldehyde, eugenol, eugenol methyl ether, eucalyptol, farnesol, fenchone, fenchyl acetate, geranyl acetate, geranyl formate, heliotropin, heptincarboxylic acid methyl ester, heptaldehyde, hydroquinone dimethyl ether, hydroxycinnamaldehyde, hydroxycinnamyl alcohol, indole, iron, isoeugenol, isoeugenol methyl ether, isosafrole, jasmon , Camphor, Karvakrol, Karvon, p-cresol methyl ether, coumarin, p-methoxyacetophenone, methyl n-amyl ketone, methyl anthranilate, p-methylacetophenone, methylchavikole, p-methylquinoline, methyl-β-naphthyl ketone, methyl-n-nonylacetaldehyde, methyl-n nonyl ketone, muskon, β-naphthol ethyl ether, β-naphthol methyl ether, nerol, nitrobenzene , n-nonylaldehyde, nonyl alcohol, n-octylaldehyde, p-oxyacetophenone, pentadecanolide, β-phenylethyl alcohol, phenylacetaldehyde dimethylacetal, phenylacetic acid, pulegone, safrole, isoamyl salicylate, methyl salicylate, hexyl salicylate, cyclohexyl salicylate, santalol, skatole, terpineol, thymene, thymol , γ-undelactone, vaniline, veratrum aldehyde, cinnamaldehyde, cinnamyl alcohol, cinnamic acid, cinnamic acid ethyl ester, cinnamic acid benzyl ester. Among the more volatile fragrances which can be used advantageously in the context of the present invention, in particular the lower-boiling fragrances include natural or synthetic origin, which can be used alone or in mixtures. Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linalyl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.

All of the aforementioned fragrances can be used alone or in a mixture according to the present invention with the advantages already mentioned.

In particular, odoriferous substances from the group of allyl alcohol esters, esters of secondary alcohols, esters of tertiary alcohols, allylic ketones, acetals, ketals, condensation products of amines and aldehydes and / or mixtures thereof can also be used.

Examples of particularly suitable fragrances in the context of the invention are bergamot oil, coriander oil, damascenia, ginger oil, orange oil, patchouli oil, rosemary oil, peppermint oil, tamarin, geraniol, geranium oil, eugenol, tangerine and orange oil, anise, jasmine, isoeugenol, menthol, coumarin, melonal , Terpineol, vanillin, ylang-ylang oil, cinnamyl alcohol, methylionone, ethyl vanillin, ethyl 2,6,6-trimethylcyclohexadiene carboxylate, methyl 2-nonenoate.

At least one fragrance is present in the cosmetic agent according to the invention in a total amount of 0.001 to 40% by weight, preferably 0.01 to 20% by weight, particularly preferably 0.1 to 10% by weight, very preferably 0.3 to 8% by weight %, in each case based on the total weight of the agent.

The cosmetically acceptable carriers are in particular aqueous or aqueous-alcoholic. An aqueous cosmetic carrier contains at least 50% by weight of water, preferably at least 70% by weight of water, and most preferably at least 80% by weight of water. For the purposes of the present invention, aqueous-alcoholic cosmetic carriers include aqueous solutions containing 3 to 95% by weight of a C ₁ -C ₆ -alcohol, in particular methanol, ethanol or propanol, isopropanol, butanol, isobutanol, tert-butanol, n-Pentanol, iso-pentanols, n-hexanol, iso-hexanols, glycol, glycerol, 1,2-pentanediol, 1,5-pentanediol, 1,2-hexanediol or 1,6-hexanediol to understand. The compositions according to the invention may additionally contain further organic solvents, for example methoxybutanol, benzyl alcohol, ethyl diglycol or 1,2-propylene glycol. Preference is given to all water-soluble organic solvents.

The preparation of the compositions according to the invention is preferably based on the requirements of the intended use.

Compositions of the invention may be in solid, semi-solid, liquid, disperse, emulsified, suspended or gel form. Furthermore, the agents according to the invention can be formulated as an aerosol, that is, they are packaged in a pressure vessel, from which they can be sprayed with the aid of a propellant. Furthermore, the agents according to the invention can be sprayed as a propellant-free pump spray.

In a particularly preferred embodiment, the agents according to the invention are in the form of a hydrogel. Hydrogels are water-containing gels based on hydrophilic but water-insoluble polymers, which exist as three-dimensional networks. In water, these networks swell up to an equilibrium volume while retaining their shape. on. The network formation occurs predominantly via chemical linkage of the individual polymer chains, but is also physically possible by electrostatic, hydrophobic or dipole / dipole interactions between individual segments of the polymer chains. The choice of the monomers used for the polymer synthesis, the type of crosslinking and the crosslinking density can be used to tailor desired properties of the hydrogels. The necessary hydrophilicity of the polymers is mediated, inter alia, by hydroxyl, carboxylate, sulfonate and / or amide groups. Synthetic hydrogels are based inter alia on poly (meth) acrylic acids, poly (meth) acrylates, polyvinylpyrrolidone or polyvinyl alcohol. Preferred anionic polymeric hydrogel formers which can promote the action of the active ingredient used according to the invention contain carboxylate and / or sulfonate groups and as monomers, for example, acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid. The acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt. Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid. Very particularly preferred anionic polymers contain 2-acrylamido-2-methylpropanesulfonic acid as the sole monomer or as a comonomer, it being possible for the sulfonic acid group to be wholly or partly in salt form. Within this embodiment, it is preferred to use copolymers of at least one anionic monomer and at least one nonionic monomer. With regard to the anionic monomers, reference is made to the substances listed above. Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic acid esters, vinylpyrrolidone, vinyl ethers and vinyl esters. Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers. A particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid groups are wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt present. This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used. Such a polymer is contained in the commercial product Sepigel ^® 305 from SEPPIC. The use of this compound has proven to be particularly advantageous in the context of the teaching of the invention. Also, the NS under the designations Simulgel ^® 600, Simulgel ^®, Simulgel ^® EG, Simulgel ^® EPG and Sepiplus ^® 400 as a compound with an oil such as isohexadecane, squalane or hydrogenated polyisobutene, and an emulsifier, such as polysorbate, Laureth-7 or Caprylyl / Capryl glucosides, sold sodium acryloyldimethyltaurate copolymers (with monomers selected from acrylamide, sodium acrylate, hydroxyethyl acrylate and / or acrylic acid) have proved to be particularly effective according to the invention. Further preferred are hydrogel ammonium acryloyldimethyltaurate vinylpyrrolidone copolymer, in particular the commercial product Aristoflex ^® AVC from Clariant.

Further particularly preferred anionic homopolymer hydrogel formers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example the commercial products Carbopol ^®. A particularly preferred anionic copolymer contains as monomer 80-98% of an unsaturated C _3-6 carboxylic acid or its anhydride and 2-20% of acrylic acid esters of C _10-30 saturated carboxylic acids, which copolymer may be crosslinked with the aforementioned crosslinking agents , Corresponding commercial products are Pemulen ^®, and Carbopol ^® grades 954, 980, 1342 and ETD 2020 (ex Noveon or BF Goodrich).

Preferred nonionic polymeric hydrogel formers are, for example, polyvinyl alcohols which may be partially saponified, e.g. B. the commercial products Mowiol ^® and vinylpyrrolidone / vinyl ester copolymers and polyvinylpyrrolidones z. B. under the trademark Luviskol ^® (BASF) are sold.

Natural hydrogel formers preferred according to the invention are in particular selected from, if desired, physically (thermally) and / or chemically modified cellulose derivatives, preferably hydroxyalkylcelluloses such as hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, methylcellulose, hydroxymethylcellulose, carboxymethylcellulose furthermore in particular starches and starch degradation products such as amylose and amylopectin, chemically and / or thermally modified starches, eg. B. Hydroxypropylstärkephosphat, Dihydroxypropyldistärkephosphat, in particular the anionic starch derivatives Aluminiumstärkeoctenylsuccinat (eg the commercial products Dry Flo ^® ), Natriumstärkeoctenylsuccinat, Calciumstärkeoctenylsuccinat, furthermore chitosan and its derivatives, furthermore polysaccharides forming gums or gums, such as guar gum, xanthan gum, alginates , in particular sodium alginate, gum arabic, karaya gum, carrageenans, locust bean gum, linseed gums, shellac and agar-agar.

In a further particularly preferred embodiment, the agents according to the invention are in the form of an oil-in-water emulsion. Such oil-in-water emulsions may, also preferably, be stabilized by at least one of the abovementioned hydrogel formers.

In a further particularly preferred embodiment, the agents according to the invention are in liquid form. The application can be carried out preferably with spray devices. These spraying devices contain in a container a filling of the inventive (liquid, mushy or powdery) skin lightening agent. The filling may be under the pressure of a propellant (compressed gas cans, compressed gas packages, aerosol dispensers), or it may be a mechanically operated pump sprayer. The containers have a removal device, preferably in the form of valves, which allow the removal of the contents as fog, smoke, foam, powder, paste or liquid jet. As a container for the sprayers are mainly cylindrical vessels made of metal (aluminum, tinplate, volume preferably <1000 ml), protected or non-splintering glass or plastic (volume preferably <220 ml) or splintering glass or plastic (volume preferably <150 ml ) in question.

Spray dispensers contribute to a particularly uniform application of the skin care agent according to the invention, which is particularly important for the final result of the treatment according to the invention.

Creamy, gelatinous, pastose and liquid agents may e.g. be packaged in pump or squeeze dispensers, especially in multi-chamber pump or squeeze dispensers.

For the purposes of the invention, the term liquid also includes any solid dispersions in liquids. Compositions according to the invention may also be present as pastes, ointments, lotions or creams. Solid funds can be present as a loose powder, pressed powder or as a pen.

The application may e.g. in the case of liquid agents, preferably also with a roller applicator, as e.g. is known from the field of deodorant scooters. Such rollers have a ball mounted in a ball bed, which can be moved by movement over a surface. The ball absorbs some of the agent to be distributed and conveys this to the surface to be treated.

The application may e.g. also be carried out with substrates which are acted upon by a preparation according to the invention. Especially preferred are wet wipes, i. prefabricated for the user, preferably individually packaged, wet wipes, such as. B. from the field of glass cleaning (eyeglass cleaning cloths) or from the field of wet toilet paper are well known. Such wet wipes, which may advantageously also contain preservatives, are then advantageously impregnated or applied with an agent according to the invention, advantageously they are individually packaged.

Preferred substrate materials are preferably selected from porous sheet-like cloths. They can be made of a fibrous or cellular flexible material which has sufficient mechanical stability and softness for application to the skin. These wipes include cloths of woven and non-woven synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam.

Preferably, conventional cloths of nonwoven material (nonwovens) are used here. Nonwovens are generally defined as adhesively bonded fibrous products having a mat or layered fibrous structure, or those comprising fibrous mats in which the fibers are randomly or randomly distributed. The fibers may be natural such as wool, silk, jute, hemp, cotton, flax, sisal or ramie; or synthetically, such as rayon, cellulose esters, polyvinyl derivatives, polyolefins, polyamides or polyesters. In general, any fiber diameter or titer is suitable for the present invention. The The nonwoven fabrics employed herein do not tend to rupture or disintegrate due to the random or random arrangement of fibers in the nonwoven material which impart excellent strength in all directions. Examples of nonwoven fabrics suitable as substrates in the present invention include, for example WO 98/18441 known. Preferred porous and flat cleaning cloths consist of one or different fiber materials, in particular of cotton, refined cotton, polyamide, polyester or mixtures of these.

The substrates in fabric form preferably have an area of from 10 to 5000 cm ² , preferably from 50 to 2000 cm ² , in particular from 100 to 1500 cm ² and particularly preferably from 200 to 1000 cm ² . The grammage of the material is usually between 20 and 1000 g / m ² , preferably from 30 to 500 g / m ² and in particular from 50 to 150 g / m ² . Skin treatment substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting the agents according to the invention onto a substrate.

The agents according to the invention, preferably liquid agents, may also be multi-phase, the phases may, for. B. horizontally, so one above the other, or vertically, so next to each other, be arranged. It may also be a disperse system in which e.g. the solid constituents are distributed inhomogeneously in the liquid matrix, so that such a dispersed system should be shaken before use.

Preferred optional ingredients of the cosmetic compositions of the invention can be defined by their function. Of course, some ingredients can also be multifunctional.

Preferred ingredients of the compositions according to the invention, preferably cosmetic products, can be:

a) absorbents

These preferably have the task of absorbing water and / or oil-soluble dissolved or finely divided substances.

b) antimicrobials

These may be added to the products to generally reduce the activities of microorganisms, particularly microorganisms responsible, for example, for the formation of acne or body odor. These germs include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci, especially Corynebacterium acnes, Corynebacterium granulosum, Propionibacterium acnes, Propionibacterium avidum and Propionibacterium granulosum, Staphylococcus hominis, Anerococcus octavius, Corynebacterium tub., Corynebacterium xerosis, Coynebacterium jekelium, Staphyllococcus epidermis. Preferred antimicrobial or antimicrobial agents according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a number of plant extracts and zinc compounds. These include triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphenbromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, benzethonium chloride, cetylpyridinium chloride, Laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride. Furthermore, phenol, phenoxyethanol, disodium dihydroxyethylsulfosuccinylundecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as. As farnesol, chlorophyllin copper complexes, α-monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C ₆ -C ₂₂ alkyl, particularly preferably α- (2-ethylhexyl) glycerol ether, commercially available as Sensiva ^® SC 50 (ex Schülke & Mayr), carboxylic esters of mono-, di- and triglycerin (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil). Antibacterial substances especially for deodorants can be selected from the group of linear, branched and unbranched, but also aromatic alcohols and acids, for example phenoxyethanol, benzyl alcohol, benzylheptanol and others. Further preferred antimicrobial active ingredients are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor or acne-forming germs of the skin microflora, but not the desired, that is, the non-odor-causing or not -Anmaking germs that belong to a healthy skin microflora. Explicitly here are the active substances, which are in the publications DE 10333245 and DE 10 2004 011 968 are disclosed as being prebiotic effective; these include conifer extracts, especially from the group of Pinaceae, and plant extracts from the group Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.

c) antiperspirants

These are preferably used in antiperspirants and reduce the sweat delivery. Antiperspirant active ingredients have a pore-astringent action and are therefore frequently used in skin treatment preparations for sebum suppression. The amounts used for sebum suppression are usually lower than the amounts used for sweat inhibition and are in the range of 0.1-10 wt .-%, preferably 2-3 wt .-%. For antiperspirant products, antiperspirant products contain from 2 to 25% by weight of the antiperspirant active ingredient for a sufficient sweat-reducing effect. For antiperspirant aerosols, the amount is based on the propellant composition. Preferred agents according to the invention comprise at least one antiperspirant astringent active ingredient selected from the water-soluble astringent inorganic and organic salts of aluminum, zirconium and zinc or any desired mixtures of these salts. Particularly preferred antiperspirant active substances are selected from the aluminum chlorohydrates, in particular the aluminum chlorohydrates having the general formula [Al ₂ (OH) ₅ Cl. 2 - 3H ₂ O] _n , which may be present in unactivated or in activated (depolymerized) form, furthermore aluminum sesquichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or polyethylene glycol (PEG), aluminum sesquichlorohydrex PG or PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, furthermore selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, Aluminum zirconium octachlorohydrate, the aluminum-zirconium-chlorohydrate-glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine, potassium aluminum sulfate (KAl (SO ₄ ) ₂ .12H ₂ O, Ala un), aluminum undecylenoyl collagen amino acid, sodium aluminum lactate + aluminum sulfate, sodium aluminum chlorhydroxylactate, aluminum bromohydrate, aluminum chloride, the complexes of zinc and sodium salts, the complexes of lanthanum and cerium, the aluminum salts of lipoamino acids, aluminum sulfate, aluminum lactate, aluminum chlorohydrate allantoinate, sodium aluminum chlorohydroxy lactate, zinc chloride, zinc sulfocarbolate , Zinc sulfate and zirconium chlorohydrate. According to the invention, water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C. The antiperspirant active ingredients can be used as an aqueous solution. Preferred anhydrous agents according to the invention preferably contain at least one activated aluminum chlorohydrate, preferably a raw material from the ^REACH® series from Summit-Reheis. Optionally, the antiperspirant effect may be enhanced by the addition of further ions such as calcium salts.

d) antifoam agent

These may be added, e.g. to eliminate foam during manufacture or to reduce the tendency of finished products to over-foam.

e) binders

They ensure e.g. the cohesion of powdered and powdered cosmetic products.

f) substances of biological origin

These are e.g. certain plant ingredients, e.g. Green tea extract. They are intended to impart certain desired properties to a product which are related to the corresponding biological material, or to further improve existing properties or to suppress undesirable properties or reduce them as much as possible.

g) bleach

These may e.g. serve to lighten the color of the hair or skin.

h) chelating agent

These are added, for example, to cosmetics to form complexes with metal ions so as to improve, for example, the storage stability of the compositions according to the invention. As a complexing substance Particularly preferred is ethylenediaminetetraacetic acid (EDTA) and its sodium salts, as available, for example, under the trade name Trilon B from BASF, nitrilotriacetic acid (NTA) and its sodium salts, β-alaninediacetic acid and its salts and phosphonic acids and their salts. The at least one complex-forming substance is preferably contained in a total amount of 0.01-0.5 wt .-%, particularly preferably 0.08-0.2 wt .-%, based on the total weight of the composition according to the invention.

i) deodorant active ingredients,

In a further preferred embodiment, the agents according to the invention may contain at least one deodorant active ingredient. This may preferably be selected from the already mentioned antimicrobial agents. Furthermore, it may be preferable to use an active substance which inhibits the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, β-glucuronidase, aminoacylase, cystathion-β-lyase, esterases, lipases and / or lipoxygenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate. Further inhibitors of the enzymes responsible for the sweat decomposition enzymes and germs are disclosed in WO 03/039505 A2 . WO 01/99376 A2 . EP 1430879 A2 . EP 1428520 A2 . EP 1738803 A1 . EP 1576946 A1 and DE 10216368 A1 , Further preferred deodorant active ingredients are odor absorbers and deodorizing ion exchangers. Silicates serve as odor absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention. Among the silicates which are particularly advantageous according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, IIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum. Further advantageous odor absorbers are, for example, zeolites, Zinkricinoleat, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll. They are preferably used in an amount of 0.1-10% by weight, more preferably 0.5-7% by weight and most preferably 1-5% by weight, based in each case on the total composition.

j) Emollients

These have the task of smoothing and smoothing the skin. Preferred compositions according to the invention, which are present as an emulsion, suspension, spray or stick, comprise as emollient at least one oil which is liquid at 20 ° C. and which does not constitute a fragrance component and does not represent an essential oil. Oils preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6-30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction. Preferred alcohol oils are Hexyldecanol (Eutanol ^® G 16, Guerbitol ^® T 16) Octyldodecanol (Eutanol ^® G, Guerbitol ^® 20), 2-ethylhexyl alcohol and the commercial products Guerbitol ^® 18, Isofol ^® 12, Isofol ^® 16, Isofol ^® 24, Isofol ^® 36, Isocarb ^® 12, Isocarb ^® 16 or Isocarb ^® 24. Further preferred oil components are mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ^® PGL (hexyldecanol and hexyldecyl laurate. Further according to the invention, preferred emollient oils are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C _8-30 fatty acids. particularly suitable, the use of natural oils such as soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, olive oil, rapeseed oil, sesame oil, safflower oil, Wheat germ oil, peach kernel oil, and the liquid portions of coconut oil and the like Ethical triglyceride oils, especially Capric / Caprylic triglycerides, e.g. As the commercial products Myritol ^® 318, Myritol ^® 331 (Cognis) or Miglyol ^® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin and the commercial products Estol ^® GTEH 3609 (Uniqema) or Myritol ^® GTEH (Cognis) with branched fatty acid residues. Further oils which are particularly preferred according to the invention are selected from the dicarboxylic acid esters of linear or branched C ₂ -C ₁₀ -alkanols, in particular diisopropyl adipate, di-n-butyl adipate, di (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n-butyl / Dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate. Further oils which are particularly preferred _{according to the} invention are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C _8-22 -alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ^®). Further oil components preferred according to the invention are selected from the esters of linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated. These include, hexyldecyl stearate (Eutanol ^® G 16 S), hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ^® C 24) and 2-ethylhexyl stearate (Cetiol ^® 868). Also suitably suitable are isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyl dodecyl palmitate, Butyloctanoic acid 2-butyloctanoate, diisotridecyl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and dipalmitate. Further oil components preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monohydric or polyhydric C _3-22 alkanols, such as butanol, butanediol, myristyl alcohol and stearyl alcohol, eg. As PPG-14 butyl ether (Ucon Fluid ^® AP), PPG-9-butyl ether (Breox B25 ^®), PPG-10 butanediol (Macol ^® 57) and PPG-15 stearyl ether (Arlamol ^® E). Further preferred oil components according to the invention are selected from the C ₈ -C ₂₂ -fatty alcohol esters of monohydric or polyhydric C ₂ -C ₇ -hydroxycarboxylic acids, in particular the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid. Such esters based on linear C _14/15 alkanols, eg. B. C _12- C ₁₅ alkyl lactate, and branched in the 2-position C _12/13 alkanols are under the trademark Cosmacol ^® by the company Nordmann, Rassmann GmbH & Co, Hamburg, to refer, in particular the commercial products Cosmacol ^® ESI , Cosmacol® ^® EMI and Cosmacol® ^® EIT. Further inventively preferred oil components are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl carbonate (Cetiol ^® CC) or the esters of DE 197 56 454 A1 , Further preferred oil components according to the invention are selected from the esters of dimers of unsaturated C ₁₂ -C ₂₂ -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C ₂ -C ₁₈ -alkanols or with polyvalent linear or branched C ₂ -C ₆ -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils. Further oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils. Silicone oils preferred according to the invention are selected from among dialkyl and alkylaryl siloxanes, such as, for example, cyclopentasiloxane, cyclohexasiloxane, dimethylpolysiloxane and methylphenylpolysiloxane, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane. Further inventively preferred silicone oils are selected from volatile silicone oils which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning, or linear, z. As hexamethyldisiloxane (L ₂ ), octamethyltrisiloxane (L ₃ ), decamethyltetrasiloxane (L ₄ ), any two and three mixtures of L ₂ , L ₃ and / or L ₄ , as described, for. B. in the commercial products DC 2-1184, Dow Corning ^® 200 (0, 65 cSt), and Dow Corning ^® 200 (1.5 cSt) from Dow Corning are included. Further inventively preferred silicone oils are selected from non-volatile higher molecular weight linear dimethylpolysiloxanes, commercially available z. Example under the name Dow Corning ^® 190, Dow Corning ^® 200 fluid having viscosities in the range of 5-100 cSt, preferably 5-50 cSt, or even 5-10 cSt, and Baysilon ^® 350 M. According to the invention preferred natural and synthetic hydrocarbons are selected from paraffinic oils, isohexadecane, isoeicosane, (optionally hydrogenated) polyisobutenes and polydecenes, which are obtainable for example under the designation Emery ^® 3004, 3006, 3010 or under the name ^® from Albemarle Ethylflo or Nexbase ^® 2004G from Nestle, and 1.3 di- (2 ethylhexyl) -cyclohexane (Cetiol ^® S). Also, mixtures of isoparaffins such as Pioneer ^® 2094, Isopar ^® G, Isopar ^® M or Isopar ^® L can be used. Particularly preferred skin care agents according to the invention are characterized in that the oil (s) liquid at 20 ° C in a total amount of 0.1-80 wt .-%, preferably 2-20 wt .-%, particularly preferably 3-15 Wt .-%, each based on the total weight of the composition, is / are included. In a further preferred embodiment of the invention, a proportion of the oil components of at least 80% by weight has a refractive index n _D of 1.39-1.51. It is particularly preferred if 5-40-50 wt .-%, most preferably 10-12-25-30 wt .-% of the oil components has a refractive index n _D of 1.43-1.51, preferably 1.44-1 , 49, more preferably 1.45-1.47-1.485, at 20 ° C (measured at λ = 589 nm). In addition to the oils, that is to say the substances which are liquid under normal conditions, it is also possible to use solid lipid or wax components as emollients under normal conditions. Particularly preferred lipid or wax components are selected from coconut fatty acid glycerol mono-, di- and triesters, Butyrospermum Parkii (shea butter) and esters of saturated, monohydric C ₈ -C ₁₈ alcohols with saturated C ₁₂ -C ₁₈ monocarboxylic acids and mixtures thereof Substances contained. These lower melting lipid or wax components allow for consistency optimization of the product and a minimization of the visible residue on the skin. Especially preferred are products sold under the INCI name Cocoglycerides, in particular the commercial products Novata ^® (ex Cognis), particularly preferably Novata AB ^®, a mixture of C ₁₂ -C ₁₈ mono-, di- and triglycerides, which in the range of 30- 32 ° C, as well as the products of the Softisan series (Sasol Germany GmbH) with the INCI name Hydrogenated Cocoglycerides, in particular Softisan 100, 133, 134, 138, 142. Further preferred esters of saturated, monohydric C ₁₂ -C ₁₈ - alcohols with saturated C ₁₂ -C ₁₈ monocarboxylic acids are stearyl laurate, cetearyl (z. B. Crodamol ^® CSS), cetyl palmitate (z. B. Cutina ^® CP) and myristyl myristate (z. B. Cetiol ^® MM). Emollients preferred according to the invention are furthermore natural vegetable waxes, eg. Candelilla wax, carnauba wax, Japan wax, sugarcane wax, ouricoury wax, cork wax, sunflower wax, fruit waxes such as orange waxes, lemon waxes, grapefruit wax, and animal waxes, e.g. Beeswax, shellac wax and spermaceti. For the purposes of the invention, it may be particularly preferred to use hydrogenated or hardened waxes. As a wax component are also chemically modified waxes, in particular the hard waxes, such as. As montan ester waxes, hydrogenated jojoba waxes and Sasol waxes used. The synthetic waxes which are likewise preferred according to the invention include, for example, polyalkylene waxes and polyethylene glycol waxes, C ₂₀ -C ₄₀ -dialkyl esters of dimer acids, C _30-50 -alkyl beeswax and alkyl and alkylaryl esters of dimer fatty acids. A particularly preferred wax component is selected from at least one ester of a saturated, monohydric C ₁₆ -C ₆₀ -alcohol and a saturated C ₈ -C ₃₆ -monocarboxylic acid. According to the invention, lactides, the cyclic double esters of α-hydroxycarboxylic acids of the corresponding chain length, also belong thereto. Esters of fatty acids and long-chain alcohols have proved to be particularly advantageous for the composition according to the invention, because they give the skin treatment compositions of the invention excellent sensory properties and (for pens) high stability. The esters are composed of saturated branched or unbranched monocarboxylic acids and saturated branched or unbranched monohydric alcohols. Esters of aromatic carboxylic acids or hydroxycarboxylic acids (eg 12-hydroxystearic acid) and saturated branched or unbranched alcohols can also be used according to the invention. It is particularly preferred to choose the wax components from the group of esters of saturated branched or unbranched alkanecarboxylic acids having a chain length of 12 to 24 carbon atoms and the saturated branched or unbranched alcohols having a chain length of 16 to 50 carbon atoms and having a melting point> 50 ° C have. In particular, C _{16-36 alkyl} stearates and C _18-38 alkyl hydroxystearoyl stearates, C _20-40 alkyl erucates and cetearyl behenate may be advantageous as the wax component. The wax or the wax components have a melting point> 50 ° C, preferably> 60 ° C, on. A particularly preferred embodiment of the invention contains as wax component a C ₂₀ -C ₄₀ alkyl stearate. This ester is known under the name Kester ^® K82H or Kesterwachs ^® K80H and is sold by Koster Keunen Inc.. It is the synthetic imitation of the monoester fraction of beeswax and is characterized by its hardness, oil gelability and broad compatibility with lipid components. This wax can be used as a stabilizer and consistency regulator for W / O and O / W emulsions. Kester wax has the advantage that it has an excellent oil gelability even at low concentrations and so does not make the pencil mass too heavy and allows a velvety abrasion. A further particularly preferred embodiment of the invention contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate. This ester is known under the name Kester ^® K62 and is sold by Koster Keunen Inc.. Further preferred lipid or wax components with a melting point> 50 ° C are the triglycerides of saturated and optionally hydroxylated C _12-30 fatty acids, such as hardened triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin) or glyceryl tri-12- hydroxystearate, further synthetic Vollester of fatty acids and glycols or polyols containing 2-6 carbon atoms as long as they have a melting point above 50 ° C, for example, preferably C ₁₈ -C ₃₆ Acid Triglyceride (Syncrowax HGL-C ^®). According to the hydrogenated castor oil as a wax component, available for example as a commercial product Cutina ^® HR, is particularly preferred. Further preferred lipid or wax components with a melting point> 50 ° C are the saturated linear C ₁₄ -C ₃₆ carboxylic acids, in particular myristic acid, palmitic acid, stearic acid and behenic acid and mixtures of these compounds, eg. B. Syncrowax ^® AW 1C (C ₁₈ -C ₃₆ fatty acids) or Cutina ^® FS 45 (palmitic and stearic acid).

k) emulsifiers / dispersants

These are surface-active substances which are preferably capable of stably dispersing immiscible liquids such as oil and water or of improving the dispersion of a pulverulent solid in a liquid medium. Particularly preferred compositions according to the invention, which are formulated as a water-in-oil emulsion, preferably contain at least one water-in-oil emulsifier. The at least one water-in-oil emulsifier is preferably in an amount of 0.1-7 wt .-%, particularly preferably 1.0-3.5-4.5 wt .-%, each based on the total weight of Emulsion, included. A particularly preferred group of water-in-oil emulsifiers according to the invention are the poly (C ₂ -C ₃ ) alkylene glycol-modified silicones whose previous INCI name was Dimethicone Copolyol, with the current INCI names PEG-x Dimethicone (with x = 2-20, preferably 3-17, more preferably 11-12), bis-PEG-y dimethicones (with y = 3-25, preferably 4-20), PEG / PPG a / b dimethicones (where a and b independently of one another represent numbers of 2-30, preferably 3-30 and particularly preferred 12-20, in particular 14-18,), bis-PEG / PPG-c / d dimethicones (where c and d independently of one another represent numbers of 10) 25, preferably 14-20 and more preferably 14-16) and bis-PEG / PPG-e / f PEG / PPG g / h dimethicones (where e, f, g and h independently of one another represent numbers of 10-20, preferably 14-18 and more preferably 16, stand). Particular preference is given to PEG / PPG-18/18 dimethicones, which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C, PEG / PPG-4/12 dimethicone, sold under the name Abil B 8852 is available as well as Bis-PEG / PPG-14/14 Dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Goldschmidt), Bis-PEG / PPG-20/20 Dimethicone, under the name Abil B 8832, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 Dimethicone (Silsoft 430 and Silsoft 440). Further preferred W / O emulsifiers according to the invention are poly (C ₂ -C ₃ ) alkylene glycol-modified silicones which are hydrophobically modified with C ₄ -C ₁₈ -alkyl groups, particularly preferably cetyl PEG / PPG-10/1 dimethicones (previously: Cetyl dimethicone copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, cetyl PEG / PPG-10/1 dimethicone and hexyl laurate under the trade name Abil WE 09), furthermore alkyl methicone copolyols and alkyl dimethicone ethoxy glucosides. Finally, as W / O - emulsifiers also commercial products such as Dehymuls® ^® PGPH or PEG-30 Dipolyhydroxystearate and other non-silicone-containing W / O - Emulgatoeren be used. The compositions according to the invention which are formulated as an emulsion, in particular as an oil-in-water emulsion or a polyol-in-water emulsion, preferably comprise at least one nonionic oil-in-water emulsifier having an HLB value of more than 7 These are emulsifiers generally known to the person skilled in the art, as are described, for example, in US Pat Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd ed., 1979, Vol. 8, pp. 913-916 , are listed. For ethoxylated products, the HLB value is calculated according to the formula HLB = (100-L): 5, where L is the weight fraction of the lipophilic groups, that is the fatty alkyl or fatty acyl groups, in the ethylene oxide adducts, expressed in weight percent. In selecting nonionic oil-in-water emulsifiers which are suitable according to the invention, it is particularly preferable to use a mixture of nonionic oil-in-water emulsifiers in order to optimally adjust the stability of the stick compositions according to the invention. The individual emulsifier components thereby deliver a proportion to the total HLB value or average HLB value of the oil-in-water emulsifier mixture in accordance with their proportion of the total amount of the oil-in-water emulsifiers. According to the invention, the mean HLB value of the oil-in-water emulsifier mixture is 7-19, preferably 10-18 and particularly preferably 14-17. In order to achieve such average HLB values, preference is given to combining oil-in-water emulsifiers from the HLB value ranges 10-14, 14-16 and optionally 16-19. Of course, the oil-in-water emulsifier mixtures may also contain nonionic emulsifiers with HLB values in the range of> 7-10 and 19-20; Such emulsifier mixtures may also be preferred according to the invention. However, in another preferred embodiment, the skin treatment agents of the invention may also contain only a single oil-in-water emulsifier having an HLB in the range of 10-19. Preferred skin care agents according to the invention are characterized in that the nonionic oil-in-water emulsifiers are selected from ethoxylated C ₈ -C ₂₄ -alkanols with an average of 10-100 moles of ethylene oxide per mole, ethoxylated C ₈ -C ₂₄ -carboxylic acids with an average of 10 100 moles of ethylene oxide per mole, silicone copolyols having ethylene oxide units or with ethylene oxide and propylene oxide units, alkyl mono- and oligoglycosides having 8 to 22 carbon atoms in the alkyl radical and their ethoxylated analogs, ethoxylated sterols, partial esters of polyglycerols having 2 to 10 glycerol units and esterified with 1 to 4, saturated or unsaturated, linear or branched, optionally hydroxylated C ₈ -C ₃₀ fatty acid residues, provided that they have an HLB value of more than 7, and mixtures of the aforementioned substances. The ethoxylated C ₈ -C ₂₄ alkanols have the formula R ¹ O (CH ₂ CH ₂ O) _n H, where R ¹ is a linear or branched alkyl and / or alkenyl radical having 8-24 carbon atoms and n, the middle Number of ethylene oxide units per molecule, for numbers of 10-100, preferably 10-30 moles of ethylene oxide to 1 mole of caprylic alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmitoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, Petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures. Adducts of 10-100 moles of ethylene oxide with technical fatty alcohols having 12-18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty alcohol, are suitable. The ethoxylated C ₈ -C ₂₄ -carboxylic acids have the formula R ¹ (OCH ₂ CH ₂ ) _n OH, where R ¹ is a linear or branched saturated or unsaturated acyl radical having 8-24 carbon atoms and n, the average number of ethylene oxide Units per molecule, for numbers of 10-100, preferably 10-30 moles of ethylene oxide to 1 mole of caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, cetylic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, arachidic acid, Gadoleic acid, behenic acid, erucic acid and brassidic acid and their technical mixtures. Also adducts of 10-100 moles of ethylene oxide with technical fatty acids having 12-18 carbon atoms, such as coconut, palm, palm kernel or tallow fatty acid, are suitable. Particularly preferred are PEG-50 monostearate, PEG-100 monostearate, PEG-50 monooleate, PEG-100 monooleate, PEG-50 monolaurate and PEG-100 monolaurate. Particular preference is given to using the C ₁₂ -C ₁₈ -alkanols or the C ₁₂ -C ₁₈ -carboxylic acids with in each case 10-30 units of ethylene oxide per molecule and mixtures of these substances, in particular ceteth-12, ceteth-20, ceteth-30, steareth- 12, Steareth-20, Steareth-30, Laureth-12 and Beheneth-20. Furthermore, preference is given to using C ₈ -C ₂₂ -alkyl mono- and -oligoglycosides. C ₈ -C ₂₂ -alkyl mono- and -oligoglycosides are known, commercially available surfactants and emulsifiers. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8-22 carbon atoms. With regard to the glycoside radical, both monoglycosides in which a cyclic sugar radical is glycosidically linked to the fatty alcohol and oligomeric glycosides having a degree of oligomerization of up to about 8, preferably 1-2, are suitable. The degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products. Products under the Trademarks Plantacare ^{® are} available contain a glucosidically bonded C ₈ -C ₁₆ alkyl group on a Oligoglucosidrest whose average degree of oligomerization is 1-2, in particular at 1.1-1.4. Particularly preferred C ₈ -C ₂₂ alkyl mono- and oligoglycosides are selected from octyl glucoside, decyl glucoside, lauryl glucoside, palmityl glucoside, isostearyl glucoside, stearyl glucoside, arachidyl glucoside and behenyl glucoside and mixtures thereof. The glucamine-derived acylglucamides are also suitable as non-ionic oil-in-water emulsifiers. Ethoxylated sterols, in particular ethoxylated soy sterols, are suitable oil-in-water emulsifiers according to the invention. The degree of ethoxylation must be greater than 5, preferably at least 10, in order to have an HLB value greater than 7. Suitable commercial products are, for. PEG-10 Soy Sterol, PEG-16 Soy Sterol and PEG-25 Soy Sterol. Furthermore, preferably partial esters of polyglycerols with 2 to 10 glycerol units and with 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C ₈ -C ₃₀ fatty acid esters esterified used, provided that they have an HLB value of more than 7. Particularly preferred Diglycerinmonocaprylat, Diglycerinmonocaprat, diglycerol, Triglycerinmonocaprylat, Triglycerinmonocaprat, triglycerol, Tetraglycerinmonocaprylat, Tetraglycerinmonocaprat, Tetraglycerinmonolaurat, Pentaglycerinmonocaprylat, Pentaglycerinmonocaprat, Pentaglycerinmonolaurat, Hexaglycerinmonocaprylat, Hexaglycerinmonocaprat, hexa are glycerol, Hexaglycerinmonomyristat, Hexaglycerinmonostearat, Decaglycerinmonocaprylat, Decaglycerinmonocaprat, decaglyceryl monolaurate, decaglyceryl monomyristate, Decaglycerinmonoisostearat, decaglycerol monostearate, Decaglycerinmonooleat, Decaglycerinmonohydroxystearat, Decaglycerindicaprylat, Decaglycerindicaprat, Decaglycerindilaurat, Decaglycerindimyristat, Decaglycerindiisostearat, Decaglycerindistearat, Decaglycerindioleat, Decaglycerindihydroxystearat, Decaglycerintricaprylat, Decaglycerintricaprat, Decaglycerintrilaurat, Decaglycerintrimyristat, Decaglycerintriisostearat, Decaglycerintristearat, Decaglyce rintrioleate and decaglycerol trihydroxystearate. Particularly preferred skin treatment agents according to the invention are characterized in that the nonionic oil-in-water emulsifier in a total amount of 0.5-10 wt .-%, particularly preferably 1-4 wt .-% and exceptionally preferably 1.5-3 wt .-%, based on the total composition. Preferred compositions according to the invention, which are formulated as an emulsion or stick, preferably further comprise at least one nonionic water-in-oil emulsifier having an HLB value greater than 1.0 and less than or equal to 7.0, selected from the mono- and diesters of Ethylene glycol and the mono-, di-, tri- and tetra-esters of pentaerythritol with linear saturated fatty acids having 12-30, in particular 14-22 carbon atoms, which may be hydroxylated, and mixtures thereof, as consistency regulator and / or water binder. According to the invention, the mono- and diesters are preferred. C ₁₂ -C ₃₀ fatty acid radicals preferred according to the invention are selected from lauric acid, myristic acid, palmitic acid, stearic acid, arachic acid and behenic acid radicals; particularly preferred is the stearic acid residue. Nonionic water-in-oil emulsifiers particularly preferred according to the invention having an HLB value greater than 1.0 and less than or equal to 7.0 are selected from pentaerythrityl monostearate, pentaerythrityl distearate, pentaerythrityl tristearate, pentaerythrityl tetrastearate, ethylene glycol monostearate, ethylene glycol distearate and mixtures thereof. According to the invention, particularly preferred water-in-oil emulsifiers having an HLB value greater than 1.0 and less than / equal to 7.0, for example as commercial products Cutina ^® PES (INCI: Pentaerythrityl distearate), Cutina ^® AGS (INCI: Glycol Distearate) or Cutina ^® EGMS (INCI: glycol stearate) available. These commercial products are already mixtures of mono- and diesters (in the pentaerythrityl esters are also tri- and tetraester contained). According to the invention it may be preferable to use only a single water-in-oil emulsifier. In another preferred embodiment, the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two water-in-oil emulsifiers. A commercial product such as Cutina ^® PES is meant, for example, a technical mixture. In addition to the stated water-in-oil emulsifiers based on the ethylene glycol or pentaerythrityl esters, in a preferred embodiment, at least one further nonionic water-in-oil emulsifier having an HLB value greater than 1.0 and less than or equal to 7, 0 should be included, the proportion of the total weight of nonionic water-in-oil emulsifiers with an HLB value greater than 1.0 and less than or equal to 7.0, but preferably should not be greater than 80%. In a particularly preferred embodiment, the compositions according to the invention contain the at least one additional water-in-oil emulsifier having an HLB value greater than 1.0 and less than or equal to 7.0 only in a proportion by weight of not more than 10% or are free of additional water -in-oil emulsifiers. Some of these additional suitable emulsifiers are, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd Ed., 1979, Vol. 8, page 913 , listed. For ethoxylated adducts, the HLB value, as already mentioned, can also be calculated. Suitable water-in-oil emulsifiers are preferably: linear saturated alkanols having 12-30 carbon atoms, in particular 16-22 carbon atoms, in particular cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl and lanolin or mixtures of these alcohols, as in the industrial hydrogenation of vegetable and animal fatty acids are obtainable, esters and in particular partial esters of a polyol having 3-6 C-atoms and linear saturated and unsaturated fatty acids having 12-30, in particular 14-22 C-atoms, which may be hydroxylated. Such esters or partial esters are, for. The mono- and diesters of glycerine or the monoesters of propylene glycol with linear saturated and unsaturated C ₁₂ -C ₃₀ - Carboxylic acids, which may be hydroxylated, in particular those with palmitic and stearic acid, the sorbitan mono-, di- or triesters of linear saturated and unsaturated C ₁₂ -C ₃₀ carboxylic acids which may be hydroxylated, in particular those of myristic acid, palmitic acid, Stearic acid or mixtures of these fatty acids and the methyl glucose mono- and diesters of linear saturated and unsaturated C ₁₂ -C ₃₀ carboxylic acids which may be hydroxylated; Sterols, ie steroids which carry a hydroxyl group at the C3 atom of the steroid skeleton and both from animal tissue (zoosterols, eg cholesterol, lanosterol) as well as from plants (phytosterols, eg ergosterol, stigmasterol, sitosterol) and from fungi and yeasts (mycosterols) which may be low ethoxylated (1-5 EO); Alkanols and carboxylic acids each having 8-24 C atoms, in particular having 16-22 C atoms, in the alkyl group and 1-4 ethylene oxide units per molecule having an HLB value greater than 1.0 and less than or equal to 7.0 exhibit; Glycerol monoethers of saturated and / or unsaturated, branched and / or unbranched alcohols of a chain length of 8-30, in particular 12-18 carbon atoms; Partial ester of polyglycerols having n = 2 to 10 glycerol units and esterified with 1 to 5 saturated or unsaturated, linear or branched, optionally hydroxylated C ₈ -C ₃₀ fatty acid residues, if they have an HLB value of 7 or less, and mixtures of aforementioned substances. According to the invention, it may be preferable to use only a single additional water-in-oil emulsifier. In another preferred embodiment, the compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two additional water-in-oil emulsifiers. For example, a commercial product such as Cutina GMS ^® is understood to be a technical mixture, which is a mixture of glyceryl monostearate and glyceryl distearate. Particularly advantageous additional water-in-oil emulsifiers are stearyl alcohol, cetyl alcohol, glyceryl monostearate, in particular in the form of the commercial products Cutina ^® GMS and Cutina ^® MD (ex Cognis), glyceryl distearate, glyceryl monocaprate, glyceryl monocaprylate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monohydroxystearate, glyceryl monooleate , Glycerylmonolanolat, Glyceryldimyristat, Glyceryldipalmitat, glyceryl dioleate, propylene glycol monostearate, propylene glycol monolaurate, sorbitan monocaprylate, sorbitan monolaurate, sorbitan monomyristate, sorbitan monopalmitate, sorbitan monostearate, Sorbitansesquistearat, sorbitan distearate, sorbitan dioleate, sorbitan sesquioleate, sucrose distearate, arachidyl alcohol, behenyl alcohol, polyethylene glycol (2) stearyl ether (steareth-2), steareth 5, oleth-2, diglycerol monostearate, diglycerol monoisostearate, diglycerol monooleate, diglycerol dihydroxystearate, diglycerol distearate, diglycerol dioleate, triglycerol distearate, tetraglycer inmonostearate, tetraglycerol distearate, tetraglycerol tristearate, decaglycerol pentastearate, decaglycerin pentahydroxystearate, decaglycerol pentaisostearate, decaglycerol pentaoleate, soy sterol, PEG-1 soy sterol, PEG-5 soy sterol, PEG-2 monolaurate and PEG-2 monostearate. Particularly preferred skin-treatment agents according to the invention are characterized in that at least one water-in-oil emulsifier is present in a total amount of 0.1-15% by weight, preferably 0.5-8.0% by weight, and particularly preferably 1-5% by weight. 4 wt .-%, based on the total composition, are included. Furthermore, amounts of 2-3% by weight, based on the total weight of the composition, according to the invention may also be extremely preferred.

l) emulsion stabilizers

These can further support the process of emulsification (see emulsifiers) and in this way further improve the stability and durability of the product.

m) moisturizer

These can contribute to the maintenance or restoration of skin moisture and counteract the drying of the skin. ₉ alkanols with 2-6 hydroxyl groups and / or water-soluble polyethylene glycols having 3-20 ethylene oxide units thereof as well as mixtures - in addition to the aforementioned emollients be suitable for this purpose in front of water-soluble polyhydric C. ₂ Preferably, these components are selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2- Pentanediol and 1,5-pentanediol, hexanediols such as 1,6-hexanediol, hexanetriols such as 1,2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol and Mixtures of the aforementioned substances. Suitable water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred. Also sugars and certain sugar derivatives such as fucose, rhamnose, fructose, glucose, maltose, maltitol, mannitol, inositol, sucrose, trehalose and xylose are suitable according to the invention. Preferred skin care agents according to the invention are characterized in that the at least one water-soluble polyhydric C ₂ -C ₉ -alkanol with 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol with 3-20 ethylene oxide units is selected from 1,2-propylene glycol, 2- Methyl 1,3-propanediol, glycerin, butylene glycols such as 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, pentylene glycols such as 1,2-pentanediol and 1,5-pentanediol, hexanediols such as 1,6-butanediol Hexanediol, hexanetriols such as 1,2,6-hexanetriol, 1,2-octanediol, 1,8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol and mixtures of the aforementioned substances. Particularly preferred skin treatment compositions according to the invention are characterized in that the at least one water-soluble polyhydric C ₂ -C ₉ -alkanol with 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol with 3-20 ethylene oxide units in total in amounts of 3-30% by weight. %, preferably 8-25 wt .-%, particularly preferably 10-18 wt .-%, each based on the total composition is included.

n) film former

These are capable of producing a protective, stabilizing film on surfaces, preferably skin, hair or nails. With regard to the agents according to the invention, this film preferably has a moisture-storing effect. Preferred moisture-film formers are selected from polysaccharides which contain at least one deoxy-block, particularly preferably from the commercial products Fucogel ^® (INCI name Biosaccharide Gum-1) from Solabia, Rhamnosoft ^® (INCI name Biosaccharide Gum-2) from Solabia, Fucogenol ^® (INCI name Biosaccharide Gum-3) of Solabia and Glycofilm ^® (INCI name Biosaccharide Gum-4) of Solabia, furthermore mixtures of the aforementioned polysaccharides containing at least one deoxy sugar building block, for example the mixture of biosaccharides Gum-2 and biosaccharides Gum-3, available as a commercial product Elastinol plus ^® from Solabia, glycosaminoglycans, more preferably hyaluronic acid, dextran, dextran sulfate, chondroitin 4-sulfate and chondroitin 6-sulfate.

o) dyes

These are added to cosmetic products to produce a product coloration,

p) preservatives

These are added to cosmetic products to protect them from the harmful effects of microorganisms (bacteria, fungi, yeasts) and thus to prevent their spoilage. Many preservatives inevitably have deodorizing properties, as they also have antimicrobial effects against odor causing bacteria, so that some substances belong to both groups. Benzoic acid and its derivatives (for example propyl, phenyl and butyl benzoate, ammonium, sodium, potassium and magnesium benzoate), propionic acid and derivatives thereof (for example ammonium, sodium and potassium) are particularly suitable as preservatives for cosmetics. , Potassium and magnesium propionate), salicylic acid and its derivatives (eg sodium, potassium and magnesium salicylate), 4-hydroxybenzoic acid and its esters and alkali metal salts (eg methyl, ethyl, propyl, isopropyl). , Butyl, isobutyl, isodecyl, phenyl, phenoxyethyl and benzylparaben, hexamidineparaben and -diparaben, sodium and potassiumparaben, sodium and potassium methylparaben, potassiumbutylparaben, sodium and potassiumpropylparaben), alcohols and their salts (eg, ethanol, propanol , Isopropanol, benzyl alcohol, phenethyl alcohol, phenol, potassium phenolate, phenoxyethanol, phenoxyisopropanol, o-phenylphenol), guaiacol and its derivatives, chlorhexidine and its derivatives (eg, chlorhexidine diacetate, digluconate, and dihydroc hlorid), hydantoin and its derivatives (e.g. DEDM and DMDM hydantoin, DEDM-hydantoindilaurate), urea and urea derivatives (eg diazolidinyl urea, imidazolidinyl urea), ferulic acid and its derivatives (eg ethyl ferulate), sorbic acid and its derivatives (eg isopropyl sorbate, TEA sorbate, sodium, potassium, and magnesium sorbate), isothiazole and oxazole derivatives (e.g., methylisothiazolinone, methylchloroisothiazolinone, dimethyloxazolidine), quaternary ammonium compounds (e.g., Polyquaternium-42, Quaternium-8, Quaternium-14, Quaternium -15), carbamates (e.g., iodopropynyl butylcarbamate), formaldehyde and sodium formate, glutaraldehyde, glyoxal, hexamidine, dehydroacetic acid, 2-bromo-2-nitropropane-1,3-diol, isopropylcresol, methyldibromo-glutaronitrile, polyaminopropyl biguanide, sodium hydroxymethylglycinate, sodium phenolsulfonate, triclocarban , Triclosan, zinc pyrithione and various peptide antibiotics (eg nisin). Preservatives preferred according to the invention are phenoxyethanol, the esters of 4-hydroxybenzoic acid, in particular methyl, ethyl, propyl, isopropyl, butyl and isobutylparaben, and iodopropynyl butylcarbamate and methylisothiazolinone. The amount of preservatives in the preferred compositions of the present invention is 0.001-10 wt.%, Preferably 0.01-5 wt.%, And more preferably 0.1-3 wt.%, Based on the total weight of the composition.

q) corrosion inhibitor

These may e.g. serve to prevent corrosion of the package, e.g. of a cosmetic agent or even the corrosion of parts that otherwise come into contact with the agent.

r) Skin cooling agents

Compositions which are particularly preferred according to the invention furthermore preferably contain at least one skin-cooling active substance. Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg. Menthyl lactate, menthyl glycolate, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxypropanediol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1,4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate and 2-hydroxymethyl-3,5 , 5-trimethylcyclohexanol. As skin-cooling active ingredients preferably menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidone carboxylic acid and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, Mentholglycolat and menthyl lactate, menthol and menthoxypropanediol or menthol, isopulegol or the commercial product Frescolat ^® Ice are (Symrise). It is particularly preferred according to the invention for at least one skin-cooling active substance to be present in a total amount of 0.01-2% by weight, more preferably 0.02-0.5% by weight and most preferably 0.05-0.2% by weight, each based on the total weight of the composition.

s) pH regulator / buffer substances

These may e.g. in cosmetics to adjust or stabilize a desired pH.

t) surfactants / wash-active substances

These are surface-active compounds which serve cleaning purposes or else the better washability of the agents according to the invention.

u) propellants

These are gaseous substances with which the cosmetic compositions according to the invention can be placed under pressure in pressure-resistant containers in order to produce the contents when the pressure is relieved. Particularly preferred compositions according to the invention, which are formulated as a propellant-driven aerosol, contain at least one propellant. Preferred propellants (propellants) are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1,1,1,3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1,1-difluoroethane, both individually and in combination. Also hydrophilic propellants, such. As carbon dioxide, can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess. Particularly preferred are propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred. The amount of blowing agent is preferably 10-95% by weight, more preferably 20-90% by weight and most preferably 40-85% by weight, based in each case on the total weight of the preparation, of the composition according to the invention and the blowing agent.

v) opacifiers

These may preferably be added to transparent or translucent products to make them more impervious to visible light or near-infrared radiation. This may be useful for protecting the photocatalytic agent during storage in transparent or translucent containers, where appropriate; the layer thickness later applied to the skin is so low that the addition of a clouding agent does not affect the effectiveness of the photocatalytic agent.

w) UV absorber / light filter substances

They are able to filter certain UV rays and in this way can be used e.g. Protect the skin from premature light-induced aging and sunburn. UV absorbers can also be used in small quantities as product protection.

x) denaturant

These are added to cosmetics containing ethanol to make them inedible.

y) viscosity regulator

These are able to increase or decrease the viscosity of a product. The aforementioned ingredients may be contained according to further preferred embodiments as the sole additive or in any combination in the inventive compositions.

In the following, preferred ingredients of the inventive compositions are described in more detail. Anionic surfactants are preferably contained in the agents according to the invention. Preferred anionic surfactants are the fatty acid soaps having a carbon chain of 12 to 30 carbon atoms. If the agent according to the invention is not formulated as a deodorant, further anionic surfactants may optionally be used. The anionic surfactants used are then, for example, those of the sulfonate and sulfates type. The surfactants of the sulfonate type are preferably C _9-13 -alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, as are obtained, for example, from C _12-18 -monoolefins having terminal or internal double bonds by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation products into consideration. Also suitable are alkanesulfonates which are obtained from C _12-18 alkanes, for example by sulfochlorination or sulfoxidation with subsequent hydrolysis or neutralization. Likewise, the esters of α-sulfo fatty acids (ester sulfonates), for example the α-sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids are suitable. Further suitable anionic surfactants are sulfated fatty acid glycerol esters. Fatty acid glycerol esters are to be understood as meaning the mono-, di- and triesters and mixtures thereof, as obtained in the preparation by esterification of a monoglycerol with 1 to 3 moles of fatty acid or in the transesterification of triglycerides with 0.3 to 2 moles of glycerol. Preferred sulfated fatty acid glycerol esters are the sulfonation products of saturated fatty acids having 6 to 22 carbon atoms, for example caproic acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid or behenic acid.

Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C ₁₂ -C ₁₈ fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C ₁₀ -C ₂₀ oxo alcohols and those half-esters of secondary alcohols of these chain lengths are preferred. Also preferred are alk (en) ylsulfates of said chain length, which contain a synthetic, produced on a petrochemical basis straight-chain alkyl radical, which have an analogous degradation behavior as the adequate compounds based on oleochemical raw materials. Of washing technology interest, the C ₁₂ -C ₁₆ alkyl sulfates and C ₁₂ -C ₁₅ alkyl sulfates and C ₁₄ -C ₁₅ alkyl sulfates are preferred. 2,3-alkyl sulfates can be obtained as commercial products from Shell Oil Company under the name DAN ^®, are suitable anionic surfactants.

The sulfuric acid monoesters of straight-chain or branched C _7-21 -alcohols ethoxylated with from 1 to 6 mol of ethylene oxide, such as 2-methyl-branched C _9-11- alcohols having on average 3.5 mol of ethylene oxide (EO) or C _12-18 . Fatty alcohols with 1 to 4 EO are suitable. Due to their high foaming behavior, they are preferably used only in relatively small amounts, for example in amounts of from 1 to 5% by weight, in detergents in particular. The agents according to the invention may preferably be free of sulfuric acid monoester.

Another class of anionic surfactants is the class of ether carboxylic acids obtainable by the reaction of fatty alcohol ethoxylates with sodium chloroacetate in the presence of basic catalysts. They have the general formula: R ¹⁰ O- (CH ₂ -CH ₂ -O) _p -CH ₂ -COOH with R ¹⁰ = C ₁ -C ₁₈ and p = 0.1 to 20. Ethercarboxylic acids are water hardness insensitive and have excellent surfactant properties on.

Suitable anionic surfactants are, for example, the partial esters of di- or polyhydroxyalkanes, mono- and disaccharides, polyethylene glycols with the EO adducts of maleic anhydride to at least monounsaturated carboxylic acids having a chain length of 10 to 25 carbon atoms with an acid number of 10 to 140.

In addition to an unbranched or branched, saturated or unsaturated, aliphatic or aromatic, acyclic or cyclic, optionally alkoxylated alkyl radical, preferred anionic surfactants have 4 to 28, preferably 6 to 20, in particular 8 to 18, particularly preferably 10 to 16, most preferably 12 to 14 carbon atoms, two or more anionic, in particular two, acid groups, preferably carboxylate, sulfonate and / or sulfate groups, in particular a carboxylate and a sulfate group on. Examples of these compounds are the alpha sulfo fatty acid salts, the acyl glutamates, the monoglyceride disulfates and the alkyl ethers of the glycerol disulfate, and in particular the monoester sulfosuccinates described below.

Particularly preferred anionic surfactants are the sulfosuccinates, sulfosuccinamates and sulfosuccinamides, especially sulfosuccinates and sulfosuccinamates, most preferably sulfosuccinates. The sulfosuccinates are the salts of the mono- and di-esters of sulfosuccinic acid HOOCCH (SO ₃ H) CH ₂ COOH, while the sulfosuccinamates are the salts of the monoamides of sulfosuccinic acid and the sulfosuccinamides are the salts of the diamides of sulfosuccinic acid ,

The salts are preferably alkali metal salts, ammonium salts and mono-, di- or trialkanolammonium salts, for example mono-, di- or triethanolammonium salts, in particular lithium, sodium, potassium or ammonium salts, particularly preferably sodium or ammonium salts , most preferably sodium salts.

In the sulfosuccinates, one or both carboxyl groups of the sulfosuccinic acid is preferably with one or two identical or different unbranched or branched, saturated or unsaturated, acyclic or cyclic, optionally alkoxylated alcohols having 4 to 22, preferably 6 to 20, in particular 8 to 18 , more preferably 10 to 16, most preferably 12 to 14 carbon atoms esterified. Particularly preferred are the esters of unbranched and / or saturated and / or acyclic and / or alkoxylated alcohols, in particular unbranched, saturated fatty alcohols and / or unbranched, saturated, with ethylene and / or propylene oxide, preferably ethylene oxide, alkoxylated fatty alcohols having a degree of alkoxylation of 1 to 20, preferably 1 to 15, in particular 1 to 10, more preferably 1 to 6, most preferably 1 to 4. The monoesters are preferred in the context of the present invention over the diesters. A particularly preferred sulfosuccinate is Sulfobernsteinsäurelaurylpolyglycolester-di-sodium salt (lauryl EO sulfosuccinate, di-sodium salt; INCI Di-sodium laureth sulfosuccinates), the weight, for example as Tego ^® sulfosuccinate F 30 (Goldschmidt) with a sulfosuccinate 30 .-% is commercially available.

In the sulfosuccinamates or sulfosuccinamides, one or both form carboxyl groups of the sulfosuccinic acid preferably with a primary or secondary amine having one or two identical or different, unbranched or branched, saturated or unsaturated, acyclic or cyclic, optionally alkoxylated alkyl radicals having 4 to 22 , preferably 6 to 20, in particular 8 to 18, more preferably 10 to 16, most preferably 12 to 14 carbon atoms carries, a carboxylic acid amide. Particular preference is given to unbranched and / or saturated and / or acyclic alkyl radicals, in particular unbranched, saturated fatty alkyl radicals. Also suitable are, for example, the following sulfosuccinates and sulfosuccinamates designated according to INCI: ammonium dinonyl sulfosuccinates, ammonium lauryl sulfosuccinates, diammonium dimethicone copolyol sulfosuccinates, diammonium lauramido-MEA sulfosuccinates, diammonium lauryl sulfosuccinates, diammonium oleamido PEG-2 Sulfosuccinate, Diamyl Sodium Sulfosuccinate, Dicapryl Sodium Sulfosuccinate, Dicyclohexyl Sodium Sulfosuccinate, Diheptyl Sodium Sulfosuccinate, Dihexyl Sodium Sulfosuccinate, Diisobutyl Sodium Sulfosuccinate, Dioctyl Sodium Sulfosuccinate, Disodium Cetearyl Sulfosuccinate, Disodium Cocamido MEA Sulfosuccinate, Disodium Cocamido Glucoside Sulfosuccinate, Disodium Cocoyl Butyl Gluceth-10 sulfosuccinates, disodium C12-15 pareth sulfosuccinates, disodium deceth-5 sulfosuccinates, disodium deceth-6 sulfosuccinates, disodium dihydroxyethyl sulfosuccinyl undecylenates, disodium dimethi Disodium Isostearamido MEA Sulfosuccinate, Disodium Isostearamido MIPA Sulfosuccinate, Disodium Isostearyl Sulfosuccinate, Disodium Laneth-5 Sulfosuccinate, Disodium Lauramido MEA Sulfosuccinate, Disodium Lauramido PEG-2 Sulfosuccinate, Disodium Lauramido PEG-5 Sulfosuccinate, Disodium Laureth-6 Sulfosuccinate, Disodium Laureth-9 Sulfosuccinate, Disodium Laureth-12 Sulfosuccinate, Disodium Lauryl Sulfosuccinate, Disodium Myristamido MEA Sulfosuccinate, Disodium Nonoxynol-10 Sulfosuccinate, Disodium Oleamido MEA Sulfosuccinate, Disodium Oleamido MIPA- Sulfosuccinates, disodium oleamido PEG-2 sulfosuccinates, disodium oleth-3 sulfosuccinates, disodium oleyl sulfosuccinates, disodium palmitamido PEG-2 sulfosuccinates, disodium palmitoleeamido PEG-2 sulfosuccinates, disodium PEG-4 cocamido MIPA sulfosuccinates, disodium PEG-5 lauryl citrate sulfosuccinates, disodium PEG-8 Palm Gl Disodium Stearyl Sulfosuccinate, Disodium Stearyl Sulfosuccinate, Disodium Stearyl Sulfosuccinate, Disodium Tallamido MEA Sulfosuccinate, Disodium Tallowamido MEA Sulfosuccinate, Disodium Tallow Sulfosuccinamate, Disodium Tridecyl Sulfosuccinate, Disodium Undecylenamido, Disodium Stearamido MEA Sulfosuccinate, Disodium Stearamido MEA Sulfosuccinates, Disodium Undecylenamido PEG-2 Sulfosuccinates, Disodium Wheat Germamido MEA Sulfosuccinates, Disodium Wheat Germamido PEG-2 Sulfosuccinates, Di-TEA Oleamido PEG-2 Sulfosuccinates, Ditridecyl Sodium Sulfosuccinates, Sodium Bisglycol Ricinosulfosuccinates, Sodium / MEA Laureth-2 Sulfosuccinates and tetrasodium dicarboxyethyl stearyl sulfosuccinamate. Yet another suitable sulfosuccinamate is disodium C _16-18 alkoxypropylene sulfosuccinamate.

Another suitable class of compounds are anionic surfactant-cation complexes, the cation itself initially having surfactant properties. Examples are transesterification products of LAS acid with amines, amine derivatives containing a C chain with> 2 C atoms, preferably C ₁₂ -C ₁₆ . These can be oxidized, for example, on the nitrogen, ie for example transesterification of LAS acid with amine oxide C _12-14 .

The content of anionic surfactants in the composition according to the invention, preferably of the anionic surfactants mentioned, can vary within wide ranges, depending on the purpose of the agent in question. Thus, an agent according to the invention can contain very large amounts of anionic surfactant, preferably up to an order of magnitude of up to 40, 50 or 60% by weight or more. Likewise, an agent according to the invention may contain only very small amounts of anionic surfactant, for example less than 15 or 10% by weight or less than 5% by weight or even less. However, anionic surfactants are advantageously present in the compositions according to the invention in amounts of from 0.1 to 40% by weight and in particular from 5 to 30% by weight, with concentrations above 10% by weight and even above 15% by weight being particular Find favor. According to a preferred embodiment, the agent according to the invention contains anionic surfactants, preferably in amounts of at least 0.01% by weight, based on the total agent. In another preferred embodiment, the agent of the invention may be free of anionic surfactant.

In addition to the anionic surfactants mentioned, but also independently of these, soaps may be present in the compositions according to the invention. Particularly suitable are saturated fatty acid soaps, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, hydrogenated erucic acid and behenic acid, and in particular of natural fatty acids, e.g. Coconut, palm kernel or tallow fatty acids, derived soap mixtures. The content of the agent in soaps, independently of other anionic surfactants, is preferably not more than 10% by weight and in particular 0.5 to 7.0% by weight, based on the total agent. According to another preferred embodiment, the agent according to the invention is free of soap.

The anionic surfactants and soaps may be in the form of their sodium, potassium or ammonium salts and as soluble salts of organic bases, such as mono-, di- or triethanolamine. Preferably, they are in the form of their sodium or potassium salts, especially in the form of the sodium salts. Anionic surfactants and soaps may also be prepared in situ by incorporating into the spray-dried composition the anionic surfactant acids and optionally fatty acids which are then neutralized by the alkali carriers in the spray-dried composition.

Advantageously, nonionic surfactants may also be included in the compositions of the invention, both in solid and in liquid compositions. For example, their content may be up to 2 or 3, 5 or 8 wt .-%. It may also contain larger amounts of nonionic surfactant, for example up to 5 wt .-% or 10 wt .-% or 15 wt .-% or 20 wt .-%, 30 wt .-%, 40 wt .-%, 50% by weight or even beyond, if appropriate. Useful lower limits may be at values of 0.01, 0.1, 1, 2, 3 or 4 wt .-%.

Preferably, however, the nonionic surfactants are in relatively large amounts, ie up to 50% by weight, advantageously from 0.1 to 40% by weight, particularly preferably from 0.5 to 30 and in particular from 1 to 25% by weight, in each case based on the total agent included. According to a preferred embodiment, the agent according to the invention contains nonionic surfactants, preferably in amounts of at least 0.1% by weight, based on the total agent. According to another preferred embodiment, the agent according to the invention may be free from nonionic surfactant.

Advantageously, all known from the prior art nonionic surfactants may be included in the inventive compositions. Preferred nonionic surfactants are presented below.

The skin treatment compositions according to the invention may preferably also contain at least one cationic surfactant. Suitable cationic surfactants are, for example, surface-active quaternary compounds, in particular having an ammonium, sulfonium, phosphonium, iodonium or arsonium group. Through the use of quaternary surface-active compounds with antimicrobial action, the agent can be designed with an antimicrobial effect or its possibly existing antimicrobial effect due to other ingredients can be improved.

Particularly preferred cationic surfactants are the quaternary, partially antimicrobial ammonium compounds (QAV, INCI quaternary ammonium compounds) according to the general formula (R ^I ) (R ^II ) (R ^III ) (R ^IV ) N ⁺ X ^- , in which R ^I to R ^{IV are} identical or different C _1-22 -alkyl radicals, C _7-28 -aralkyl radicals or heterocyclic radicals, where two or, in the case of an aromatic incorporation, such as in pyridine, even three radicals together with the nitrogen atom form the heterocycle, for example a pyridinium or imidazolinium compound, and X ^{- are} halide ions, sulfate ions, hydroxide ions or similar anions. For optimum antimicrobial activity, preferably at least one of the radicals has a chain length of 8 to 18, in particular 12 to 16, carbon atoms.

QACs are prepared by reacting tertiary amines with alkylating agents, e.g. Methyl chloride, benzyl chloride, dimethyl sulfate, dodecyl bromide, but also ethylene oxide produced. The alkylation of tertiary amines with a long alkyl radical and two methyl groups succeeds particularly easily, and the quaternization of tertiary amines with two long radicals and one methyl group can be carried out with the aid of methyl chloride under mild conditions. Amines having three long alkyl radicals or hydroxy-substituted alkyl radicals are less reactive and are preferably quaternized with dimethyl sulfate.

Suitable QACs are, for example, benzalkonium chloride (N-alkyl-N, N-dimethylbenzylammonium chloride, CAS No. 8001-54-5), benzalkone B (m, p-dichlorobenzyl-dimethyl-C ₁₂ -alkylammonium chloride, CAS No. 58390-78 -6), benzoxonium chloride (benzyldodecyl-bis (2-hydroxyethyl) ammonium chloride), cetrimonium bromide (N-hexadecyl-N, N-trimethyl-ammonium bromide, CAS No. 57-09-0), benzetonium chloride (N, N Dimethyl N- [2- [2- [p- (1,1,3,3-tetramethylbutyl) phenoxy] ethoxy] ethyl] benzylammonium chloride, CAS No. 121-54-0), dialkyldimethylammonium chlorides such as N-decyldimethyl-ammonium chloride (CAS No. 7173-51-5-5), didecyldimethylammonium bromide (CAS No. 2390-68-3), dioctyldimethylammoniumchloric, 1-cetylpyridiniumchloride (CAS No. 123-03-5 ) and thiazoline iodide (CAS No. 15764-48-1) and mixtures thereof. Preferred QACs are the benzalkonium chlorides having C ₈ -C ₁₈ -alkyl radicals, in particular C ₁₂ -C ₁₄ -alkyl-benzyl-dimethylammonium chloride. A particularly preferred QAC Kokospentaethoxymethylammoniummethosulfat (INCI PEG-5 Cocomonium Methosulfate; Rewoquat CPEM ^®).

In order to avoid possible incompatibilities of the antimicrobial cationic surfactants with anionic surfactants contained in the agent according to the invention anionic surfactant compatible and / or optionally cationic surfactant are preferably used or omitted in a particular embodiment of the invention entirely on cationic surfactants. Further below, in particular in connection with conditioning agents and plasticizers, further cationic surfactants, including quaternary ammonium compounds, are described. These may also be contained in the compositions according to the invention.

The skin-treating agents of the invention may contain one or more cationic surfactants, advantageously in amounts, based on the total composition, of from 0 to 30% by weight, more preferably greater than 0 to 20% by weight, preferably from 0.01 to 10% by weight. , in particular 0.1 to 5 wt .-%. Suitable minimum values may also be 0.5, 1, 2 or 3 wt .-%. According to a preferred embodiment, the agent according to the invention contains cationic surfactants, preferably in amounts of at least 0.1% by weight, based on the total agent. According to another preferred embodiment, the agent according to the invention may be free of cationic surfactant.

Likewise, the skin treatment compositions according to the invention may also contain at least one amphoteric surfactant. These are described in more detail below, in particular in connection with conditioning agents and plasticizers.

The skin treatment compositions of the invention may contain one or more amphoteric surfactants, advantageously in amounts, based on the total composition, of from 0 to 30% by weight, more preferably greater than 0 to 20% by weight, preferably from 0.01 to 10% by weight. , in particular 0.1 to 5 wt .-%. In another preferred embodiment, the agent of the invention may be free of amphoteric surfactants.

According to a particular embodiment, the agents according to the invention can contain only very little total surfactant, e.g. the total amount of surfactant may be less than 20% by weight, 15% by weight, 10% by weight or 5% by weight, advantageously even less than 3% by weight or less than 1% by weight, in particular even less than 0.5 Wt .-% or less than 0.1 wt .-%, wt .-% each based on the total agent. However, the total surfactant content is preferably at least 0.01% by weight, 0.1% by weight or 1% by weight, based on the total agent.

Soluble complexing agents may preferably be used in amounts of from 0.1% by weight to 30% by weight, preferably from 5% by weight to 25% by weight and particularly preferably from 10% by weight to 20% by weight, of the composition according to the invention. based on the total weight of the agent, with citrates, triphosphates, phosphonates, aliphatic dicarboxylic acids (eg adipic, glutaric, succinic) examples.

In another preferred embodiment, the agent of the invention may be free of soluble complexing agents.

The agent according to the invention preferably contains at least one complexing agent in a total amount of usually 0 to 30 wt .-%, preferably 0.1 to 15 wt .-%, in particular 0.5 to 10 wt .-%, particularly preferably 1 to 8 wt. -%, most preferably 1.5 to 6 wt .-%, based on the total agent.

It should be noted at this point that the term% by weight, unless otherwise indicated, refers to the entire average.

The content of water in preferred agents according to the invention depends i.a. Accordingly, whether the agent is in liquid or solid form, is therefore preferably 0 to less than 100 wt .-% and in particular 0.5 to 95 wt .-%, with values of at most 5 wt .-%, in particular for solid or non-aqueous find special preference for liquid funds. Not included here was the water of crystallization present in individual raw materials, in particular the antiperspirant aluminum and / or zirconium compounds. In the case of liquid agents, the composition of the invention according to a preferred embodiment contains water in an amount of more than 20 wt .-%, advantageously more than 30 wt .-%., More preferably more than 40 wt .-%, even more advantageous as 50 wt .-%, in particular 60 to 99 wt .-%, particularly preferably 70 to 98 wt .-% and most preferably 80 to 95 wt .-%, based on the total agent.

The upper limit of water may also be 80 wt%, 70 wt%, 60 wt%, 50 wt%, 40 wt%, 30 wt%, 20 wt%, or 10 Wt .-% wt .-%, based on the total agent.

The lower limit of water may e.g. also at 80 wt .-%, 70 wt .-%, 60 wt .-%, 50 wt .-%, 40 wt .-%, 30 wt .-%, 20 wt .-% or 10 wt .-% are , relative to the entire remedy. The above upper and lower limits can of course be meaningfully combined, z. B. to water contents of 60-80 wt .-% or 10-30 wt .-%, etc.

In a further preferred embodiment, the skin treatment agent according to the invention contains at least one UV-absorbing substance. When used in small amounts (up to about 1 wt .-%), the UV-absorbing substance is used to advantageously improve the light resistance of other formulation ingredients (product protection). When used in higher amounts (greater than 1% by weight), the UV-absorbing substance serves to protect the treated skin from the harmful effects of UV radiation. Under UV-absorbing substance are organic and inorganic substances (sunscreen) to understand, which are able to absorb ultraviolet rays and the absorbed energy in the form of longer-wave radiation, eg heat to give back. Compounds having these desired properties include, for example, the non-radiative deactivating compounds and derivatives of benzophenone having substituents in the 2- and / or 4-position. Also suitable are substituted benzotriazoles, phenyl-substituted acrylates (cinnamic acid derivatives) in the 3-position, optionally with cyano groups in the 2-position, salicylates and natural substances such as umbelliferone and the endogenous urocanic acid. The biphenyl and especially stilbene derivatives, commercially available as Tinosorb ^® FD or Tinosorb ^® FR available ex Ciba. 3-benzylidene camphor or 3-benzylidene norcamphor and derivatives thereof, for example 3- (4-methylbenzylidene) camphor, may be mentioned as UV-B absorbers; 4-aminobenzoic acid derivatives, preferably 2-ethylhexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and 4- (dimethylamino) benzoic acid ester; Esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid iso-amyl ester, 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene); Esters of salicylic acid, preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate; Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone; Esters of benzalmalonic acid, preferably di-2-ethylhexyl 4-methoxybenzmalonate; Triazine derivatives, such as 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1,3,5-triazine and Octyl Triazone or Dioctyl Butamido Triazone (Uvasorb HEB ^®); Propane-1,3-diones such as 1- (4-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione; Ketotricyclo (5.2.1.0) decane derivatives. Also suitable are 2-phenylbenzimidazole-5-sulfonic acid and its alkali metal, alkaline earth metal, ammonium, alkylammonium, alkanolammonium and glucammonium salts; Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts; Sulfonic acid derivatives of 3-Benzylidencamphers, such as 4- (2-oxo-3-boryl-nylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) sulfonic acid and salts thereof.

As a typical UV-A filter in particular derivatives of benzoylmethane are suitable, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl 4'-methoxydibenzoylmethane (Parsol 1789), 1-phenyl-3- (4'-isopropylphenyl) -propane-1,3-dione and enamine compounds. Of course, the UV-A and UV-B filters can also be used in mixtures. In addition to the soluble substances mentioned, insoluble photoprotective pigments, namely finely dispersed, preferably nano-metal oxides or salts, are also suitable for this purpose. Examples of suitable metal oxides are in particular zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof. As salts silicates (talc), barium sulfate or zinc stearate can be used. The oxides and salts are already used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics. The particles should have an average diameter of less than 100 nm, preferably from 5 to 50 nm and in particular from 15 to 30 nm. They may have a spherical shape, but it is also possible to use those particles which have an ellipsoidal or otherwise deviating shape from the spherical shape. The pigments can also be surface-treated, ie hydrophilized or hydrophobized. Typical examples are coated titanium dioxides, for example Titandioxid T 805 (Degussa) or Eusolex ^® T2000 (Merck). Suitable hydrophobic coating agents are in particular silicones and in particular trialkoxyoctylsilanes or simethicones.

Also preferably, micronized zinc oxide can be used. Further suitable UV light protection filters can be found in the relevant prior art.

The at least one UV-absorbing substance is in preferred skin treatment compositions according to the invention in a total amount of 0.01 wt .-% to 20 wt .-%, particularly preferably 1-10 wt .-%, most preferably 2 wt .-% to 7 wt .-%, contain. These amounts do not include the at least one photocatalytically active metal oxide used according to the invention which can also absorb in the UV range.

In a further preferred embodiment, the agents according to the invention are in liquid form. To achieve a liquid consistency, the use of both liquid organic solvents and water may be indicated. Therefore, preferred agents according to the invention optionally contain at least one solvent.

Solvents which can be used in preferred agents according to the invention originate, for example, from the group of monohydric or polyhydric alcohols, alkanolamines or glycol ethers, provided they are miscible with water in the concentration range indicated. Preferably, the solvents are selected from ethanol, n- or i-propanol, butanols, glycol, propane or butanediol, glycerol, diglyol, propyl or butyl diglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, ethylene glycol mono n-butyl ether, diethylene glycol methyl ether, diethylene glycol ethyl ether, propylene glycol methyl, ethyl or propyl ether, butoxy-propoxy-propanol (BPP), dipropylene glycol monomethyl, or ethyl ether, di-isopropylene glycol monomethyl, or ethyl ether, methoxy, ethoxy or Butoxytriglycol, 1-butoxyethoxy-2-propanol, 3-methyl-3-methoxybutanol, propylene glycol t-butyl ether, 1,2-propylene glycol, dipropylene glycol and mixtures of these solvents. Some glycol ethers are available under the trade name Arcosolv ^® (Arco Chemical Co.) or Cellosolve ^®, carbitol ^® or Propasol ^® (Union Carbide Corp.); this includes for example ButylCarbitol® ^®, hexyl carbitol ^®, MethylCarbitol® ^®, and carbitol ^® itself, (2- (2-ethoxy) ethoxy) ethanol. The choice of glycol ether can be readily made by one skilled in the art on the basis of its volatility, water solubility, weight percent of the total dispersion, and the like. Pyrrolidone solvents, such as N-alkyl-pyrrolidones, for example N-methyl-2-pyrrolidone or NC ₈ -C ₁₂ -alkyl-pyrrolidone, or 2-pyrrolidone, may also be used. Also preferred as the sole solvent or as part of a solvent mixture are glycerol derivatives, in particular glycerol carbonate.

Among the alcohols which may be preferably used as cosolvents in the present invention are low molecular weight liquid polyethylene glycols, for example, polyethylene glycols having a molecular weight of 200, 300, 400 or 600. Further suitable cosolvents are other alcohols, for example (a) lower alcohols such as ethanol, propanol, isopropanol and n-butanol, (b) ketones such as acetone and methyl ethyl ketone, (c) C ₂ -C ₄ polyols such as a diol or a triol, for example ethylene glycol, propylene glycol, glycerol or mixtures thereof. Especially preferred is 1,2-octanediol from the class of diols.

In a preferred embodiment, the agent according to the invention contains one or more solvents from the group comprising C ₁ to C ₄ monoalcohols, C ₂ to C ₆ glycols, C ₃ to C ₁₂ glycol ethers and glycerol, in particular ethanol , The inventive C ₃ - to C ₁₂ glycol ethers contain alkyl or Alkenyl groups having less than 10 carbon atoms, preferably up to 8, in particular up to 6, more preferably 1 to 4 and most preferably 2 to 3 carbon atoms.

Preferred C ₁ to C ₄ monohydric alcohols are ethanol, n-propanol, isopropanol and tert-butanol. Preferred C ₂ to C ₆ glycols are ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,5-pentanediol, neopentyl glycol and 1,6-hexanediol, especially ethylene glycol and 1,2-propylene glycol. Preferred C ₃ - to C ₁₂ glycol ethers are di-, tri-, tetra- and pentaethylene glycol, di-, tri- and tetrapropylene glycol, propylene glycol monotertiary butyl ether and propylene glycol monoethyl ether and the solvents designated according to INCI butoxydiglycol, butoxyethanol, butoxyisopropanol, butoxypropanol, butyloctanol, ethoxydiglycol, Ethoxyethanol, ethyl hexanediol, isobutoxypropanol, isopentyldiol, 3-methoxybutanol, methoxyethanol, methoxyisopropanol and methoxymethylbutanol.

Preferred agents according to the invention contain one or more solvents in a total amount of usually up to 90% by weight, preferably 0.1 to 50% by weight, in particular 2 to 40% by weight, particularly preferably 3 to 30% by weight. , most preferably 5 to 15 wt .-% each based on the total agent.

In a further preferred embodiment, the agent according to the invention contains at least one viscosity regulator, which preferably acts as a thickener.

The viscosity of the compositions according to the invention can be measured by conventional standard methods (for example Brookfield viscometer RVD-VII at 20 rpm and 20 ° C., spindle 3) and is preferably in the range from 10 to 5000 mPas. Preferred liquid to gel compositions have viscosities of 20 to 4000 mPas, with values between 40 and 2000 mPas being particularly preferred.

Suitable thickeners are inorganic or polymeric organic compounds. It is also possible to use mixtures of several thickeners.

The inorganic thickeners include, for example, polysilicic acids, clay minerals such as montmorillonites, zeolites, silicas, aluminum silicates, phyllosilicates, organically modified phyllosilicates such as quaternium hectorite and others, and bentonites.

The organic thickeners are derived from the groups of natural polymers, modified natural polymers and fully synthetic polymers.

Naturally derived polymers which are used as thickeners are, for example, xanthan gum, agar agar, carrageenan, tragacanth, gum arabic, alginates, pectins, polyoses, guar gum, gellan gum, locust bean gum, starch, dextrins, gelatin and casein.

Modified natural products come mainly from the group of modified starches and celluloses, examples which may be mentioned here carboxymethylcellulose and other cellulose ethers, hydroxyethyl and propylcellulose, highly etherified methylhydroxyethylcellulose and core flour ethers.

A large group of thickeners, which find wide use in a variety of applications, are the fully synthetic polymers such as polyacrylic and polymethacrylic compounds, which may be crosslinked or uncrosslinked and optionally cationically modified, vinyl polymers, polycarboxylic acids, polyethers, activated polyamide derivatives, Castor oil derivatives, polyimines, polyamides and polyurethanes. Examples of such polymers are acrylic resins, ethyl acrylate-acrylamide copolymers, acrylic ester-methacrylic acid ester copolymers, ethyl acrylate-acrylic acid-methacrylic acid copolymers, N-methylolmeth-acrylamide, maleic anhydride-methyl vinyl ether copolymers, polyether-polyol copolymers and butadiene -styrene copolymers.

Further suitable thickeners are derivatives of organic acids and their alkoxide adducts, for example aryl polyglycol ethers, carboxylated nonylphenol ethoxylate derivatives, sodium alginate, diglycerol monoisostearate, nonionic ethylene oxide adducts, coconut fatty acid diethanolamide, isododecenylsuccinic anhydride and galactomannan. Thickener from the mentioned classes of substances are commercially available and, for example, under the trade names Acusol ^® -820 (methacrylic acid (stearyl alcohol 20 EO) ester-acrylic acid copolymer, 30% in water, Rohm & Haas), Da-Pral ^® -GT -282-S (alkyl polyglycol ethers, Akzo), DEUTEROL ^® polymer-11 (dicarboxylic acid copolymer, Schoner GmbH) deuteron ^® -xg (anionic heteropolysaccharide based on β-D-glucose, D-mannose, D-glucuronic acid, Beautiful GmbH), -XN deuteron ^® (non-ionic polysaccharide, Schoner GmbH), DICRYLAN ^® -Verdicker-O (ethylene oxide adduct, 50% solution in water / isopropanol, Pfersse Chemie), EMA ^® -81 and EMA ^® -91 (ethylene Maleic anhydride copolymer, Monsanto), Thickener QR-1001 (polyurethane emulsion, 19-21% in water / diglyme, Rohm & Haas), Mirox ^® -AM (anionic acrylic acid-acrylate copolymer dispersion, 25% in water, Stockhausen), SER- AD FX 1100 (hydrophobic urethane polymer, servo Delden), Shellflo ^® -S (high-molecular weight polysaccharide, stabilized with formaldehyde, Shell), Shellflo XA ^® (xanthan biopolymer, stabilized with formaldehyde, Shell), Kelzan, Keltrol T (Kelco).

Dyes can be used optionally in the composition according to the invention, wherein the amount of one or more dyes is to be chosen so small that remain after application of the agent no visible residues. Preferably, the agent according to the invention is free of dyes.

The agent according to the invention may preferably contain one or more antimicrobial agents or preservatives in an amount of usually 0.0001 to 3 wt.%, Preferably 0.0001 to 2 wt.%, In particular 0.0002 to 1 wt. more preferably 0.0002 to 0.2% by weight, most preferably 0.0003 to 0.1% by weight.

Depending on the antimicrobial spectrum and mechanism of action, antimicrobial agents or preservatives are distinguished between bacteriostats and bactericides, fungistatics and fungicides, etc. Important substances from these groups are, for example, benzalkonium chlorides and halophenols. The terms antimicrobial action and antimicrobial agent have the usual meaning within the scope of the teaching according to the invention. Suitable antimicrobial agents are preferably selected from the groups of alcohols, amines, aldehydes, antimicrobial acids or their salts, carboxylic acid esters, acid amides, phenols, phenol derivatives, diphenyls, diphenylalkanes, urea derivatives, oxygen, nitrogen acetals and formal, benzamidines, phthalimide derivatives , antimicrobial surface-active compounds, quinolines, 1,2-dibromo-2,4-di-cyanobutane, iodo-2-propyl-butyl-carbamate, iodine, iodophors, peroxo compounds and any mixtures of the above.

The antimicrobial agent may be selected from n-propanol, i-propanol, 1,3-butanediol, phenoxyethanol, 1,2-propylene glycol, glycerol, undecylenic acid, benzoic acid, salicylic acid, 2,4,4'-trichloro-2 '-hydroxydiphenylether (trichlosan), chlorhexidine, N- (4-chlorophenyl) -N- (3,4-dichlorophenyl) urea and natural antimicrobial agents of plant origin (eg from spices or herbs), of animal and microbial origin. Preferably, antimicrobial surface-active quaternary compounds, a natural antimicrobial agent of plant origin and / or a natural antimicrobial agent of animal origin, most preferably at least one natural antimicrobial agent of plant origin from the group comprising caffeine, theobromine and theophylline and essential oils such as eugenol, thymol and geraniol, and / or at least one natural antimicrobial agent of animal origin from the group, comprising enzymes such as protein from milk, lysozyme and lactoperoxidase, and / or at least one antimicrobial surface-active quaternary compound with an ammonium, sulfonium, phosphonium, iodonium - or Arsoniumgruppe, peroxo compounds and chlorine compounds are used. Also substances of microbial origin, so-called bacteriocins, can be used. Glycine, glycine derivatives, formaldehyde, compounds which readily split off formaldehyde, formic acid and peroxides are preferably used.

The suitable as antimicrobial agents quaternary ammonium compounds (QAV) have been described above. Is particularly suitable, for example, benzalkonium chloride, etc. Benzalkonium halides and / or substituted benzalkonium halides are for example commercially available as Barquat ^® ex Lonza, Marquat® ^® ex Mason, Variquat ^® ex Witco / Sherex and Hyamine ^® ex Lonza and as Bardac ^® ex Lonza. Other commercially obtainable antimicrobial agents are N- (3-chloroallyl) hexaminium chloride such as Dowicide and Dowicil ^{® ®} ex Dow, benzethonium chloride such as Hyamine ^® 1622 ex Rohm & Haas, methylbenzethonium as Hyamine ^® 10X ex Rohm & Haas, cetylpyridinium chloride such as Cepacol ex Merrell Labs ,

in der R₁, R₂, R₃ und R₄ unabhängig voneinander für ein Wasserstoffatom, eine Methyl-, Ethyl-, n-Propyl-, Isopropyl-, n-Butyl-, sek.-Butyl-, tert. Butyl- oder C₂-C₆-Hydroxyalkyl-Gruppe, die mit 1 bis 5 Hydroxylgruppen oder C₁-C₄-Hydroxyalkyl-Gruppen substituiert ist, stehen, mit der Maßgabe, dass mindestens einer der Reste R₁–R₄ eine C₂-C₆-Hydroxyalkyl-Gruppe, die mit 1 bis 5 Hydroxylgruppen oder C₁-C₄-Hydroxyalkyl-Gruppen substituiert ist, darstellt. Further preferred compositions according to the invention are characterized in that at least one alkyl- or hydroxyalkyl-substituted urea of the general formula (A) is present to improve the skin moisture,

in which R ₁ , R ₂ , R ₃ and R ₄ independently of one another represent a hydrogen atom, a methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert. Butyl or C ₂ -C ₆ hydroxyalkyl group which is substituted with 1 to 5 hydroxyl groups or C ₁ -C ₄ hydroxyalkyl groups, provided that at least one of R ₁ -R _{4 is} a C C ₂ -C ₆ hydroxyalkyl group substituted with 1 to 5 hydroxyl groups or C ₁ -C ₄ hydroxyalkyl groups.

Further preferred compositions according to the invention are characterized in that the at least one alkyl- or hydroxyalkyl-substituted urea of the general formula (A) is selected from compounds in which R ₁ , R ₂ , R ₃ and R ₄ independently of one another represent a hydrogen atom, a methyl , Ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, tert. Butyl or C ₂ -C ₆ hydroxyalkyl group substituted with 1 to 5 hydroxyl groups or C ₁ -C ₄ hydroxyalkyl groups, provided that at least one of R ₁ and R ₂ and simultaneously at least one of R ₃ and R _{4 is} a C ₂ -C ₆ hydroxyalkyl group substituted with 1 to 5 hydroxyl groups or C ₁ -C ₄ hydroxyalkyl groups.

Further preferred compositions according to the invention are characterized in that the at least one alkyl or hydroxyalkyl-substituted urea of the general formula (A) is selected from bis-N, N '- (2-hydroxyethyl) urea. Particularly preferred compositions according to the invention are characterized in that they contain at least one alkyl or hydroxyalkyl-substituted urea of the formula (A), in particular N, N'-bis (2-hydroxyethyl) urea, in a total amount of 0.01-50% by weight. %, preferably 0.1-20 wt .-%, more preferably 1-10 wt .-% and most preferably 2-5 wt .-%, based on the total composition, included. N, N'-bis- (2-hydroxyethyl) urea, a crystalline solid at room temperature, is available, for example, as a Hydrovance commercial product from National Starch and Chemical Company as an approximately 45-55% aqueous solution containing urea and ammonium lactate.

In a preferred embodiment, the compositions according to the invention contain at least one further cosmetic active ingredient which is selected from monomers, oligomers and polymers of amino acids, NC ₂ -C ₂₄ -acylamino acids and / or the esters and / or the physiologically tolerable metal salts of these substances, as well as mixtures of these agents.

The monomers of the amino acids and / or the NC ₂ -C ₂₄ -acylamino acids are selected from alanine, arginine, asparagine, aspartic acid, canavanine, citrulline, cysteine, cystine, desmosine, dipalmitoylhydroxyproline, glutamine, glutamic acid, glycine, histidine, homophenylalanine, hydroxylysine, Hydroxyproline, isodesmosine, isoleucine, leucine, lysine, methionine, methylnorleucine, ornithine, phenylalanine, proline, pyroglutamic acid, sarcosine, serine, taurine, threonine, thyroxine, tryptophan, tyrosine, valine, N-acetyl-L-cysteine, zinc pyroglutamate, sodium octanoylglutamate, Sodium decanoyl glutamate, sodium lauroyl glutamate, sodium myristoyl glutamate, sodium cetoyl glutamate and sodium stearoyl glutamate. Particularly preferred are lysine, serine, N-acetyl-L-cysteine, zinc and sodium pyroglutamate and sodium lauroylglutamate.

The C ₂ -C ₂₄ acyl radical with which the said amino acids are derivatized on the amino group is selected from an acetyl, propanoyl, butanoyl, pentanoyl, hexanoyl, heptanoyl, octanoyl, nonanoyl, decanoyl , Undecanoyl, lauroyl, tridecanoyl, myristoyl, pentadecanoyl, cetoyl, palmitoyl, stearoyl, elaidoyl, arachidoyl or behenoyl radical. Mixtures of C ₈ -C ₁₈ acyl radicals are also referred to as cocoyl radical and are likewise preferred substituents. With the aforementioned C ₂ -C ₂₄ acyl radicals, the amino acids which carry an OH group may also be esterified to this OH group. A preferred example of this according to the invention is hydroxyproline, which is N-acylated and esterified with two, preferably linear, C ₂ -C ₂₂ fatty acid residues, more preferably dipalmitoylhydroxyproline, which is e.g. B. Sepilift DPHP available from the company Seppic.

The physiologically acceptable salts of the inventively preferred active ingredients containing acid groups and can form salts are selected from the ammonium, alkali metal, magnesium, calcium, aluminum, zinc and manganese salts. Preferred are the sodium, potassium, magnesium, aluminum, zinc and manganese salts.

According to the invention, amino acid oligomers are peptides having 2-30, preferably 2-15, amino acids. The oligomers of the amino acids and / or the NC ₂ -C ₂₄ -acylamino acids are preferably selected from di-, tri-, tetra-, penta-, hexa- or pentadecapeptides which may be N-acylated and / or esterified. Many of these amino acid oligomers stimulate collagen synthesis or are able to recruit immune system cells, such as mast cells and macrophages, which then induce tissue repair processes via the release of growth factors, eg collagen synthesis, or are able to sequence them To bind Arg-Phe-Lys in thrombospondin I (TSP-1) and thus to release active TGF-ß (tissue growth factor), which induces the synthesis of collagen in dermal fibroblasts. Such amino acid oligomers can be used as anti-aging agents.

According to preferred, optionally N-acylated and / or esterified dipeptides are acetyl-citrullyl-arginine (eg Exsy-algins of exsymol with the INCI name Acetyl Citrull Amido Arginine), Tyr-Arg (dipeptide-1), Val- Trp (dipeptide-2), Asn-Phe, Asp-Phe, N-palmitoyl-.beta.-Ala-His, N-acetyl-Tyr-Arg-hexyldecylester (eg Calmosensine from Sederma), carnosine (.beta. His) and N-palmitoyl-Pro-Arg. According to preferred, optionally N-acylated and / or esterified tripeptides are Gly-His-Lys, z. B. under the name "Omega-CH activator" from GfN or in acylated form (N-palmitoyl-Gly-His-Lys) under the name Biopeptide CL is available from Sederma, but (in acylated form) also a component of the product Matrixyl 3000 from Sederma. The tripeptide Gly-His-Lys can also be used as a copper salt (Cu ²⁺ ) and is available as such from ProCyte Corporation. Furthermore, analogues of Gly-His-Lys can be used, wherein a maximum of two amino acids are substituted by suitable other amino acids. For the substitution of Gly, Ala, Leu and Ile are suitable according to the invention. The inventively preferred amino acids that can replace His or Lys include a side chain with a nitrogen atom that is predominantly charged at pH 6, eg. Pro, Lys, Arg, His, desmosine and isodesmosine. Most preferably, Lys is replaced by Arg, Orn or citrulline. A further preferred tripeptide according to the invention is Gly-His-Arg (INCI name: tripeptide-3) and its derivative N-myristoyl-Gly-His-Arg, which, for. B. available under the name Collasyn 314-GR from Therapeutic Peptide Inc.; Further preferred tripeptides according to the invention are selected from Lys-Val-Lys, Lys-Val-Dab (Dab = diaminobutyric acid), Lys-Phe-Lys, Lys-Ile-Lys, Dab-Val-Lys, Lys-Val-Orn, Lys- Val-Dap (Dap = diaminopropionic acid), Dap-Val-Lys, palmitoyl-Lys-Val-Lys, e.g. As sold by the company Pentapharm under the name ^® SYN -COLL, Lys-Pro-Val, Tyr-Tyr-Val, Tyr-Val-Tyr, Val-Tyr-Val (Tripeptide-2), Tripeptide-4 (z. ATPeptides, via IMPAG), His-Ala-Orn N -elaidoyl-Lys-Phe-Lys and N-acetyl-Arg-Lys-Arg-NH ₂ .

Preference according to the invention, optionally N-acylated and / or esterified tetrapeptides are selected from Rigin and Rigin-based tetrapeptides and ALAMCAT tetrapeptides. Rigin has the sequence Gly-Gln-Pro-Arg. Rigin-based tetrapeptides include the Rigin analogs and Rigin derivatives, in particular the invention particularly preferred N-palmitoyl-Gly-Gln-Pro-Arg, z. B. is available under the name Eyeliss of Sederma, but also forms part of the product Matrixyl 3000 of Sederma. The Rigin analogs include those in which the four amino acids are rearranged and / or in which a maximum of two amino acids are substituted to Rigin, z. For example, the sequence Ala-Gln-Thr-Arg. Preferably, at least one of the amino acids of the sequence has a Pro or Arg, and more preferably, the Tetrapeptide includes both Pro and Arg, and their order and position may vary. The substituting amino acids can be selected from any amino acid defined below. Particularly preferred rigin-based tetrapetides include: Xaa-Xbb-Arg-Xcc, Xaa-Xbb-Xcc-Pro, Xaa-Xbb-Pro-Arg, Xaa-Xbb-Pro-Xcc, Xaa-Xbb-Xcc-Arg, where Xaa , Xbb and Xcc may be the same or different amino acids and wherein Xaa is selected from Gly and the amino acids that can substitute Gly, Xbb is selected from Gln and the amino acids that can substitute for Gln, Xcc is selected from Pro or Arg and the Amino acids that can substitute Pro and Arg.

The preferred amino acids that can replace Gly include an aliphatic side chain, e.g. Β-Ala, Ala, Val, Leu, Pro, sarcosine (Sar) and isoleucine (Ile).

The preferred amino acids which can replace Gln include a side chain having an amino group predominantly uncharged at neutral pH (pH 6-7), e.g. Asn, Lys, Orn, 5-hydroxyproline, citrulline and canavanine.

The preferred amino acids which can replace Arg include a side chain having a nitrogen atom predominantly charged at pH 6, e.g. Pro, Lys, His, Desmosin and Isodesmosin.

As Rigin analogs according to the invention Gly-Gln-Arg-Pro and Val-Val-Arg-Pro are preferred. ALAMCAT tetrapeptides are tetrapeptides containing at least one amino acid with an aliphatic side chain, z. Β-Ala, Ala, Val, Leu, Pro, sarcosine (Sar) and isoleucine (Ile). Furthermore, ALAMCAT tetrapeptides include at least one amino acid having a side chain with an amino group predominantly uncharged at neutral pH (pH 6-7), eg Gln, Asn, Lys, Orn, 5-hydroxyproline, citrulline and canavanine. Furthermore, ALAMCAT tetrapeptides include at least one amino acid having a side chain with a nitrogen atom predominantly charged at pH 6, e.g. Arg, Pro, Lys, His, Desmosin and Isodesmosin. As the fourth amino acid, ALAMCAT tetrapeptides may contain any amino acid; however, preferably the fourth amino acid is also selected from the three abovementioned groups. Optionally N-acylated and / or esterified pentapeptides which are preferred according to the invention are selected from Lys-Thr-Thr-Lys-Ser and its N-acylated derivatives, particularly preferably N-palmitoyl-Lys-Thr-Thr-Lys-Ser, which can be obtained under the Matrixyl is available from Sederma, further N-palmitoyl-Tyr-Gly-Gly-Phe-Met, Val-Val-Arg-Pro-Pro, N-palmitoyl-Tyr-Gly-Gly-Phe-Leu, Gly- Pro-Phe-Pro-Leu and N-benzyloxycarbonyl-Gly-Pro-Phe-Pro-Leu (the latter two are serine proteinase inhibitors for desquamation inhibition). Preferred, if appropriate, N-acylated and / or esterified hexapeptides according to the invention are Val-Gly-Val-Ala-Pro-Gly and its N-acylated derivatives, particularly preferably N-palmitoyl-Val-Gly-Val-Ala-Pro-Gly Acetyl-Hexapeptide-3 (Argireline from Lipotec), Hexapeptide-4 (e.g., Collasyn 6KS from Therapeutic Peptide Inc. (TPI)), Hexapeptide-5 (e.g. Collasyn 6VY from TPI), myristoyl hexapeptide-5 (e.g., Collasyn 614VY from TPI), myristoyl hexapeptide-6 (e.g., Collasyn 614VG from TPI), hexapeptide-8 (e.g., Collasyn 6KS from TPI ), Myristoyl hexapeptide-8 (eg Collasyn Lipo-6KS from TPI), hexapeptide-9 (eg Collaxyl from Vincience) and hexapeptide-10 (eg Collaxyl from Vincience or Seriseline from Lipotec), Ala -Arg-His-Leu-Phe-Trp (hexapeptide-1), acetyl hexapeptide-1 (e.g., modulene from Vincience), acetyl glutamyl hexapeptide-1 (e.g., SNAP-7 from Centerchem), hexapeptide-2 (eg, melanostatine-DM from Vinci ence), Ala-Asp-Leu-Lys-Pro-Thr (hexapeptide-3, e.g. Peptide 02 from Vincience), Val-Val-Arg-Pro-Pro-Pro, hexapeptide-4 (e.g., Collasyn 6KS from Therapeutic Peptide Inc. (TPI)), hexapeptide-5 (e.g., Collasyn 6VY from TPI), myristoyl hexapeptide-5 (eg Collasyn 614VY from TPI), myristoyl hexapeptide-6 (eg Collasyn 614VG from TPI), Ala-Arg-His-methylnorleucine-homophenylalanine-Trp (hexapeptide-7) Hexapeptide-8 (e.g., Collasyn 6KS from TPI), myristoyl hexapeptide-8 (e.g., Collasyn Lipo-6KS from TPI), hexapeptide-9 (e.g., Collaxyl from Vincience), hexapeptide-10 (e.g. B. Collaxyl from Vincience or Seriseline from Lipotec) and hexapeptide-11 (eg, Peptamide-6 from Arch Personal Care). An inventively preferred pentadecapeptide is z. As the raw material Vinci 01 by Vincience (Pentadecapeptide-1). Another preferred amino acid oligomer is the peptide derivative L-glutamylaminoethyl-indole (glistine exsymol).

Particularly preferred according to the invention is the combination of N-palmitoyl-Gly-His-Lys and N-palmitoyl-Gly-Gln-Pro-Arg, as obtainable, for example, in the raw material Matrixyl 3000 from Sederma.

The polymers of the amino acids and / or the NC ₂ -C ₂₄ -acylamino acids are preferably selected from vegetable and animal protein hydrolysates and / or proteins. Animal protein hydrolysates are z. B. elastin, collagen, keratin, silk, conchiolin and milk protein protein hydrolysates, which may also be in the form of salts. Vegetable protein hydrolysates, eg. Soy, wheat, almonds, peas, potato and rice protein hydrolysates. Corresponding commercial products are z. B. DiaMin® ^® (Diamalt) Gluadin ^® (Cognis), Lexein ^® (Inolex) and Crotein ^® (Croda). Particularly preferred are soy protein hydrolysates, more preferably soy protein hydrolysates having an average molecular weight in the range of 1200-1800 daltons, preferably in the range of 1400-1700 daltons, e.g. B. under the trade name Ridulisse C ^{® available} from the company Silab, and soy protein hydrolysates having an average molecular weight in the range of 600-1000 Dalton, preferably 800 Dalton, z. As available under the trade name Phytokine ^® from Coletica. with coconut fatty acids N-acylated and / or esterified Soyaproteinhydrolysaten in the form of their alkali metal salts. Coconut fatty acids include predominantly alkanecarboxylic acids having a number of carbon atoms of 8-18, especially caprylic, capric, lauric, myristic, palmitic and stearic acids. Preferred alkali metal salts are selected from lithium, sodium and potassium salts, with the potassium salts being particularly preferred.

Another particularly preferred soy protein hydrolyzate according to the invention is an N-acylated and / or esterified soy protein hydrolyzate with coconut fatty acids in the form of the potassium salt, which is available from Sinerga under the trade name Coccopolipeptide di Soya.

Also preferred according to the invention are keratin hydrolysates, in particular wool keratin hydrolysates. A particularly preferred wool keratin hydrolyzate is available under the name Keratec Pep from Croda. Keratec Pep has a smaller molecular weight fraction having an average molecular weight of 150 daltons and a larger molecular weight fraction having an average molecular weight of 1265 daltons. Also preferred according to the invention are conchiolin hydrolysates, in particular those available under the names Pearl Protein Extract and Pearl Protein Extract BG from Maruzen. Conchiolin is a complex protein produced from the outer epithelium of molluscs, in particular pearl shells and various types of snails, and forms the very stable shell of these molluscs by incorporation of calcium carbonate crystals. Naturally, protein hydrolysates may also contain monomeric amino acids and oligopeptides; their composition is usually undefined.

Also preferred is the use of acyl derivatives of protein hydrolysates, z. In the form of their fatty acid condensation products. Corresponding commercial products are z. B. Lamepon ^® (Cognis), Gluadin ^® (Cognis), Lexein ^® (Inolex), Crolastin ^{® ®} or Crotein (Croda).

Another active ingredient which is preferred according to the invention and whose action is improved in the presence of the photocatalytically active metal oxide used in accordance with the invention is the peptide derivative L-glutamylaminoethyl-indole (obtainable, for example, under the trade name glistin from exsymol).

Also preferred according to the invention are cationized protein hydrolysates. Particularly preferred are cationic protein hydrolysates whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 5000 daltons. Furthermore, cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof. Furthermore, the cationic protein hydrolysates may also be further derivatized. As typical examples of cationic protein hydrolysates and derivatives used in the present invention, some of them are listed under the INCI names in "International Cosmetic Ingredient Dictionary and Handbook," (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, suite 300, Washington, DC 20036-4702) Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Silk, Cocodimonium Hydroxypropyl Hydrolyzed Silk Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Hydroxypropyl Arginine Lauryl / Myristyl ether HCl. Very particular preference is given to the cationic protein hydrolysates and derivatives based on plants.

In a further preferred embodiment, the polymers of the amino acids are selected from DNA repair enzymes.

DNA repair enzymes preferred according to the invention are photolyase and T4 endonuclease V, the latter abbreviated to "T4N5" below. These two enzymes are already known in the art as so-called DNA repair enzymes. DNA repair is defined as the cleavage or removal of UV-induced pyrimidine dimers from the DNA. Photolyase is the abbreviation for deoxyribodipyrimidine photolyase or DNA photolyase, an enzyme with the classification number EC 4.1.99.3. A particularly efficient photolyase is derived from Anacystis nidulans, a phototrophic marine microorganism. The photolyase from A. nidulans is now obtained in technically relevant quantities from E. coli. Photolyase relies on light for activation.

The enzyme T4 endonuclease V is produced by the denV gene of bacteriophage T4 and belongs to the phosphodiesterases which hydrolytically cleave the nucleic acids at the (5`-3`) bond. T4N5 is also active without the influence of light.

Particularly preferred according to the invention is the use of liposome-encapsulated DNA repair enzymes. Liposome-encapsulated photolyase is commercially available for. B. under the product name Photosome ^TM , liposome-encapsulated T4N5 z. Available under the name Ultrasome ^™ from AGI Dermatics, USA.

Particularly preferred compositions according to the invention are characterized in that they comprise at least one of the commercial products Photosomes ^™ or Ultrasomes ^™ in total amounts of 0.1-10% by weight, preferably 0.5-5.0% by weight and particularly preferably 1.0 -4.0 wt .-%, based on the total composition of the invention.

Particularly preferred compositions according to the invention are characterized in that they comprise at least one monomer, oligomer or polymer of amino acids, NC ₂ -C ₂₄ -acylamino acids and / or the esters and / or the physiologically tolerable metal salts of these substances in total amounts of 0.0000001-10 wt .-%, preferably 0.001-5 wt .-% and particularly preferably 0.01-1-2-3 wt .-%, each based on the active substance content in the total composition according to the invention.

In a further preferred embodiment, the compositions according to the invention comprise at least one DNA oligonucleotide or at least one RNA oligonucleotide. According to the invention, an oligonucleotide is understood as meaning polymers of from 2 to 20, preferably from 2 to 10, mononucleotides which, like polynucleotides and nucleic acids, are linked by phosphoric diester bridges. The nucleotides consist of nucleobases (usually pyrimidine or purine derivatives), pentoses (usually D-ribofuranose or 2-deoxy-D-ribofuranose in β-N-glycosidic bond to the nucleobase) and phosphoric acid. The mononucleotides are, for example, adenosine phosphates, cytidine phosphates, guanosine phosphates, uridine phosphates and thymidine phosphates, in particular CMP (cytidine 5'-monophosphate), UDP (uridine 5'-diphosphate), ATP (adenosine 5'-triphosphate) and GTP (guanosine). 5'-triphosphate).

An oligonucleotide particularly preferred according to the invention is the thymidine dinucleotide. Particularly preferred compositions according to the invention are characterized in that they contain at least one DNA oligonucleotide and / or one RNA oligonucleotide in total amounts of 0.000001-5 wt.%, Preferably 0.0001-0.5 wt.%, And particularly preferably 0.001-0.05 wt .-%, based on the total composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one natural betaine compound. Natural betaine compounds of the invention are naturally occurring compounds having the atomic group R ₃ N ⁺ -CH ₂ -X-COO ^- according to IUPAC Rule C-816.1. So-called betaine surfactants (synthetic) do not fall under the betaine compounds used according to the invention, nor any other zwitterionic compounds in which the positive charge on N or P and the negative charge formally reside on O, S, B or C, but which are not of the IUPAC Comply with rule C-816.1. According to the invention preferred betaine are betaine (Me ₃ N ⁺ -CH ₂ -COO ^-) carnitine and (Me ₃ N ⁺ -CH ₂ -CHOH-CH ₂ -COO ^-), each with Me = methyl and X = C-C single bond (in Case of betaine) or X = -CHOH-CH ₂ - (in the case of carnitine).

Particularly preferred compositions according to the invention are characterized in that they contain at least one natural betaine compound in a total amount of 0.05 to 15% by weight, preferably 0.1 to 3% by weight, particularly preferably 0.5 to 2% by weight. , in each case based on the total composition.

In a further preferred embodiment, the compositions according to the invention contain at least one vitamin, provitamin or a compound designated as vitamin precursor from the vitamin groups A, B, C, E, H and K and the esters of the aforementioned substances.

The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the provitamin of retinol. Particularly preferred vitamin A components according to the invention are vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol, and also esters thereof, such as retinyl palmitate and retinyl acetate. Particularly preferred compositions according to the invention are characterized in that they contain, in addition to the photocatalytically active metal oxide used according to the invention, at least one vitamin, provitamin or a compound designated as vitamin precursor from the vitamin group A or at least one ester thereof in total amounts of 0.001-2% by weight, preferably 0 , 05-0.05-1 wt .-%, based on the total composition.

• – Vitamin B₁, Trivialname Thiamin, chemische Bezeichung 3-[(4´-Amino-2´-methyl-5´-pyrimidinyl)-methyl]-5-(2-hydroxyethyl)-4-methylthiazoliumchlorid. Bevorzugt wird Thiaminhydrochlorid in Mengen von 0,0005 bis 0,1–1 Gew.-%, bezogen auf die gesamte erfindungsgemäße Zusammensetzung, eingesetzt.
• – Vitamin B₂, Trivialname Riboflavin, chemische Bezeichung 7,8-Dimethyl-10-(1-D-ribityl)-benzo[g]pteridin-2,4(3H,10H)-dion. Bevorzugt werden Riboflavin oder seine Derivate in Mengen von 0,0005 bis 0,1–1 Gew.-%, bezogen auf die gesamte erfindungsgemäße Zusammensetzung, eingesetzt.
• – Vitamin B₃. Unter dieser Bezeichnung werden die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt. Erfindungsgemäß bevorzugt ist das Nicotinsäureamid, das in den erfindungsgemäßen Zusammensetzungen bevorzugt in Mengen von 0,0005 bis 0,1–1 Gew.-%, bezogen auf die gesamte erfindungsgemäße Zusammensetzung, enthalten ist.
• – Vitamin B₅ (Pantothensäure und Panthenol). Bevorzugt wird Panthenol eingesetzt. Erfindungsgemäß bevorzugte Derivate des Panthenols sind insbesondere die Ester und Ether des Panthenols sowie kationisch derivatisierte Panthenole. In einer weiteren bevorzugten Ausführungsform der Erfindung werden an Stelle von sowie zusätzlich zu Pantothensäure oder Panthenol auch Derivate des 2-Furanon mit der allgemeinen Strukturformel (VIT-I) eingesetzt.

The vitamin B group or the vitamin B complex include, among others

• - Vitamin B ₁ , trivial name thiamine, chemical name 3 - [(4'-amino-2'-methyl-5'-pyrimidinyl) methyl] -5- (2-hydroxyethyl) -4-methylthiazolium chloride. Thiamine hydrochloride is preferably used in amounts of from 0.0005 to 0.1-1% by weight, based on the total composition according to the invention.
• - Vitamin B ₂ , common name riboflavin, chemical name 7,8-dimethyl-10- (1-D-ribityl) -benzo [g] pteridine-2,4 (3H, 10H) -dione. Riboflavin or its derivatives are preferably used in amounts of from 0.0005 to 0.1-1% by weight, based on the total composition according to the invention.
• - Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are performed. Preferred according to the invention is the nicotinic acid amide, which is preferably present in the compositions according to the invention in amounts of from 0.0005 to 0.1-1% by weight, based on the total composition according to the invention.
• - Vitamin B ₅ (pantothenic acid and panthenol). Panthenol is preferably used. Preferred derivatives of panthenol according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. In a further preferred embodiment of the invention, derivatives of 2-furanone having the general structural formula (VIT-I) are used instead of and in addition to pantothenic acid or panthenol.

Particularly preferred are the 2-furanone derivatives in which the substituents R ¹ to R ^{6 are} independently a hydrogen atom, a hydroxyl radical, a methyl, methoxy, aminomethyl or hydroxymethyl radical, a saturated or mono- or diunsaturated, linear or branched C ₂ -C ₄ -hydrocarbon radical, a saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy-C ₂ -C ₄ -hydrocarbon radical or a saturated or mono- or diunsaturated, branched or linear mono , Di- or triamino-C ₂ -C ₄ hydrocarbon radical. Particularly preferred derivatives are the commercially available substances dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone with the trivial name pantolactone (Merck), 4-hydroxymethyl-γ-butyrolactone (Merck), 3,3 Dimethyl 2-hydroxy-γ-butyrolactone (Aldrich) and 2,5-dihydro-5-methoxy-2-furanone (Merck), expressly including all stereoisomers. The extremely preferred 2-furanone derivative according to the invention is pantolactone (dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone), where in formula (I) R ^{1 is} a hydroxyl group, R ^{2 is} a hydrogen atom, R ³ and R ^{4 represent} a methyl group and R ⁵ and R ^{6 represent} a hydrogen atom. The stereoisomer (R) -pantolactone is formed during the degradation of pantothenic acid.

• – Vitamin B₆, wobei man hierunter keine einheitliche Substanz, sondern die unter den Trivialnamen Pyridoxin, Pyridoxamin und Pyridoxal bekannten Derivate des 5-Hydroxymethyl-2-methylpyridin-3-ols versteht. Erfindungsgemäß besonders bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens eine Vitamin B₆-Komponente in einer Gesamtmenge von 0,0001 bis 1,0 Gew.-%, insbesondere in Mengen von 0,001 bis 0,01 Gew.-%, enthalten.
• – Vitamin B₇ (Biotin), auch als Vitamin H oder "Hautvitamin" bezeichnet. Bei Biotin handelt es sich um (3aS, 4S, 6aR)-2-Oxohexahydrothienol[3,4-d]-imidazol-4-valeriansäure. Erfindungsgemäß besonders bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens eine Komponente, ausgewählt aus Biotin und den Biotinestern, in einer Gesamtmenge von 0,0001 bis 1,0 Gew.-%, insbesondere 0,001 bis 0,01 Gew.-%, enthalten.
• – Folsäure (Vitamin B₉, Vitamin B_c). Internationaler Freiname für N-[4-(2-Amino-3,4-dihydro-4-oxo-6-pteridinylmethylamino)-benzoyl]-L-glutaminsäure (N-Pteroyl-L-glutaminsäure, PteGlu). Folat wird synonym zu Pteroylglutamat gebraucht, Folate ist der Sammelbegriff für alle Folsäure-wirksamen Verbindungen und bezeichnet eine Substanzklasse, die einen mit 4-Aminobenzoesäure und L-Glutaminsäure verbundenen Pteridin-Ring enthält. Folsäure ist ein Wachstumsfaktor für verschiedene Mikroorganismen und eine Verbindung mit Vitamincharakter, die in der Natur meist als Polyglutamat und in reduzierter Form (7,8-Dihydrofolsäure, H₂Folat, DHF; Tetrahydrofolsäure, H₄Folat, THF; 5′-Methyl-Tetrahydrofolsäure, CH₃-H₄Folat, MeTHF) vorkommt. Erfindungsgemäß besonders bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens eine Komponente, ausgewählt aus Folsäure, Folaten und deren Estern, in einer Gesamtmenge von 0,0001 bis 1,0 Gew.-%, insbesondere 0,01 bis 0,5 Gew.-%, bezogen auf die Zusammensetzung, enthalten.
• – Orotsäure (Vitamin B₁₃, 1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidin-carbonsäure, Uracil-6-carbonsäure, Molkensäure). Orotsäure, ihr Cholinester oder Orotsäure-Metallsalze (Orotate von Ca, Cr, Fe, K, Co, Cu, Li, Mg, Mn, Na, Zn, Sn) sind erfindungsgemäß besonders bevorzugt. Erfindungsgemäß besonders bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens eine Komponente, ausgewählt aus Orotsäure, Orotaten und deren Estern, in einer Gesamtmenge von 0,0001–1,0 Gew.-%, insbesondere 0,01–0,5 Gew.-%, bezogen auf die Zusammensetzung, enthalten.

Particularly preferred compositions according to the invention are characterized in that they contain at least one of the said compounds of the vitamin B ₅ type and of the 2-furanone derivatives in a total amount of 0.01 to 5% by weight, preferably 0.1 to 3% by weight. , Particularly preferably 0.5 to 2 wt .-%, each based on the total composition.

• - Vitamin B ₆ , which is understood hereunder no uniform substance, but the known under the common names pyridoxine, pyridoxamine and pyridoxal derivatives of 5-hydroxymethyl-2-methylpyridin-3-ols. Particularly preferred compositions according to the invention are characterized in that they contain at least one vitamin B ₆ component in a total amount of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
• - Vitamin B ₇ (biotin), also known as vitamin H or "skin vitamin". Biotin is (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid. Particularly preferred compositions according to the invention are characterized in that they contain at least one component selected from biotin and the biotin esters in a total amount of from 0.0001 to 1.0% by weight, in particular from 0.001 to 0.01% by weight.
• - Folic acid (Vitamin B ₉ , Vitamin B _c ). International generic name for N- [4- (2-amino-3,4-dihydro-4-oxo-6-pteridinylmethylamino) -benzoyl] -L-glutamic acid (N-pteroyl-L-glutamic acid, PteGlu). Folate is used synonymously with pteroylglutamate, folate is the generic term for all folic acid-active compounds and refers to a class of compounds containing a 4-aminobenzoic acid and L-glutamic connected pteridine ring. Folic acid is a growth factor for various microorganisms and a compound of vitamin character, which is usually found in nature as polyglutamate and in reduced form (7,8-dihydrofolic acid, H ₂ folate, DHF, tetrahydrofolic acid, H ₄ folate, THF, 5'-methyl). Tetrahydrofolic acid, CH ₃ -H ₄ folate, MeTHF). Particularly preferred compositions according to the invention are characterized in that they contain at least one component selected from folic acid, folates and their esters, in a total amount of from 0.0001 to 1.0% by weight, in particular from 0.01 to 0.5% by weight. %, based on the composition.
• - Orotic acid (vitamin B ₁₃ , 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidine-carboxylic acid, uracil-6-carboxylic acid, molar acid). Orotic acid, its choline ester or orotic acid metal salts (orotates of Ca, Cr, Fe, K, Co, Cu, Li, Mg, Mn, Na, Zn, Sn) are particularly preferred according to the invention. Particularly preferred compositions according to the invention are characterized in that they contain at least one component selected from orotic acid, orotates and their esters, in a total amount of 0.0001-1.0% by weight, in particular 0.01-0.5% by weight. %, based on the composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one substance which is selected from the vitamins, provitamins and vitamin precursors of the group B ₁ , B ₂ , B ₃ , B ₆ , B ₇ , B ₉ , B ₁₃ and their esters and pantolactone. Preferred vitamins, provitamins and vitamin precursors of group C and their esters are vitamin C (ascorbic acid) and the derivatives ascorbyl palmitate, stearate, dipalmitate, acetate, magnesium ascorbyl phosphate, sodium ascorbyl phosphate, sodium and magnesium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate or ascorbyl. The combination with tocopherols may also be preferred.

Particularly preferred compositions according to the invention are characterized in that they contain at least one of the said compounds of the vitamin C type in a total amount of 0.01 to 5 wt.%, Preferably 0.1 to 3 wt.%, Particularly preferably 0.5 to 1-2 wt .-%, each based on the total composition.

The vitamin E group includes tocopherol, especially α-tocopherol, and its derivatives. Preferred derivatives are in particular the esters, such as tocopheryl acetate, nicotinate, phosphate, succinate, linoleate, oleate, tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50 and tocopherol. Particularly preferred compositions according to the invention are characterized in that they comprise at least one substance selected from tocopherol and its derivatives in a total amount of 0.05 to 5 wt.%, Preferably 0.1 to 3 wt.%, Particularly preferably 0, 5 to 1-2 wt .-%, each based on the total composition included.

Vitamin H is another name for biotin or vitamin B ₇ (see above).

The fat-soluble vitamins of the vitamin K group, which are based on the basic structure of 2-methyl-1,4-naphthoquinone, include phylloquinone (vitamin K ₁ ), farnoquinone or menaquinone-7 (vitamin K2) and menadione (vitamin K ₃ ) , Particularly preferred compositions according to the invention are characterized in that they contain at least one vitamin K in a total amount of from 0001 to 1.0% by weight, preferably from 0.05 to 0.01% by weight, particularly preferably from 0.1 to 0.5 Wt .-%, each based on the total composition included.

Vitamin A palmitate (retinyl palmitate), pantolactone, nicotinamide, pyridoxine, pyridoxamine, pyridoxal, biotin, ascorbyl palmitate, ascorbyl acetate, Mg ascorbyl phosphate, Na ascorbyl phosphate, sodium and magnesium ascorbate and the tocopherol esters, especially tocopheryl acetate, are particularly preferred in the present invention.

In a further preferred embodiment, the compositions according to the invention contain, in addition to the active ingredient combination according to the invention, at least one α-hydroxycarboxylic acid, α-ketocarboxylic acid or β-hydroxycarboxylic acid or their ester, lactone or salt form. Preferred α-hydroxycarboxylic acids or α-ketocarboxylic acids according to the invention are glycolic acid, lactic acid, tartaric acid, citric acid, 2-hydroxybutanoic acid, 2,3-dihydroxypropanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyheptanoic acid, 2-hydroxyoctanoic acid, 2-hydroxydecanoic acid, 2- Hydroxydodecanoic acid, 2-hydroxytetradecanoic acid, 2-hydroxyhexadecanoic acid, 2-hydroxyoctadecanoic acid, mandelic acid, 4-hydroxymandelic acid, malic acid, erythraric acid, threaric acid, glucaric acid, galactaric acid, mannaric acid, gular acid, 2-hydroxy-2-methylsuccinic acid, gluconic acid, pyruvic acid, glucuronic acid and galacturonic acid. Particularly preferred α-hydroxycarboxylic acids are lactic acid, citric acid, glycolic acid and gluconic acid. A particularly preferred β-hydroxycarboxylic acid is salicylic acid. The esters of said acids are selected from the methyl, ethyl, propyl, isopropyl, butyl, amyl, pentyl, hexyl, 2-ethylhexyl, octyl, decyl, dodecyl and hexadecyl esters. Particularly preferred compositions according to the invention are characterized in that in addition to the combination of active substances according to the invention at least one α-hydroxycarboxylic acid, α-ketocarboxylic acid and / or β-hydroxycarboxylic acid or a derivative, in particular an ester, a lactone or a salt thereof, in a total amount of 0, 01-10 wt .-%, preferably 0.1-5 wt .-%, particularly preferably 0.5-1-2 wt .-%, each based on the total composition. In a further preferred embodiment, the compositions according to the invention contain at least one flavonoid or at least one flavonoid-rich plant extract. The flavonoids preferred according to the invention include the glycosides of the flavones, the flavanones, the 3-hydroxyflavones (flavonols), the aurones and the isoflavones. Particularly preferred flavonoids are selected from naringin (aurantiine, naringenin-7-rhamnoglucoside), α-glucosylrutin, α-glucosylmyricetin, α-glucosylisoquercetin, α-glucosylquercetin, dihydroquercetin (taxifolin), hesperidin (3 ', 5,7-trihydroxy-4 '-methoxyflavanone-7-rhamnoglucoside, hesperetin-7-O-rhamnoglucoside), neohesperidin, rutin (3,3', 4 ', 5,7-pentahydroxy-flavone-3-rhamnoglucoside, quercetin-3-rhamnoglucoside), troxerutin (3, 5-dihydroxy-3 ', 4', 7-tris (2-hydroxyethoxy) flavone-3- (6-O- (6-deoxy-α-L-mannopyranosyl) -β-D-glucopyranoside)), monoxerutin ( 3,3 ', 4', 5-Tetrahydroxy-7- (2-hydroxyethoxy) flavone-3- (6-O- (6-deoxy-α-L-mannopyranosyl) -β-D-glucopyranoside)), diosmin (3 ', 4', 7-trihydroxy-5-methoxyflavanone-7-rhamnoglucoside), eriodictin and apigenin-7-glucoside (4 ', 5,7-trihydroxyflavone-7-glucoside).

Extremely preferred flavonoids according to the invention are α-glucosylrutin, naringin and apigenin-7-glucoside.

Also preferred are the constructed from two flavonoid biflavonoids, z. B. occur in gingko species. Other preferred flavonoids are the chalcones, especially phloricin, hesperidin methyl chalcone and neohesperidin dihydrochalcone.

Particularly preferred compositions according to the invention are characterized in that they contain at least one flavonoid in a total amount of from 0.0001 to 1% by weight, preferably from 0.0005 to 0.5% by weight and more preferably from 0.001 to 0.1% by weight. %, in each case based on the flavonoid active substance in the entire cosmetic composition.

In a further preferred embodiment, the compositions according to the invention contain at least one isoflavonoid or at least one isoflavonoid-rich plant extract. The isoflavones and the isoflavone glycosides are counted at this point as isoflavonoids.

For the purposes of the present invention, isoflavones are to be understood as meaning substances which are hydrogenation, oxidation or substitution products of 3-phenyl-4H-1-benzopyran, hydrogenation of which may be in the 2,3-position of the carbon skeleton, oxidation under Formation of a carbonyl group in the 4-position may be present, and by substitution of the replacement of one or more hydrogen atoms by hydroxy or methoxy groups to understand.

The isoflavones preferred according to the invention include, for example, daidzein, genistein, prunetin, biochanin, orobol, santal, pratense, irigenin, glycitein, biochanin A and formononetin. Particularly preferred isoflavones are daidzein, genistein, glycitein and formononetin.

In the isoflavone glycosides preferred according to the invention, the isoflavones are glycosidically linked via at least one hydroxy group to at least one sugar. Suitable sugars are mono- or oligosaccharides, in particular D-glucose, D-galactose, D-glucuronic acid, D-galacturonic acid, D-xylose, D-apiose, L-rhamnose, L-arabinose and rutinose. Particularly preferred isoflavone glycosides according to the invention are daidzin and genistin.

It is furthermore preferred according to the invention if the isoflavones and / or their glycosides are contained in the preparations as constituents of a substance mixture obtained from a plant, in particular a plant extract. Such vegetable substance mixtures can be obtained in a manner familiar to the person skilled in the art, for example by squeezing or extracting from plants such as soya, red clover or chickpeas. Isoflavones or isoflavone glycosides in the form of extracts obtained from soybean are particularly preferably used in the preparations according to the invention, as described, for example, under the product name Soy Protein Isolate SPI (Protein Technology International, St. Louis) or Soy Phytochemicals Concentrate SPC (Archer Daniels Midland, Decatur) are commercially available. Another particularly preferred isoflavonoid-rich plant extract is apple seed extract, in particular the commercial product Ederline from Seporga. Ederline contains phytohormones, isoflavonoids, phytosterols, triterpenoids, tocopherols and natural waxes.

Particularly preferred compositions according to the invention are characterized in that they contain at least one isoflavonoid in a total amount of 0.00001 to 1% by weight, preferably 0.0005 to 0.5% by weight and more preferably 0.001 to 0.1% by weight. %, in each case based on the Isoflavonoidaktivsubstanz in the entire cosmetic composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one polyphenol or one polyphenol-rich plant extract.

According to the invention, polyphenols are aromatic compounds which contain at least two phenolic hydroxyl groups in the molecule. These include the three dihydroxybenzenes catechol, resorcinol and hydroquinone, phloroglucin, pyrogallol and hexahydroxybenzene. In nature, free and etherified polyphenols occur, for example, in floral dyes (anthocyanidins, flavones), in tannins (catechins, tannins), as lichen or fern ingredients (usnic acid, acylpolyphenols), in lignins and as gallic acid derivatives.

Preferred polyphenols are flavones, catechins, usnic acid, and as tannins the derivatives of gallic acid, digallic acid and digalloylgallic acid. Particularly preferred polyphenols are the monomeric catechins, ie the derivatives of flavan-3-ols, and leucoanthocyanidins, ie the derivatives of leucoanthocyanidins which preferably carry phenolic hydroxyl groups in the 5,7,3 ', 4', 5 'position, prefers Epicatechin and epigallocatechin, as well as the resulting from self-condensation tannins. Such tannins are preferably not used in isolated pure substance, but as extracts of tanning-rich plant parts, eg. Extracts of catechu, quebracho, oak bark and pine bark, as well as other tree bark, leaves of green tea (camellia sinensis) and mate. Also particularly preferred are the tannins.

A particularly preferred polyphenol-rich cosmetic active ingredient is the commercial product Sepivinol R, an extract of red wine, available from Seppic. Another particularly preferred polyphenol-rich cosmetic active ingredient is the commercial product Crodarom Chardonnay L, an extract from the cores of the Chardonnay grape, available from Croda.

According to the invention, the polyphenols are preferred in amounts of 0.001 to 10% by weight, more preferably 0.005 to 5% by weight and very preferably 0.01 to 3% by weight, based in each case on the weight of the commercial product, of at least one polyphenol contains, used in the entire composition of the invention.

mit n = 6, 7, 8, 9 oder 10. In a further preferred embodiment, the compositions according to the invention comprise at least one ubiquinone or a ubiquinol or derivatives thereof. Ubiquinols are the reduced form of ubiquinones. The preferred ubiquinones according to the invention have the formula (UBI-I):

with n = 6, 7, 8, 9 or 10.

Particularly preferred is the ubiquinone of formula (II) with n = 10, also known as coenzyme Q10. Particularly preferred compositions according to the invention are characterized in that they contain at least one ubiquinone, ubiquinol or a derivative thereof in a total amount of from 0.0001 to 1% by weight, preferably from 0.001 to 0.5% by weight and more preferably from 0.005 to 0, 1 wt .-%, each based on the total composition included.

In a further preferred embodiment, the compositions according to the invention contain silymarin. According to the invention, silymarin is an active substance concentrate from the fruits of the milk thistle (Silybum marianum) which was previously regarded as a uniform substance. The main constituents of silymarin are silybin (silymarin I), silychristin (silymarin II) and silydianin, which belong to the group of flavanolignans.

Compositions which are particularly preferred according to the invention are characterized in that they contain silymarin in amounts of 0.00001 to 1% by weight, preferably 0.0001 to 0.01% by weight and more preferably 0.005 to 0.1% by weight, in each case based on the total composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one naturally occurring xanthine derivative selected from caffeine, theophylline, theobromine and aminophylline. According to the invention, the naturally occurring xanthine derivatives are preferred in amounts of from 0.0001 to 1% by weight, more preferably from 0.001 to 0.5% by weight and most preferably from 0.005 to 0.1% by weight, based in each case on entire composition, included.

In a further preferred embodiment, the compositions according to the invention contain ectoine. Ectoin is the common name for 2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylate. According to the invention, ectoine is preferably present in amounts of 0.0001 to 1% by weight, more preferably 0.001 to 0.5% by weight and most preferably 0.005 to 0.01% by weight, based in each case on the total composition.

In a further preferred embodiment, the compositions according to the invention contain creatine. Creatine is the common name for N-methyl-guanidino-acetic acid or N-amidinosarcosine. According to the invention, creatine is preferred in amounts of 0.0001 to 1% by weight, more preferably 0.001 to 0.5% by weight and most preferably 0.01 to 0.1% by weight, based in each case on the total composition, contain.

In a further preferred embodiment, the compositions according to the invention contain at least one olive leaf extract (Olea Europaea (Olive) Leaf Extract). An inventively particularly preferred olive leaf extract is available under the trade name Oleanoline DPG from the company Vincience. Another invention particularly preferred olive leaf extract is under the trade name Olea europ Fol extr. S. sicc. available from Fruitarom.

Particularly preferred compositions according to the invention are characterized in that they contain at least one olive leaf extract in a total amount of from 0.01 to 5% by weight, preferably from 0.1 to 3% by weight and more preferably from 0.5 to 1 to 2% by weight. %, in each case based on the extract as a commercial product tel quel in the entire composition according to the invention. Olive leaf extracts may have a high content of oleanolic acid and / or oleanol. In a further preferred embodiment, the compositions according to the invention contain oleanolic acid, oleanol and / or oleuropein. Particularly preferred compositions according to the invention are characterized in that they contain oleanolic acid, oleanol and / or oleuropein in a total amount of 0.00001 to 2% by weight, preferably 0.001 to 1% by weight and more preferably 0.05 to 0.1% by weight .-%, in each case based on the total composition of the invention.

In a further preferred embodiment, the compositions according to the invention contain ursolic acid. Particularly preferred compositions according to the invention are characterized in that they comprise ursolic acid in a total amount of 0.00001 to 2% by weight, preferably 0.001 to 1% by weight and particularly preferably 0.05 to 0.1% by weight, in each case to the entire composition of the invention.

In a further preferred embodiment, the compositions according to the invention contain at least one active substance which is selected from the mono- and polyhydroxystilbenes and their esters. According to the invention, polyhydroxystilbenes are understood to mean stilbenes which are substituted by 2, 3, 4, 5, 6, 7, 8, 9 or 10 hydroxyl groups on the two phenyl radicals, it being possible for these to be esterified. Mono- and polyhydroxystilbenes and their esters increase and / or enhance the interaction between the extracellular matrix and the fibroblasts. Particularly preferred hydroxystilbenes and their esters according to the invention are selected from resveratrol (trans-stilbene-3,4'-5-triol), the resveratrol mono-, di- and triphosphoric acid esters and their salts. An inventively particularly preferred Resveratrolphosphorsäureester is trisodium resveratrol triphosphates, z. Available from Ajinomoto.

Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one active agent selected from the mono- and polyhydroxystilbenes and their esters, in a total amount of 0.000001-5% by weight, preferably 0.00001-1 Wt .-%, particularly preferably 0.0001-0.1 wt .-% and most preferably 0.005-0.05 wt .-%, in each case based on the content of active substance in the total composition.

• – sodium mannuronate methylsilanol (Algisium, Exsymol)
• – methylsilanol mannuronate (Algisium C^®, Exsymol)
• – methylsilanol mannuronate Nylon-12 (Algisium C powder^®, Exsymol)
• – ascorbylmethylsilanol (Ascorbosilane concentrate C^®, Exsymol)
• – ascorbylmethylsilanol pectinate (Ascorbosilane C^®, Exsymol)
• – dimethyl oxobenzodioxsilane (DSBC^®, Exsymol)
• – dimethyl oxobenzodioxasilane Nylon-12 (DSBC powder^®, Exsymol)
• – sodium hyaluronate dimethylsilanol (DSH^®, Exsymol)
• – dimethylsilanol hyaluronate (DSHC^®, Exsymol)
• – methysilanol glycyrrhizinate (Glysinol^®, Exsymol)
• – methylsilanolhydroxyproline (Hydroxyprolisilane^®, Exsymol)
• – methylsilanolhydroxyproline aspartate (Hydroxyprolisilane C^®, Exsymol)
• – sodium lactate methylsilanol (Lasilium^®, Exsymol)
• – lactoylmethylsilanol elastinate (Lasilium C^®, Exsymol)
• – dioleyl tocopheryl methylsilanol (Liposiliol C^®, Exsymol)
• – methylsilanol acetylmethionate (Methiosilane^®, Exsymol)
• – acetylmethionylmethylsifanol elastinate (Methiosilane C^®, Exsymol)
• – methylsilanol PEG 7 glyceryl cocoate (Monosiliol^®, Exsymol)
• – methylsilanol tri PEG 7 glyceryl cocoate (Monosiliol C^®, Exsymol)
• – methylsilanol elastinate (Proteosilane C^®, Exsymol)
• – pyrollidone carboxylate caustic methylsilanol (Silhydrate^®, Exsymol)
• – pyrollidone carboxylate copper methylsilanol (Silhydrate C^®, Exsymol)
• – methylsilanolcarboxymethyl theophylline (Theophyllisilane^®, Exsymol)
• – methylsilancarboxymethyl theophylline alginate (Theophyllisilane C^® Exsymol)
• – methylsilanol acetyltyrosine (Tyrosilane^®, Exsymol)
• – copper acetyl tyrosinate methylsilanol (Tyrosilane C^®, Exsymol).

In a further preferred embodiment, the compositions according to the invention contain at least one derivative of methylated silanol, preferably at least one ester of methylated silanol. Preferred derivatives of methylated silanol are selected from:

• - sodium mannuronate methylsilanol (algisium, exsymol)
• - Mannuronate methylsilanol (Algisium C ^®, Exsymol)
• - Methylsilanol Mannuronate Nylon-12 (Algisium C powder ^®, Exsymol)
• - ascorbylmethylsilanol (Ascorbosilane concentrate C ^®, Exsymol)
• - ascorbylmethylsilanol pectinate (Ascorbosilane C ^®, Exsymol)
• - dimethyl oxobenzodioxsilane (DSBC ^®, Exsymol)
• - dimethyl oxobenzodioxasilane Nylon-12 (DSBC ^® powder, Exsymol)
• - sodium hyaluronate dimethylsilanol (DSH ^®, Exsymol)
• - dimethylsilanol hyaluronate (DSHC ^®, Exsymol)
• - Methysilanol glycyrrhizinate (Glysinol ^® , exsymol)
• - methylsilanolhydroxyproline (Hydroxyprolisilane ^®, Exsymol)
• - methylsilanolhydroxyproline aspartate (Hydroxyprolisilane C ^®, Exsymol)
• - sodium lactate methylsilanol (Lasilium ^® , exsymol)
• - lactoylmethylsilanol elastinate (Lasilium C ^®, Exsymol)
• - dioleyl tocopheryl methylsilanol (Liposiliol C ^®, Exsymol)
• - Methylsilanol acetylmethionate (Methiosilane ^®, Exsymol)
• - acetylmethionylmethylsifanol elastinate (Methiosilane C ^®, Exsymol)
• - methylsilanol PEG 7 glyceryl cocoate (Monosiliol ^®, Exsymol)
• - methylsilanol tri PEG 7 glyceryl cocoate (Monosiliol C ^®, Exsymol)
• - Methylsilanol elastinate (Proteosilane C ^®, Exsymol)
• - pyrollidone carboxylate caustic methylsilanol (Silhydrate ^® , exsymol)
• - pyrollidone carboxylate copper methylsilanol (Silhydrate C ^®, Exsymol)
• - methylsilanolcarboxymethyl theophylline (Theophyllisilane ^®, Exsymol)
• - methylsilancarboxymethyl theophylline alginate (Theophyllisilane ^® C Exsymol)
• - Methylsilanol acetyltyrosine (Tyrosilane ^®, Exsymol)
• - copper acetyl tyrosinate methylsilanol (Tyrosilane C ^®, Exsymol).

Particularly preferred are sodium hyaluronates dimethylsilanol, dimethylsilanol hyaluronates, methylsilanol mannuronates, methylsilanol hydroxyproline and methylsilanol hydroxyproline aspartates. In a further preferred embodiment, the compositions according to the invention contain at least one derivative of methylated silanol in total amounts of 0.001-5% by weight, preferably 0.005-1% by weight and particularly preferably 0.01-0.5% by weight, in each case based on the active substance in the entire composition according to the invention. In a further preferred embodiment, the compositions according to the invention contain phytic acid. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain phytic acid in a total amount of 0.001-1% by weight, preferably 0.01-0.5% by weight and more preferably 0.05-0.1% by weight. -%, in each case based on the total composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one extract of maize kernels (Zea may (kernel extract)). An extract of corn kernels which is particularly preferred according to the invention is obtainable under the trade name Deliner from Coletica. This extract increases and / or improves the interaction between the extracellular matrix and the fibroblasts.

Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one active ingredient selected from extracts of maize kernels (Zea mays (Corn) Kernel Extract) in a total amount of 0.01-5% by weight, preferably 0 , 1-3 wt .-%, more preferably 1-2 wt .-%, each based on the content of extract tel quel in the entire composition. Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one active ingredient selected from corn kernel extracts (Zea mays (Corn) Kernel Extract) in a total amount of 0.00001-1% by weight, preferably 0 , 0001-0.1 wt .-%, particularly preferably 0.001-0.05 wt .-%, each based on the content of active substance in the total composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one extract of oat grains (Avena sativa (Oat) Kernel Extract). A particularly preferred extract of oat grains according to the invention is available under the trade name Drago Beta Glucan (02/060800) from Symrise. This extract increases and / or improves the interaction between the extracellular matrix and the fibroblasts.

Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one active ingredient selected from extracts of oat grains (Avena Sativa (Oat) Kernel Extract) in a total amount of 0.01-5% by weight, preferably 0 , 1-3 wt .-%, more preferably 1-2 wt .-%, each based on the content of extract tel quel in the entire composition. Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they comprise at least one active ingredient selected from extracts of oat grains (Avena sativa (Oat) Kernel Extract) in a total amount of 0.00001-1% by weight, preferably 0 , 0001-0.1 wt .-%, particularly preferably 0.001-0.05 wt .-%, each based on the content of active substance in the total composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one product which is obtained by fermentation of sweetened black tea with the two symbiotic microorganisms Saccharomyces and Acetobacter ylinum, referred to as kombucha and bears the INCI name Saccharomyces / xylinum / Black Tea Ferment. Such products increase and / or improve the interaction between the extracellular matrix and the fibroblasts. A particularly preferred product is available under the trade name Kombuchka from the company Sederma (INCI name: Saccharomyces / Xylinum / Black Tea Ferment, glycerol, hydroxyethyl cellulose).

Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one active ingredient selected from products obtained by fermentation of sweetened black tea with the two symbiotic microorganisms Saccharomyces and Xylinum and the INCI name Saccharomyces / xylinum / Black Tea Ferment carry, in a total amount of 0.01-5 wt .-%, preferably 0.1-3 wt .-%, more preferably 1-2 wt .-%, each based on the content of product tel quel in the entire composition. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one active ingredient selected from products obtained by fermentation of sweetened black tea with the two symbiotic microorganisms Saccharomyces and Acetobacter Xylinum and the INCI name Saccharomyces / Xylinum / Black Tea ferment carry, in a total amount of 0.00001-1 wt .-%, preferably 0.0001-0.1 wt .-%, particularly preferably 0.001-0.05 wt .-% contained, each based on the content of Active substance in the entire composition.

In a further preferred embodiment, the compositions according to the invention contain at least one extract of apple seed extracts (Pyrus malus (Apple) Fruit Extract). Such extracts increase and / or enhance the interaction between the extracellular matrix and the fibroblasts. Particularly preferred apple seed extracts according to the invention are available under the trade name Ederline from Seporga. The product Ederline contains phytohormones, isoflavonoids, phytosterols, triterpenoids, tocopherols and natural waxes. Ederline is once in water-soluble form as Ederline-H (INCI: PEG-40 Hydrogenated Castor Oil, PPG-2-Ceteareth-9, Pyrus Malus (Apple) Fruit Extract), on the other in fat-soluble form as Ederline-L (INCI: Hexyldecanol , Pyrus Malus (Apple) Fruit Extract).

Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain the raw material Ederline in amounts of 0.1-10% by weight, preferably 1-8% by weight and particularly preferably 3-5% by weight, in each case on the entire composition, included. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one apple seed extract in quantities of 0.00001-2% by weight, preferably 0.001-1.6% by weight and more preferably 0.03-1% by weight. %, in each case based on the content of active substance in the total composition.

In a further preferred embodiment, the compositions according to the invention contain at least one extract of lotus nuclei (Nelumbo nucifera germ extract). Such extracts increase and / or enhance the interaction between the extracellular matrix and the fibroblasts. A particularly preferred lotus germ extract according to the invention is available under the trade name Lotus Germ Extract with the INCI name Water, Butylene Glycol, Nelumbo Nucifera Germ Extract from Maruzen.

Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one extract of lotus nuclei (Nelumbo nucifera germ extract) in amounts of 0.1-10% by weight, preferably 1-8% by weight and more preferably 2-5% by weight. 3 wt .-%, each based on the total composition included. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one extract of lotus nuclei in amounts of 0.00001-1% by weight, preferably 0.0001-0.1% by weight and particularly preferably 0.001-0, 05 wt .-%, each based on the content of active substance in the total composition.

In a further preferred embodiment, the compositions according to the invention contain at least one extract of red wine. Such extracts increase and / or enhance the interaction between the extracellular matrix and the fibroblasts. A particularly preferred red wine extract according to the invention is available under the trade name Sepivinol R from Seppic.

Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one extract of red wine in quantities of 0.1-10% by weight, preferably 1-8% by weight and particularly preferably 2-3% by weight. in each case based on the total composition. Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one extract of red wine in quantities of 0.00001-1 wt .-%, preferably 0.0001-0.1 wt .-% and particularly preferably 0.001-0.05 wt .-%, each based on the content of active substance in the total composition.

In a further preferred embodiment, the compositions according to the invention comprise at least one extract of grape seeds (Vitis vinifera (Grape) seed extract). Such extracts increase and / or enhance the interaction between the extracellular matrix and the fibroblasts. The grape seed extracts are particularly preferably derived from the Chardonnay grape. Particularly preferred grape seed extracts according to the invention are available under the trade name Herbalia Grape from Cognis or under the trade name Crodarom Chardonnay from Croda.

Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one extract of grape seeds in quantities of 0.1-10% by weight, preferably 1-8% by weight and particularly preferably 2-3% by weight. in each case based on the total composition. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one extract of grape seeds in quantities of 0.00001-1% by weight, preferably 0.0001-0.1% by weight and particularly preferably 0.001-0, 05 wt .-%, each based on the content of active substance in the total composition.

In a further preferred embodiment, the compositions according to the invention contain at least one extract of black elder flowers (Sambucus Nigra Flower Extract). Such extracts increase and / or enhance the interaction between the extracellular matrix and the fibroblasts. An invention particularly preferred extract of black elderflower is available under the trade name Sambucus AO from the company Alpaflor / Centerchem or Permcos.

Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one extract of black elderflower in amounts of 0.1-10% by weight, preferably 1-5% by weight and particularly preferably 2-3% by weight. , in each case based on the total composition. Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one extract of black elder flower in amounts of 0.00001-1% by weight, preferably 0.0001-0.1% by weight and more preferably 0.001-0 , 05 wt .-%, each based on the content of active substance in the total composition included.

In a further preferred embodiment, the compositions according to the invention comprise at least one active ingredient which stimulates beta-endorphin synthesis in keratinocytes. Particularly preferred according to the invention stimulators of beta-endorphin synthesis are selected from mixtures of at least one extract of the leaves of Mentha piperita and at least one extract of cocoa beans, wherein aqueous, glycolic or aqueous-glycolic preparations of these extract mixtures under the trade names Caomint, Caophenol , Caobromine, Caospice and Caoorange available from the company Solabia, are particularly preferred. Another particularly preferred stimulator of beta-endorphin synthesis is the dipeptide derivative N-acetyl-Tyr-Arg-hexyldecylester with the INCI name acetyl dipeptide-1 cetyl ester, z. B. as an aqueous preparation under the trade name Calmosensine from the company Sederma is available.

Further preferred stimulators of beta-endorphin synthesis are extracts of Helichrysum italicum, e.g. B. available under the trade name Areaumat Perpetua from Codif, extracts from Crithmum Maritimum, z. B. available under the trade names Areaumat Samphira and Aroleat Samphira by Codif, extracts of Lavendula stoechas, z. B. available under the trade name Areaumat Lavanda by the company Codif, extracts of Mentha piperita, as z. Available under the trade names Authenticals of Peppermint (Solabia) and Calmiskin (Silab), glutamylamidoethyl indoles, e.g. B. available under the trade name Glistin exsymol, obtained by microbial fermentation branched polysaccharide with rhamnose, galactose and glucuronic acid units with the INCI name Biosaccharides Gum-2, z. B. available under the trade name Rhamnosoft from the company Solabia, extracts from the seeds of Tephrosia Purpurea with the INCI name Tephrosia Purpurea Seed Extract, z. B. available under the trade name Tephroline from Vincience, mixtures of the oil of Mentha arvensis leaves, lime skin oil, cypress oil, lavender oil and Cistus Ladaniferus oil with the INCI name Mentha Arvensis Leaf Oil and Citrus Medica Limonum (Lemon) Peel Oil and Cupressus Sempervirens Oil and Lavandula Hybrida Oil and Cistus Ladaniferus Oil, eg. B. available under the trade name V-Tonic (Gattefossé), and hexasaccharides according to FR 2842201 as well as any mixtures of these active ingredients.

Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one active substance for stimulating beta-endorphin synthesis in total amounts of 0.01-10% by weight, preferably 0.1-5% by weight, and particularly preferably 1-3 wt .-%, each based on the commercial product containing the active ingredient, in the entire composition of the invention included. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one active ingredient for stimulating beta-endorphin synthesis in total amounts of 0.00001-1% by weight, preferably 0.0001-0.1% by weight and particularly preferably 0.001-0.05% by weight, based in each case on the content of active substance in the total composition according to the invention.

In a further preferred embodiment, the compositions according to the invention contain at least one further skin-lightening active ingredient to assist the skin-lightening action of the photocatalytically active metal oxide used according to the invention, in particular titanium dioxide. Skin-lightening active ingredients preferred according to the invention are selected individually or in mixtures from hydroquinone, kojic acid, arbutin, extracts from licorice root (Glycyrrhiza glabra), extracts from different parts of the mulberry tree (Morus spp., In particular from Morus alba and in particular extracts from the bark, the strain , leaves and fruits), extracts of Scutellaria spp. (Skullcap), in particular from Scutellaria baicalensis (Baikal helmetwort) and here in particular extracts from the root, extracts from Waltheria indica ("Sleepy Morning") and in particular extracts from the leaves, extracts of bearberry (Arctostaphylos uva-ursi (L. ), Ericaceae) and in particular extracts from the leaves, extracts of cranberry (leaves and flowers), extracts of blueberry (fruits), extracts of leaf buds of pear trees, aniseed oil, extracts of blackberry leaves, furthermore extracts of Pyrola rotundifolia (round-leaved wintergreen), Cucumber and / or lime, furthermore ascorbic acid, coumaric acid ((Z) -2-hydroxycinnamic acid) and cis-9-octadecenedioic acid (other nomenclature: cis-8-hexadecene dicarboxylic acid), the latter being commercially available, for example. B. under the name Arlatone DIOIC DCA from Uniqema, and the esters and / or salts of these acids. Particularly preferred cosmetic or dermatological compositions according to the invention are characterized in that they contain at least one further skin-lightening active ingredient in total amounts of 0.00001 to 10% by weight, preferably 0.01 to 5% by weight and particularly preferably 0.1 to 1. 2 wt .-%, each based on the active ingredient in the total composition according to the invention.

In a further preferred embodiment, the compositions according to the invention contain at least one sebum-regulating active ingredient. Sebum-regulating active substances preferred according to the invention are selected from 10-hydroxydecanoic acid, sebacic acid, azelaic acid and the esters of azelaic acid, in particular potassium azeloyl diglycinate, 1,10-decanediol and at least one extract of Spiraea ulmaria, glycyrrhizin, which is also referred to as glycyrrhizic acid or glycyrrhetinic acid glycoside and the beta-glucuronido-alpha-glucuronide of glycyrrhetinic acid, and their salts, tannic acid and its salts, gallotannins, naringin, mixtures of glycyrrhizin (salts), tannic acid (salts) and / or gallotannins and naringin, as for example as a commercial product BiSCos Glynarin PF (INCI: Aqua (Water), Alacohol, Ohenoxyethanol, Ammonium Glycyrrhizate, Tannic Acid, Naringine) from the company Biesterfeld are available, further from water and oil-soluble extracts of witch hazel, burdock root and stinging nettle, Zimtbaumextract (z. (B. Sepicontrol A5 ^® by the company SEPPIC), chrysanthemum extract eg Laricyl ^®, ex Laboratoires Serobiologiques), Hefeproteinhydrolysaten as they are available, for example in the commercial products the Asebiol® series ex Laboratoires Serobiologiques, particularly Asebiol ^® LS 2539 BT 2 (INCI:. Aqua, Hydrolyzed Yeast Protein, Pyridoxine, Niacinamide, glycerine, panthenol, allantoin, biotin) and Asebiol ^® LS 2539 BT (Aqua, Hydrolyzed Yeast protein, Pyridoxine, Niacinamide, glycerin, panthenol, propylene glycol, allantoin, Disodium azelates, biotin), and PEG-8 Isolauryl thioether as such. B. in the commercial product "Antifettfaktor ^® COS-218/2-A" of Cosmetochem is included (INCI: Aqua, cetyl-PCA, PEG-8 Isolauryl thioether, PCA, cetyl alcohol), and mixtures of the aforementioned substances. Preferred blends are available, for example, as the commercial product Acnacidol PG (propylene glycol, 10-hydroxydecanoic acid, sebacic acid, 1,10-decanediol) from Vincience. A preferred extract of Spiraea ulmaria is z. B. contained in the product Seboregul 2 Silab. Kaliumazeloyldiglycinat is z. B. contained in the product Azeloglicina Sinerga. Cosmetic or dermatological compositions which are particularly preferred according to the invention are characterized in that they contain at least one sebum-regulating active ingredient in total amounts of 0.00001 to 10% by weight, preferably 0.01 to 5% by weight and more preferably 0.1 to 1-2 Wt .-%, each based on the active ingredient in the total composition according to the invention.

In a further preferred embodiment, the compositions according to the invention furthermore contain at least one particulate, sebum-sorbing active ingredient, in particular talc, starch and other particles.

Cosmetic or dermatological compositions preferred according to the invention are characterized in that the particulate, sebum-sorbing active ingredient is selected from inorganic and organic cosmetic adsorbents having average particle diameters of 0.1-100 .mu.m, preferably 0.5-50 .mu.m, particularly preferably 5-30 .mu.m and extremely preferably 10-25 μm. Particularly preferred inorganic adsorbents are selected from silicas, particularly Aerosil ^® grades, silica gels, silica, clays and layered silicates, in particular bentonite or kaolin, magnesium aluminum silicates, in particular talc, and boron nitride, and mixtures of said substances. Particularly preferred organic adsorbents are selected from starches and starch derivatives, which may be chemically and / or physically modified, in particular modified starch derivatives of type DRY FLO ^® of National Starch and Chemical Company, cellulose powders, lactoglobulin, particularly sodium C _8-16 -Isoalkylsuccinyllactoglobulinsulfonat, z. B. available as a commercial product Biopol ^® OE Brooks Industries, polymer powders of polyolefins, polycarbonates, polyurethanes, polyamides, polyesters, polystyrenes, polyacrylates, polymethacrylates, polymethyl methacrylates, (meth) acrylate or (meth) acrylate-vinylidene copolymers, Teflon or silicones , Wherein said polymer powders may be crosslinked in a particularly preferred embodiment of the invention, and mixtures of said substances.

Polymer powder based on a polymethacrylate copolymer are z. B. as a commercial product Polytrap ^® 6603 (Dow Corning) available. Other polymer powders, e.g. Example based on polyamides, obtainable under the name Orgasol ^® 1002 (polyamide-6) and Orgasol ^® 2002 (polyamide-12) from Elf Atochem. Further according to the invention particularly preferred polymer powders are crosslinked polymethacrylates (Micro Pearl ^® M from SEPPIC or Plastic Powder A of NIKKOL), cross-linked polymethyl (Micro Pearl ^® 305 and Micro Pearl ^® M 310 from SEPPIC), styrene-divinylbenzene copolymers (e.g., B. Plastic Powder FP (of NIKKOL), polyethylene and polypropylene powder z. B. ACCUREL EP ^® 400 from AKZO), or silicone polymers (eg. B. silicone powder X2-1605 from Dow Corning).

In a further preferred embodiment of the invention, the particulate, sebumsorbierende drug on cavities. In a further preferred embodiment of the invention, the particulate, sebumsorbierende agent has hemispherical particles, more preferably at least 50 wt .-% of the particles are hemispherical. In a further preferred embodiment of the invention, the particulate, sebumsorbierende agent has hemispherical particles with cavities, more preferably at least 50 wt .-% of the particles are hemispherical with cavities.

Particularly preferred particulate, sebumsorbierende agents are crosslinked polymethyl methacrylates with average particle diameters of 5-50 microns, in particular the commercial products Micropearl ^® 305 and Micropearl ^® M 310 from SEPPIC. Extremely preferred particulate, sebumsorbierende agents are crosslinked polymethyl methacrylates with average particle diameters of 5-50 microns, which include hemispherical particles with cavities, more preferably at least 50 wt .-% of the particles are hemispherical with cavities, such as the commercial product Micropearl ^® M 310 of SEPPIC.

Particularly preferred compositions according to the invention are characterized in that they contain at least one particulate sebum-sorbing agent in a total amount of from 0.5 to 10% by weight, preferably from 1 to 5% by weight and more preferably from 1.5 to 3% by weight, in each case based on the total composition.

In a further preferred embodiment, the compositions according to the invention also contain at least one astringent active ingredient which leads to a temporary narrowing of the skin pores, for example tannins or tanning agents or polyphenols in general, furthermore aluminum salts, such as are also used as antiperspirant active ingredients. These agents regulate the amount of sebum on the skin surface by delaying sebum leakage.

In a further preferred embodiment, the compositions according to the invention also contain at least one sebum-regulating active substance which inhibits the enzyme 5-alpha-reductase which is involved in the activity of the sebaceous glands. Preferred inhibitors of 5-alpha-reductase are selected from finasteride ^®, 4-androstene-3-one-17β-carboxylic acid, (4R) -5,10-seco-19-norpregna-4,5-diene-3,10, 20-trian, (5-alpha, 20-R) -4-diazo-21-hydroxy-20-methylpregnan-3-one, 4-azasteroid, especially 17β-N, N-diethylcarbamoyl-4-methyl-4-aza 5-alpha-androstan-3-one, 17-alpha-acetoxy-6-methylene pregn-4-ene-3,20-dione, 3-carboxyandrosta-3,5-diene steroid derivatives and 3-carboxy A ring-aryl steroids, 3-androstene-3-carboxylic acids, 3-carboxy-17β-substituted steroids, 17β- (Nt-butylcarboxamide) -5-α-androst-1-en-4-aza-3-one, 17β- (Nt-butylcarboxamide) -androst-3,5-diene-3-carboxylic acid, 17β- (N, N-diisopropylcarboxamide) -androst-3,5-diene-3-carboxylic acid, 17β- (N, N-diisopropylcarboxamide ) -estra-1,3,5 (10) -triene-3-carboxylic acid, 17β- (N-) t-butylcarboxamide) -estra-1,3,5 (10) -triene-3-carboxylic acid, 17β- (N, N-diisopropylcarboxamide) -estra-1,3,5 (10) -triene-3-sulfonic acid, 17β - (Nt-butylcarboxamide) -estra-1,3,5 (10) -triene-3-sulfonic acid, 17β- (N, N-diisopropylcarboxamide) -estra-1,3,5 (10) -triene-3-phosphonic acid , 17β- (Nt-butylcarboxamide) -estra-1,3,5 (10) -triene-3-phosphonic acid, 17β- (N, N-diisopropylcarboxamide) -estra-1,3,5 (10) -triene-3 -phosphinic acid, 17β- (Nt-butylcarboxamide) -estra-1,3,5 (10) -triene-3-phosphinic acid, 17β- (Nt-butylcarboxamide) -androst-3,5-diene-3-phosphinic acid, 17β- (N, N-diisopropylcarboxamide) -androst-3,5-diene-3-phosphinic acid, 17β- (Nt-butylcarboxamide) -androst-3,5-diene-3-phosphonic acid, (Z) -17β- (N, N -diisopropylcarboxamide) -androst-4-en-3-ylidene-acetic acid, 17β- (N, N-diisopropylcarboxamide) -5α-androst-2-ene-3-acetic acid, (Z) -17β- (N, N-diisopropylcarboxamide ) -5α-androst-3-ylidene-acetic acid, 17β- (N, N-diisopropylcarboxamide) -5α-androst-3-ene-3-acetic acid and 17β- (Nt-butylcarboxamide) -5α-androst-2-ene 3-acetic acid and d en physiologically acceptable salts of the aforementioned acids.

Particularly preferred compositions according to the invention are characterized in that they contain at least one inhibitor of 5-alpha reductase in a total amount of from 0.0001 to 1% by weight, preferably from 0.001 to 0.5% by weight and more preferably from 0.01 to 0.1 wt .-%, each based on the total composition included.

In a further preferred embodiment, the compositions according to the invention comprise at least one deoxy sugar or a polysaccharide containing at least one deoxy sugar building block.

Preferred deoxysugars according to the invention are selected from rhamnose and fucose. An inventively particularly preferred, deoxy devices containing polysaccharide is the commercial product fucogel ^® from Solabia with the INCI name Biosaccharide Gum -1. Another inventively particularly preferred, deoxy devices containing polysaccharide is the commercial product Rhamnosoft ^® from Solabia with the INCI name Biosaccharide Gum-2. An inventively particularly preferred, deoxy devices containing polysaccharide is the commercial product Fucogenol ^® from Solabia with the INCI name Biosaccharide Gum-third An inventively particularly preferred, deoxy devices containing polysaccharide is the commercial product Glycofilm ^® from Solabia with the INCI name Biosaccharide Gum-fourth According to the invention furthermore given to mixtures of the above, containing at least one deoxy-block polysaccharides, for example the mixture of Biosaccharide Gum-2 and Biosaccharide Gum-3, available as a commercial product Elastinol plus ^® from Solabia are.

Cosmetic compositions which are particularly preferred according to the invention are characterized in that they contain at least one polysaccharide containing deoxy sugar and / or at least one deoxy sugar building block in total amounts of from 0.001 to 5% by weight, preferably from 0.01 to 2% by weight and more preferably 0.1 to 1 wt .-%, each based on the total composition of the invention.

Advantageously, the skin treatment compositions according to the invention are in the form of a liquid, flowable or solid oil-in-water emulsion, water-in-oil emulsion, multiple emulsion, in particular an oil-in-water-in-oil or water-in Oil-in-water emulsion, macroemulsion, miniemulsion, microemulsion, PIT emulsion, nanoemulsion, Pickering emulsion, hydrodispersion, hydrogel, lipogel, a mono- or multiphase solution, a foam, a powder, or a mixture with at least one polymer suitable as a medical adhesive. The agents may also be presented in anhydrous form, such as an oil or a balm. Here, the carrier may be a vegetable or animal oil, a mineral oil, a synthetic oil or a mixture of such oils.

In a particular embodiment of the agents according to the invention, the agents are present as microemulsions. In the context of the invention, microemulsions are understood as meaning not only the thermodynamically stable microemulsions but also the so-called "PIT" emulsions. These emulsions are systems with the 3 components water, oil and emulsifier, which are present at room temperature as an oil-in-water emulsion. When these systems are heated, microemulsions are formed in a certain temperature range (referred to as the phase inversion temperature or "PIT") and, on further heating, convert to water-in-oil emulsions. Upon subsequent cooling, O / W emulsions are again formed, but they are also present at room temperature as microemulsions or as very finely divided emulsions having an average particle diameter of less than 400 nm and in particular of about 100-300 nm. According to the invention, those micro- or "PIT" emulsions may be preferred which have an average particle diameter of about 200 nm.

The inventive form of administering the composition according to the invention may take the form of sticks, aerosols, creams, gels, spray applications with and without the formation of a foam facilitating the application, as a cloth impregnated with the composition according to the invention or as plaster. The dosage form depends on the desired application, deodorant, skincare skin cleanser and more.

Another object of this invention is a process for deodorization in which a cosmetic composition according to any one of claims 1 to 7 is applied to the skin and there until their removal, for example, by washing or make-up removal or showering for at least 30 minutes to several hours remains.

Another object of this invention is a method for influencing the mood after the application of a cosmetic composition, wherein a cosmetic composition according to any one of claims 1 to 7 is applied to the skin and there to their removal, for example, by washing or make-up or showering for at least 30 minutes to several hours.

Another object of the present invention is finally the use of a cosmetic agent according to any one of claims 1 to 7 for deodorization and long-lasting protection against body odor.

Long-lasting protection against body odor is understood as protection against body odor of at least 12 h, preferably 24 h, more preferably 48 h and particularly preferably 72 h. Finally, another object of the present invention is the use of a cosmetic agent according to any one of claims 1 to 7 for the purpose of providing a soothing or harmonizing or invigorating or stimulating or attractiveness-enhancing or exonerating effect.

EXAMPLES

The following formulation examples are intended to illustrate the subject matter of the invention without limiting it thereto. The quantities are based on wt .-%. Emulsion according to the PIT method: Emulgade® ^® SE-PF 5.0 Eumulgin ^® B1 3.0 Cetiol ^® SN 5.0 Cetiol ^® CC 10.0 Phenon ^® IP ME 0.5 Matrixyl 3000 ^® Lipo 3.0 Ederline ^® LS 2.0 androstadienone 0.000008 water 57.19 Glycerin 86% 5.0 1,6-hexanediol 1.0 Hydrovance ^® 3.0 Arlasilk ^® Phospholipid PTC 0.3 1,2-propanediol 1.0 water ad 100 O / W emulsion ^® 202 Montanov® 5.0 Caprylic / capric 7.0 Cetiol ^® CC 3.0 Novata ^® AB Ph 2.0 DC EL-8040 ID ^® Silicone Organic Blend 0.9 Vitamin E acetate 0.5 Controx ^® KS 0.05 Cetiol ^® SB 45 1.5 Glycerine 99.5% 5.0 1,6-hexanediol 1.0 Betafin ^® BP 20 2.0 ^Tego® Carbomer 140 0.4 NaOH beads 0.05 Hydrovance ^® 3.0 Phenonip ^® ME 0.5 allantoin 0.05 Panthenol 75% 0.75 bisabolol 0.05 Matrixyl ^® 3000 PEG free 3.0 Simulgel ^® EPG 1.0 Perfume Nice 0.35 oxytocin 0.1 androstadienone 0.000008 Arlasilk ^® Phospholipid PTC 0.3 water ad 100 O / W emulsion ^® 202 Montanov® 5.0 Caprylic / capric 7.0 Cetiol ^® CC 3.0 Novata ^® AB Ph 2.0 DC EL-8040 ID ^® Silicone Organic Blend 0.9 Vitamin E acetate 0.5 Controx ^® KS 0.05 Cetiol ^® SB 45 0.5 water 5.0 Glycerol 99.5% 1.0 1,6-hexanediol 2.0 Betafin ^® BP 20 0.4 ^Tego® Carbomer 140 0.05 NaOH beads 3.0 Hydrovance ^® 0.05 Phenonip ^® ME 2.0 allantoin 0.75 androstadienone 0.000008 Arlasilk ^® Phospholipid PTC 0.3 Ethanol 96% 0.05 Panthenol 75% 3.0 bisabolol 1.0 Matrixyl ^® 3000 PEG free 0.35 Simulgel ^® EPG 0.0001 Perfume Nice 0.0999 oxytocin 0.1 water ad 100 Serum: Keltrol ^® SF 0.2 Cosmedia ^® SP 0.4 Glycerine 99.5% 5.0 Propanediol 1,2 1.0 Lipochroman- ^6® 0.01 Phenonip ^® ME 1.0 Dow Corning 9701 Cosmetic Powder ^® 0.9 DSH CN 5.0 androstadienone 0.000008 Arlasilk ^® Phospholipid PTC 0.3 Matrixyl ^® 3000 PEG free 3.0 PhytoCell ^® Tec Malus Domestica 1.0 Cetiol ^® CC 5.0 Vitamin A palmitate 1.7mIU / g 0.1 Perfume rosewater 0.2 oxytocin 0.1 Timiron ^® Splendid Copper 0.5 water ad 100 W / O emulsion Dehymuls® ^® PGPH 1.0 Monomuls ^® 90-O-18 1.0 Zincum ^® N29 1.5 Lame form TGI ^® 2.0 Softisan ^® 649 1.0 Paraffin wax microcrystalline 0.9 Novata ^® AB 1.0 Cetiol ^® CC 1.5 Cetiol ^® SN 5.0 Caprylic / capric 4.0 Matrixyl 3000 ^® Lipo 3.0 androstadienone 0.000008 Arlasilk ^® Phospholipid PTC 0.3 Vitamin E acetate 0.5 Vitamin A palmitate 1.7mlU / g 0.03 Ethylparaben 0.05 beeswax 0.8 Glycerin 86% 5.0 magnesium sulfate 1.0 methylparaben 0.05 RonaCare ^® AP 0.4 Crossential ^® SA14 0.5 Amaranth seed oil 0.1 Cosmedia ^® Silc 2.0 NP Moist ^24® 3.0 Perfume Nice 0.3 oxytocin 0.1 water ad 100 Antiperspirant emulsions (O / W) 1 2 3 ALUMINUM CHLOROHYDRATE 13.0 13.0 13.0 POTASSIUM ALUMINUM SULFATE KAl (SO4) 2 · 12H2O 1.5 1.5 1.5 TALC 1.0 - - BENTONITES - 1.0 - hectorites - - 5.0 STEARETH-2 2.5 2.5 2.5 STEARETH-21 1.5 1.5 1.5 OXYTOCIN 0.0001 0.0005 0.001 androstadienone 0.000008 0.000008 0.000008 Arlasilk ^® Phospholipid PTC 0.3 0.3 0.3 PERFUME 0.1 1.1 1.1 PPG-15 STEARYL ETHER 0.5 0.5 0.5 BISABOLOL 0.1 0.1 0.1 ALUMINUM STARCH OCTENYLSUCCINATE 0.1 0.1 0.1 BIS-PEG-18 METHYL ETHER DIMETHYL SILANE 0.1 0.1 0.1 TOCOPHERYL ACETATE 0.1 0.1 0.1 AQUA ad 100 a d 100 ad 100

The emulsion according to Example 1 had a viscosity of 1800 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature. Suspensions for spraying as an antiperspirant spray 1.1 1.2 1.3 1.4 1.5 1.6 Perfume 5.00 5.00 5.00 5.00 5.00 5.00 OXYTOCIN 0.0001 0.0005 0.001 0.01 0.1 0.005 Aluminum chlorohydrate (activated) 30.00 35,00 35,00 35,00 28,00 32,00 KAl (SO4) 2 · 7 H2O 2.00 - - - - - KAl (SO4) 2 · 8 H2O - 2.00 - - - - KAl (SO4) 2 · 9 H2O - - 2.00 - - - KAl (SO4) 2 · 10 H2O - - - 1.50 - - KAl (SO4) 2 · 11 H2O - - - - 1.00 - KAl (SO4) 2 · 12 H2O - - - - - 1.50 isopropyl palmitate 5.00 5.00 - - - 6.00 C12-15 alkyl benzoate - - 5.00 5.00 - - Cosmacol PLG - - - - 5.00 - androstadienone 0.000008 0.000008 0.000008 0.000008 0.000008 0.000008 Arlasilk ^® Phospholipid PTC 0.3 0.3 0.3 0.3 0.3 0.3 Disteardimonium hectorite 4.50 3.90 4.00 3.80 5.00 4.50 propylene carbonate 1.50 1.30 1.30 1.30 1.70 1.50 ethylhexyl palmitate ad 100 ad 100 ad 100 ad 100 ad 100 ad 100

Cosmacol PLG (INCI: DI-C12-13 ALKYL TARTRATE, TRI-C12-13 ALKYL CITRATE, SILICA) Compositions 1.1 to 1.6 were packaged in aluminum-painted aluminum spray cans and weighted with an isobutane / butane / propane blowing agent mixture Suspension: Propellant applied at 25:75, 22:78, 20:80, 18:82, 15:85 and 13:87. Suspensions for spraying as an antiperspirant spray: 1 2 3 isopropyl 2.34 3.20 3.10 Persea Gratissima oil 0.10 0.15 0.10 Disteardimonium hectorite 4.00 3.80 3.90 Aluminum Chlorohydrate 35.0 33.0 37.0 Lactic acid / silver lactate 0.7 0.3 0.1 androstadienone 0.000008 0.000008 0.000008 Arlasilk ^® Phospholipid PTC 0.3 0.3 0.3 OXYTOCIN 0.0001 0.0005 0.001 Perfume 5.33 5.0 5.1 Sodium Starch Octenylsuccinate + Mannitol 2.67 0 1.23 Cyclomethicone ad 100 ad 100 ad 100

Compositions 1 to 3 were filled in aerosols made of internally painted aluminum and mixed with an isobutane / butane / propane blowing agent mixture in the weight ratio suspension: propellant of 25:75, 22:78, 20:80, 18:82, 15:85 and 13:87 charged. Antitranspirantsticks: 4 5 6 Hydrogenated Castor Oil 1.5 1.5 1.6 Talc 4.0 2.5 4.15 PPG-14-butyl ether 15.0 14.43 0 Caprylic / Capric Triglycerides 2 2 14.5 Aluminum Chlorohydrate 0 20.0 0 Aluminum zirconium tetrachlorohydrex GLY 16.0 0 16.0 androstadienone 0.000008 0.000008 0.000008 Arlasilk ^® Phospholipid PTC 0.3 0.3 0.3 Stearyl Alcohol 20.0 21.0 20.5 Lactic acid / silver lactate 0.3 0.35 0.3 OXYTOCIN 0.0001 0.0005 0.001 Perfume 0.8 0.8 0.6 Sodium Starch Octenylsuccinate + Mannitol 0.6 0.65 0.7 Cyclomethicone ad 100 ad 100 ad 100 Sprayable alcoholic deodorant: 99% ethanol ad 100 Triethyl citrate 6.0 1,2-hexanediol, caprylyl glycol, tropolone 0.5 androstadienone 0.000008 Arlasilk ^® Phospholipid PTC 0.3 Dipropylene glycol 0.06

QUOTES INCLUDE IN THE DESCRIPTION

This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.

Cited patent literature

• EP 562843 B1 [0004]
• US 5272134 [0005]
• US 5278141 [0005]
• WO 2004/009051 A2 [0006]
• WO 98/18441 [0069]
• DE 10333245 A [0075]
• DE 102004011968 [0075]
• WO 03/039505 A2 [0082]
• WO 01/99376 A2 [0082]
• EP 1430879 A2 [0082]
• EP 1428520 A2 [0082]
• EP 1738803 A1 [0082]
• EP 1576946 A1 [0082]
• DE 10216368 A1 [0082]
• DE 19756454 A1 [0083]
• FR 2842201 [0244]

Cited non-patent literature

• RÖMPP Chemie Lexikon, as of December 2007 [0043]
• "The Cosmetic Preparations, 4th Edition, Volume I, The Perfumery, Chemical Industry Publishing, H. Ziolkowsky KG, Augsburg, Ga Nowak, Chapter I and Chapter II [0044]
• Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd ed., 1979, Vol. 8, pages 913-916 [0084]
• Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd ed., 1979, Vol. 8, page 913 [0084]
• "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1101 17th Street, NW, Suite 300, Washington, DC 20036-4702) [0176]

Claims (10)

Cosmetic composition comprising in a suitable cosmetic carrier a) 1 × 10 ^-7 to 1 × 10 ^-2 % by weight of at least one steroid selected from - 16-androstene-steroids of the formula (I)

wherein R ^{1 is} an oxo group, a hydroxy group, a C ₁ -C ₆ alkoxy, an acyloxy, or a benzoyloxy group, R ^{2 is} hydrogen, hydroxy, C ₁ -C ₆ alkyl, hydroxyC C ₁ -C ₆ -alkyl, C ₁ -C ₆ -alkoxy-C ₁ -C ₆ -alkyl, C ₁ -C ₆ -alkoxy, acyl, acyloxy, acyl-C ₁ -C ₆ -alkyl- or acyloxy-C ₁ -C ₆ -alkyl group, and the dashed lines a and b represent alternative sites of a double bond, and - Estrensteroiden of formula (II)

wherein R ^{4 is} an oxo group, hydrogen, hydroxy, C ₁ -C ₆ alkyl, sulfate, 3-cyclopentylpropionate or acetate, R ^{5 is} hydrogen or hydroxy and R ^{6 is} hydrogen, C ₁ -C ₆ Alkyl group, a benzoyl, 3-cyclopentylpropionate, acetyl, C ₁ -C ₆ acyl or a sulfate group, and the dashed lines c is an optional double bond, and b) at least 0.01% by weight to to 7.5% by weight based on the total weight of the composition of at least one phospholipid. Composition according to claim 1, characterized in that as steroid 4,16-androstadien-3-one,

A composition according to any one of claims 1 or 2, characterized in that the phospholipid is selected from the phospholipids with the designation Linoleamidopropyl PG-Dimonium Chloride Phosphate, Cocamidopropyl PG-Dimonium Chloride Phosphate and Stearamidopropyl PG-Dimonium Chloride Phosphate. Composition according to any one of Claims 1 to 3, characterized in that the phospholipid is cocamidopropyl PG-dimonium chloride phosphates. Composition according to any one of Claims 1 to 4, characterized in that the cosmetic composition also contains at least one perfume. A composition according to claim 5, characterized in that the fragrance in a total amount of 0.001 to 40 wt.%, Preferably 0.01 to 20 wt.%, Particularly preferably 0.1 to 10 wt.%, Most preferably 0.3 to 8 % By weight, based in each case on the total weight of the composition. Composition according to one of claims 1 to 6, characterized in that the cosmetic carrier is an aqueous alcoholic carrier with 3 to 95 wt.% Of a C ₁ -C ₆ alcohol. Agent according to one of claims 1 to 7, characterized in that it is used as a deodorant, antiperspirant, Eau de Solid, Eau de Cologne, Eau de Toilette, Eau de Parfum, Extraction Perfume, Cream, Lotion, Powder, Tonic, make-up composition, shower gel, Bath additive, soap bar, liquid soap, hair tonic, shampoo, hair conditioner, hair conditioner or dentifrice is made up. A process for deodorization in which a cosmetic composition according to any one of claims 1 to 7 is applied to the skin and remains there until removal thereof, for example, by washing or make-up removal or showering for at least 30 minutes to several hours. Use of a cosmetic composition according to any one of claims 1 to 7 for deodorization and protection against long-lasting body odor.